STOCK PURCHASE AGREEMENT BY AND BETWEEN HEALTHSOUTH CORPORATION AND SELECT MEDICAL CORPORATION DATED AS OF JANUARY 27, 2007
Exhibit 2.1
BY AND BETWEEN
HEALTHSOUTH CORPORATION
AND
SELECT MEDICAL CORPORATION
DATED AS OF JANUARY 27, 2007
TABLE OF CONTENTS
Page | ||||
ARTICLE I PURCHASE AND SALE |
1 | |||
1.1 Purchase and Sale of the Shares |
1 | |||
1.2 Consideration |
2 | |||
1.3 Closing |
2 | |||
1.4 Deliveries by Seller |
2 | |||
1.5 Deliveries by Buyer |
2 | |||
1.6 Related Calculations |
3 | |||
ARTICLE II RELATED MATTERS |
6 | |||
2.1 Ancillary Agreement |
6 | |||
2.2 Intercompany Agreements; Certain Other Intercompany Matters |
6 | |||
2.3 Resignations |
7 | |||
2.4 Restructuring Transactions |
7 | |||
2.5 Guaranties |
9 | |||
2.6 Payment of Division Indebtedness |
9 | |||
ARTICLE III REPRESENTATIONS AND WARRANTIES OF SELLER |
9 | |||
3.1 Organization of Seller; Authority |
9 | |||
3.2 Title to Shares |
10 | |||
3.3 Organization and Qualification |
10 | |||
3.4 Capitalization of the Company |
10 | |||
3.5 Capitalization of the Division Entities |
11 | |||
3.6 No Violation; Consents and Approvals |
11 | |||
3.7 Financial Statements; Undisclosed Liabilities |
12 | |||
3.8 Absence of Certain Changes or Events |
13 | |||
3.9 Real Property |
14 | |||
3.10 Intellectual Property |
14 | |||
3.11 Litigation |
15 | |||
3.12 Employee Benefit Plans |
15 | |||
3.13 Taxes |
16 |
i
TABLE OF CONTENTS
(continued)
(continued)
Page | ||||
3.14 Material Contracts and Commitments |
17 | |||
3.15 Compliance with Laws; Permits |
18 | |||
3.16 Labor Matters |
19 | |||
3.17 Environmental |
19 | |||
3.18 Health Care Regulatory Matters |
20 | |||
3.19 Assets of the Division |
22 | |||
3.20 Brokers |
22 | |||
3.21 NO OTHER REPRESENTATIONS |
23 | |||
ARTICLE IV REPRESENTATIONS AND WARRANTIES OF BUYER |
23 | |||
4.1 Organization; Authority |
23 | |||
4.2 No Violation; Consents and Approvals |
23 | |||
4.3 Litigation |
24 | |||
4.4 Financing |
24 | |||
4.5 Acquisition of the Shares for Investment; Securities Act |
24 | |||
4.6 Vote/Approval Required |
24 | |||
4.7 Solvency |
24 | |||
4.8 Investigation by Buyer |
25 | |||
4.9 Brokers |
25 | |||
ARTICLE V COVENANTS OF THE PARTIES |
25 | |||
5.1 Conduct of the Division |
25 | |||
5.2 Access to Information Prior to the Closing; Confidentiality; Cooperation |
27 | |||
5.3 Commercially Reasonable Efforts |
28 | |||
5.4 Consents |
28 | |||
5.5 Antitrust Notification |
29 | |||
5.6 Public Announcements |
29 | |||
5.7 Supplemental Disclosure |
30 | |||
5.8 Certain Licenses and Permits |
30 | |||
5.9 Records; Cooperation |
30 | |||
5.10 Preparation of Financial Statements |
32 |
ii
TABLE OF CONTENTS
(continued)
(continued)
Page | ||||
5.11 Covenant Not to Compete |
33 | |||
ARTICLE VI ADDITIONAL AGREEMENTS |
35 | |||
6.1 Tax Matters |
35 | |||
6.2 Division Employees; Employee Contracts and Benefits |
43 | |||
6.3 Workers’ Compensation |
46 | |||
6.4 Use of Seller’s Name and Logo |
46 | |||
6.5 Software |
46 | |||
6.6 Enterprise Systems |
47 | |||
ARTICLE VII CONDITIONS TO OBLIGATIONS OF EACH OF SELLER AND BUYER |
47 | |||
7.1 Mutual Conditions |
47 | |||
ARTICLE VIII CONDITIONS TO OBLIGATIONS OF SELLER |
48 | |||
8.1 Conditions |
48 | |||
ARTICLE IX CONDITIONS TO OBLIGATIONS OF BUYER |
48 | |||
9.1 Conditions |
48 | |||
ARTICLE X TERMINATION, AMENDMENT AND WAIVER |
49 | |||
10.1 Termination |
50 | |||
10.2 Procedure and Effect of Termination |
51 | |||
10.3 Amendment and Modification |
51 | |||
ARTICLE XI SURVIVAL OF REPRESENTATIONS; INDEMNIFICATION |
52 | |||
11.1 Survival of Representations |
52 | |||
11.2 Seller’s Agreement to Indemnify |
52 | |||
11.3 Seller’s Limitation of Liability |
52 | |||
11.4 Buyer’s Agreement to Indemnify |
53 | |||
11.5 Buyer’s Limitation of Liability |
54 | |||
11.6 Conditions of Indemnification With Respect to Third-Party Claims |
54 | |||
11.7 Other Claims |
55 | |||
11.8 Sole Remedy |
56 |
iii
TABLE OF CONTENTS
(continued)
(continued)
Page | ||||
ARTICLE XII MISCELLANEOUS |
57 | |||
12.1 Fees and Expenses |
57 | |||
12.2 Further Assurances |
58 | |||
12.3 Notices |
58 | |||
12.4 Entire Agreement |
59 | |||
12.5 Severability |
59 | |||
12.6 Binding Effect; Assignment |
59 | |||
12.7 No Third-Party Beneficiaries |
59 | |||
12.8 Counterparts |
59 | |||
12.9 Interpretation |
59 | |||
12.10 Forum; Service of Process |
60 | |||
12.11 Governing Law |
60 | |||
12.12 Specific Performance |
60 | |||
12.13 Waivers |
60 | |||
12.14 Defined Terms |
60 |
iv
INDEX OF DEFINED TERMS
Page | ||||
2005 Pro Forma Financial Information |
13 | |||
2005 Segment Information |
13 | |||
90% Lease Condition |
61 | |||
90% Payor Contract Condition |
62 | |||
Accounting Arbiter |
5 | |||
Accounting Principles |
3 | |||
Actual Closing Cash Balance |
3 | |||
Actual Net Working Capital |
4 | |||
Adjusted Grossed Up Basis |
37 | |||
Affiliate |
62 | |||
Affiliated Group |
17 | |||
Aggregate Deemed Sales Price |
37 | |||
Agreement |
1 | |||
Allocation |
43 | |||
Allocation Dispute Notice |
43 | |||
Ancillary Agreements |
8 | |||
Anti-Kickback Law |
20 | |||
Applicable Buyer Plan |
45 | |||
Audited Financial Statements |
13 | |||
Basket |
54 | |||
Benefit Plans |
63 | |||
Business |
1 | |||
Business Day |
63 | |||
Buyer |
1 | |||
Buyer Claims |
53 | |||
Buyer Indemnified Parties |
53 | |||
Buyer Representatives |
28 | |||
Capitalized Lease Indebtedness |
63 | |||
Cash |
63 | |||
Cash Adjustment Amount |
4 | |||
Cash Due to Minority Interest Holders |
63 | |||
CIA |
21 | |||
Closing |
1 | |||
Closing Cash Balance |
3 | |||
Closing Date |
2 | |||
Code |
64 | |||
Company |
1 | |||
Conclusive Statement |
5 | |||
Confidentiality Agreement |
29 | |||
Consent |
12 | |||
Consented Leases |
64 | |||
Consented Third Party Payor Contracts |
64 | |||
Consolidated Income Tax Return |
41 | |||
Contract |
65 | |||
Courts |
61 | |||
Damages |
53 | |||
Deficiency Amount |
4 | |||
Disclosure Letter |
6 | |||
Disregarded Entities |
38 | |||
Distributions |
65 | |||
Division |
1 | |||
Division Entities |
1 | |||
Division Offerees |
44 | |||
DOJ |
29 | |||
DRE Sales |
38 | |||
Earn-Out Indebtedness |
65 | |||
EBITDA |
65 | |||
Effective Time |
2 | |||
Election |
36 | |||
Enterprise Systems |
48 | |||
Environmental Law |
66 | |||
ERISA |
66 | |||
ERISA Affiliate |
66 | |||
Estimated Closing Cash Balance |
3 | |||
Estimated Net Working Capital |
3 | |||
Estimated Net Working Capital Adjustment |
2 | |||
Excess Amount |
4 | |||
Excess Restructuring Costs |
8 | |||
Exchange Act |
12 | |||
Excluded Assets |
7 | |||
Excluded Representations |
53 | |||
Facilities |
66 | |||
Federal Health Care Programs |
20 | |||
Filing |
12 | |||
Final Allocation |
44 | |||
Form 8023 |
36 | |||
FTC |
29 | |||
GAAP |
67 | |||
Going Clinics |
7 | |||
Good Faith Statement |
3 | |||
Governmental Entity |
12 |
v
Page | ||||
Guaranties |
9 | |||
Hazardous Substances |
67 | |||
Health Care Related Liabilities |
67 | |||
HIPAA |
20 | |||
HSR Act |
12 | |||
Indebtedness |
67 | |||
Independent Accounting Firm |
37 | |||
Initial Purchase Price |
2 | |||
Intellectual Property Rights |
15 | |||
Intercompany Agreements |
6 | |||
Interest Rate |
68 | |||
Interim Pro Forma Income Statements |
13 | |||
Interim Segment Information |
14 | |||
IT Systems |
15 | |||
Knowledge of Seller |
68 | |||
Law |
68 | |||
Leased Real Property |
14 | |||
Liens |
2 | |||
Litigation |
15 | |||
Material Adverse Effect |
69 | |||
Material Contracts |
18 | |||
Minority Interest Holders |
69 | |||
Net Working Capital |
3 | |||
Net Working Capital Adjustment Amount |
4 | |||
Non Required Consent Third Party Payor Contract |
70 | |||
Notice of Disagreement |
4 | |||
Pension Plan |
70 | |||
Permits |
19 | |||
Permitted Liens |
70 | |||
Person |
70 | |||
Post-Closing Taxes |
40 | |||
Pre-Closing Taxes |
39 | |||
Pre-Closing Transactions |
32 | |||
Purchase Price |
6 | |||
Real Property |
14 | |||
Records |
31 | |||
Release |
71 | |||
Replacement Lease |
9 | |||
Required Consent Lease |
71 | |||
Required Consent Third Party Payor Contract |
71 | |||
Restricted Territory |
71 | |||
Restructuring Agreements |
8 | |||
Restructuring Transactions |
8 | |||
Retained Liabilities |
46, 71 | |||
Retained Litigation |
32 | |||
SEC |
33 | |||
Seller |
1 | |||
Seller Claims |
54 | |||
Seller Indemnified Parties |
54 | |||
Seller Outpatient Employee |
35 | |||
Seller Returns |
38 | |||
Seller’s Knowledge |
68 | |||
Seller’s Trademarks and Logos |
47 | |||
September 30 Form 10-Q |
13 | |||
Severance Policy |
45 | |||
Shares |
1 | |||
Xxxxx Law |
20 | |||
Statement |
3 | |||
Staying Clinics |
8 | |||
Straddle Period Returns |
38 | |||
Straddle Statement |
38 | |||
Subsidiary |
72 | |||
Subsidiary Shares |
10 | |||
Target Net Working Capital |
72 | |||
Tax |
18 | |||
Tax Benefit |
57 | |||
Tax Indemnified Party |
42 | |||
Tax Indemnifying Party |
42 | |||
Tax Return |
18 | |||
Tax Third-Party Claim |
42 | |||
Termination Date |
51 | |||
Third-Party Claims |
55 | |||
Transfer Taxes |
43 | |||
Transferred Employees |
44 | |||
Transition Agreement |
6 | |||
Transition Date |
33 | |||
Unadjusted Purchase Price |
2 | |||
Unrelated Liabilities |
73 | |||
Welfare Plan |
74 | |||
Wind-down Period |
47 |
vi
STOCK PURCHASE AGREEMENT, dated as of January 27, 2007 (the “Agreement”), by and between
HealthSouth Corporation, a Delaware corporation (“Seller”), and Select Medical Corporation, a
Delaware corporation (“Buyer”).
RECITALS
WHEREAS, Seller is engaged, directly and through the Division Entities (as hereinafter
defined), in the business of operating and managing outpatient rehabilitation facilities offering a
range of rehabilitative health care services, including physical therapy and occupation therapy,
with a particular focus on orthopedic, sports-related, hand and spine injuries and various
neurological/neuromuscular conditions (the “Business”);
WHEREAS, the Business is operated by Seller through the entities listed on Schedule I
attached hereto (collectively, the “Division Entities”);
WHEREAS, prior to Closing (as hereinafter defined), all of Seller’s equity interests in the
Division Entities shall be held, directly or indirectly, by HealthSouth Holdings, Inc., a Delaware
corporation (the “Company” and, collectively with the Division Entities, the “Division”);
WHEREAS, Seller is the record and beneficial owner of all of the issued and outstanding shares
of common stock, par value $0.01 per share (the “Shares”), of the Company;
WHEREAS, Buyer desires to purchase and acquire from Seller, and Seller desires to sell and
transfer to Buyer, all of Seller’s right, title and interest in and to the Division by way of a
purchase by Buyer and sale by Seller of the Shares, upon the terms and subject to the conditions
hereinafter set forth; and
WHEREAS, the respective Board of Directors of each of Seller and Buyer has approved this
Agreement and the transactions contemplated hereby.
NOW, THEREFORE, in consideration of the foregoing and of the representations, warranties,
covenants, agreements and conditions contained herein, and intending to be legally bound hereby,
the parties hereto agree as follows:
TERMS
ARTICLE I
PURCHASE AND SALE
PURCHASE AND SALE
1.1 Purchase and Sale of the Shares. Upon the terms and subject to the conditions of this
Agreement, at the closing provided for in Section 1.3 hereof (the “Closing”), Seller shall sell,
convey, assign, transfer and
deliver to Buyer, and Buyer shall purchase, acquire and accept from Seller, all of Seller’s right,
title and interest in and to the Shares, free and clear of all liens, encumbrances, security
interests, mortgages, pledges, claims and options (collectively, “Liens”).
1.2 Consideration. Upon the terms and subject to the conditions of this Agreement, in
consideration of the aforesaid sale, conveyance, assignment, transfer and delivery of the Shares at
the Closing, Buyer shall pay to Seller an amount in cash, equal to (i) Two Hundred Forty Five
Million Dollars ($245,000,000) (the “Unadjusted Purchase Price”), plus (ii) an amount equal
to the Estimated Closing Cash Balance (as hereinafter defined), minus (iii) an amount equal
to Capitalized Lease Indebtedness as of the Effective Time, minus (iv) an amount equal to
Earn-Out Indebtedness as of the Effective Time, plus (v) the amount, if any, by which the
Estimated Net Working Capital exceeds the Target Net Working Capital, minus (vi) the
amount, if any, by which the Estimated Net Working Capital is less than the Target Net Working
Capital (such amount, the “Initial Purchase Price”). Any increase or decrease to the Unadjusted
Purchase Price pursuant to clauses (v) or (vi) of this Section 1.2 shall be referred to herein as
the “Estimated Net Working Capital Adjustment.”
1.3 Closing. Subject to Article X hereof, the Closing of the transactions
contemplated by this Agreement shall take place at the offices of Bradley, Arant, Rose & White LLP,
0000 Xxxxx Xxxxxx Xxxxx, Xxxxxxxxxx, Xxxxxxx 00000, at 10:00 a.m., local time, on the first
Business Day of the month immediately following the month in which the condition set forth in
Section 7.1(c) is satisfied, but no sooner than March 1, 2007; provided that all other
conditions set forth in Article VII, Article VIII and Article IX hereof are satisfied or capable of
being satisfied at the Closing, or at such other place, date and time as shall be agreed upon in
writing by the parties hereto (the date that the Closing actually occurs shall be referred to
herein as the “Closing Date”). Notwithstanding the foregoing, the parties hereto intend that such
Closing shall be deemed to be effective, and the transactions contemplated by this Agreement shall
be deemed to occur simultaneously, at 11:59 p.m., Central Time, on the last day of the month
immediately prior to the Closing Date (the “Effective Time”).
1.4 Deliveries by Seller. Prior to or at the Closing, Seller shall deliver or cause
to be delivered to Buyer the following:
(a) stock certificate(s) representing the Shares, duly endorsed or accompanied by stock powers
duly executed in blank;
(b) each of the Ancillary Agreements, duly executed by Seller;
(c) the resignations referred to in Section 2.3 hereof; and
(d) the officer’s certificate referred to in Section 9.1(c) hereof.
1.5 Deliveries by Buyer. Prior to or at the Closing, Buyer shall deliver or cause to
be delivered to Seller the following:
(a) cash in an amount equal to the Initial Purchase Price by wire transfer of immediately
available funds to a bank account designated in writing by Seller at least two (2) Business Days
prior to the Closing Date;
(b) each of the Ancillary Agreements, duly executed by Buyer; and
(c) the officer’s certificate referred to in Section 8.1(c) hereof.
2
1.6 Related Calculations.
(a) Cash Balance and Net Working Capital Calculations.
(i) Seller shall, at least five (5) Business Days prior to the Closing Date, cause to
be prepared and delivered to Buyer a statement (the “Good Faith Statement”) setting forth a
good faith estimate of the Closing Cash Balance (as hereinafter defined) of the Division as
of the Effective Time (the “Estimated Closing Cash Balance”) and the Net Working Capital (as
hereinafter defined) of the Division as of the Effective Time (the “Estimated Net Working
Capital”) and the respective components and calculations of each thereof. Buyer and its
representatives shall have an opportunity to review and comment upon the Good Faith
Statement, which shall be subject to Buyer’s reasonable approval. As used herein, “Closing
Cash Balance” shall mean an amount equal to (A) Cash less (B) Cash Due to Minority
Interest Holders as of the Effective Time (it being understood that Seller shall be
responsible for any checks that are outstanding as of the Effective Time that relate to the
Company or the Division Entities). As used herein, “Net Working Capital” shall mean (i) the
sum of (A) accounts receivable, net of reserves for doubtful accounts (but excluding any
intercompany accounts receivable) and (B) other current assets, less (ii) the sum of
(A) trade accounts payable (but excluding any intercompany accounts payable and unapplied
cash), (B) refunds due to patients and third-party payors, principally as reflected in
account 2512 (which as of September 30, 2006 reflected an accrued liability of $1.5
million), (C) accrued liabilities (but excluding any intercompany accrued liabilities and
excluding the current portion of long-term Indebtedness) and (D) other current liabilities,
and shall be calculated in accordance with the Accounting Principles. The “Accounting
Principles” shall mean GAAP utilizing the methodologies, accounting principles and practices
used in the preparation of the Audited Financial Statements (as hereinafter defined), and as
adjusted to derive the 2005 Pro Forma Financial Information, consistent with the
reconciliation thereof set forth in Section 3.7(d) of the Disclosure Letter. Net Working
Capital shall be prepared in a manner consistent with the example thereof set forth in
Schedule II hereto, which Schedule II is derived from the September 30, 2006
pro forma balance sheet of the Division attached as Schedule III hereto.
(ii) Between eight-five (85) and ninety (90) days after the Closing Date, Seller shall
cause to be prepared and delivered to Buyer a statement (the “Statement”) setting forth the
Closing Cash Balance of the Division as of the Effective Time (the “Actual Closing Cash
Balance”) and the Net Working Capital of the Division as of the Effective Time (the “Actual
Net Working Capital”) and the components and calculations of each thereof. The Statement
shall also set forth (i) the difference, if any, determined by subtracting the Estimated
Closing Cash Balance from the Actual Closing Cash Balance (any such difference, the “Cash
Adjustment Amount”), it being understood that the Cash Adjustment Amount may be either a
positive or negative number and (ii) the difference, if any, determined by subtracting the
Estimated Net Working Capital from the Actual Net Working Capital (such difference, the “Net
Working Capital Adjustment Amount”), it being understood that the Net Working Capital
Adjustment Amount may be either a positive or negative number. Subject to Sections
1.6(a)(iii)-(v), (i) Buyer shall pay to Seller the amount of any positive Cash Adjustment
Amount and any positive Net
3
Working Capital Amount and (ii) Seller shall pay to Buyer the
amount of any negative Cash Adjustment Amount and any negative Net Working Capital
Adjustment Amount, in each case, as finally determined pursuant to this Section 1.6(a). To
the extent that netting the payments referenced in the preceding sentence results in a net
payment by Buyer to Seller, the amount of such net payment shall be referred to herein as
the “Excess Amount” and, to the extent that netting the payments referenced in the preceding
sentence results in a net payment by Seller to Buyer, the amount of such net payment shall
be referred to herein as the “Deficiency Amount.” Contemporaneously with its delivery to
Buyer of the Statement, Seller shall also deliver to Buyer a copy of the work papers
prepared in connection with the Statement’s preparation. The Statement shall be prepared in
accordance with the Accounting Principles. Buyer shall provide Seller and its
representatives reasonable access, during normal business hours of Buyer, to all personnel,
books and records of the Division as reasonably requested by Seller to assist it in its
preparation of the Statement.
(iii) After receipt of the Statement, Buyer shall have forty-five (45) days to review
the Statement together with the work papers used in its preparation. During the course of
the preparation of the Statement and following the delivery of the Statement, Seller shall
provide Buyer and its representatives reasonable access, during normal business hours of
Seller, to all personnel, books and records of Seller as reasonably requested by Buyer to
assist it in its review of the Statement and its preparation. The Statement shall become
final and binding upon the parties on the forty-fifth day following receipt thereof by Buyer
unless Buyer gives written notice of its disagreement (a “Notice of Disagreement”) to Seller
prior to such date. Any Notice of Disagreement shall (A) specify in reasonable detail the
nature and amount of any disagreement so asserted, and (B) include Buyer’s calculation of
the Closing Cash Balance and/or Net Working Capital (whichever is being disputed) of the
Division as of the Effective Time. If Buyer has given Seller a Notice of Disagreement prior
to the forty-fifth day following receipt by Buyer of the Statement, then the Statement shall
become final and binding upon the parties on the date the parties hereto resolve in writing
any differences they have with respect to any matter properly included in the Notice of
Disagreement, in accordance with this Section 1.6(a). During the twenty (20) Business Days
immediately following the receipt by Seller of a Notice of Disagreement, the respective
Chief Financial Officers of Seller and Buyer or their
designees shall negotiate in good faith to resolve any disputed items timely included
in a Notice of Disagreement. During such period, Buyer shall have full access to the
working papers of Seller prepared in connection with Seller’s preparation of the Statement,
and Seller shall have full access to the working papers of Buyer prepared in connection with
Buyer’s preparation of the Notice of Disagreement. Any resolution of disputed items
included in the Notice of Disagreement that is agreed upon in writing by Buyer and Seller
shall be final, binding and conclusive as to Seller, Buyer and their respective Affiliates.
At the end of such twenty (20) Business Day period, at the request of Seller or Buyer, any
and all matters which remain in dispute, and which were properly included in the Notice of
Disagreement, shall be submitted to a mutually acceptable, nationally recognized independent
accounting firm or other professional service organization that provides financial dispute
resolution services (the “Accounting Arbiter”) selected by Seller and Buyer, with no
material relationship to Seller or Buyer or any of their respective
4
Affiliates, for a binding resolution of such disputed items. If Buyer and Seller are not able to agree upon
an Accounting Arbiter, the appointment of an Accounting Arbiter will be finally selected by
mutual agreement of an independent accounting firm selected by Seller and an independent
accounting firm selected by Buyer; provided that, neither of the independent accounting
firms selected by Buyer or Seller shall serve as the Accounting Arbiter. The fees and
expenses of the Accounting Arbiter shall be paid one-half by Seller and one-half by Buyer.
(iv) The Accounting Arbiter shall determine and report in writing to Seller and Buyer
as to its determination of all disputed matters submitted to the Accounting Arbiter and the
effect of such determinations on the Statement within twenty (20) Business Days after such
submission, and such determinations shall be final, binding and conclusive as to Seller,
Buyer and their respective Affiliates. In resolving any disputed item, the Accounting
Arbiter, acting in its capacity as an expert and not as an arbitrator: (A) shall limit its
review to matters specifically set forth in such Notice of Disagreement delivered pursuant
to Section 1.6(a)(iii) as a disputed item (other than those items thereafter resolved by
mutual written agreement of Seller and Buyer), (B) shall further limit its review to whether
the calculation of any such disputed item is mathematically accurate and whether the
calculation of the Closing Cash Balance and/or Net Working Capital was made in accordance
with the Accounting Principles and the terms of this Agreement, and (C) shall not assign a
value to any item greater than the greatest value for such item claimed by any party or less
than the smallest value for such item claimed by any other party in the Statement or the
Notice of Disagreement delivered pursuant to Section 1.6(a)(iii). Each of Seller and Buyer
shall have the right, within five (5) Business Days of submission of any disputed item to
the Accounting Arbiter, to meet with representatives of the Accounting Arbiter and present
its position as to the resolution of such disputed item. In addition, Seller and Buyer
shall each furnish to the Accounting Arbiter such work papers and other documents and
information relating to the disputed items, as the Accounting Arbiter may reasonably
request.
(v) At such time as the Statement becomes final, binding and conclusive upon Seller,
Buyer and their respective Affiliates in accordance with this Section 1.6(a), the Statement
shall become the “Conclusive Statement.” If the Conclusive Statement contains a Deficiency
Amount, then Seller
shall pay to Buyer an amount in cash equal to such Deficiency Amount. If the
Conclusive Statement contains an Excess Amount, then Buyer shall pay to Seller an amount in
cash equal to such Excess Amount. Any payment to be made pursuant to this Section 1.6 shall
be made on the third Business Day following the date on which the Statement becomes the
Conclusive Statement pursuant to this Section 1.6(a). Any payment to be made pursuant to
this Section 1.6(a) shall be made on the third Business Day following the date on which the
Statement becomes the Conclusive Statement pursuant to this Section 1.6(a). Any payment
required to be made by Seller or Buyer pursuant to this Section 1.6(a) shall bear interest
from the Closing Date through the date of payment at the Interest Rate and shall be payable
by wire transfer of immediately available funds to an account or accounts designated by the
party entitled to receive such funds prior to the date when such payment is due.
5
(b) The Initial Purchase Price, as increased by any Excess Amount or decreased by any
Deficiency Amount, as the case may be, shall be referred to herein as the “Purchase Price.”
ARTICLE II
RELATED MATTERS
RELATED MATTERS
2.1 Ancillary Agreement. Prior to or at the Closing, Seller and Buyer shall enter
into the Transition Services Agreement between Seller and Buyer, substantially in the form set
forth in Exhibit A attached hereto, pursuant to which Seller shall provide, or cause to be
provided, to the Division certain transition services, as set forth therein, for the time periods
set forth therein, in accordance with the terms thereof (the “Transition Agreement”).
2.2 Intercompany Agreements; Certain Other Intercompany Matters.
(a) Section 2.2(a)(i) of the disclosure letter delivered by Seller to Buyer simultaneously
herewith (the “Disclosure Letter”) lists all intercompany agreements between Seller or any of its
Affiliates (other than the Company or any Division Entity), on the one hand, and the Company or any
Division Entity, on the other hand (the “Intercompany Agreements”). Except as set forth in Section
2.2(a)(ii) of the Disclosure Letter and except for those Intercompany Agreements to be assigned by
Seller to the Company pursuant to Section 2.4(a) hereof, as of the Closing, Seller, the Company and
the Division Entities shall cause all Intercompany Agreements to be terminated in all respects
(pursuant to documentation reasonably acceptable to Buyer) such that there is no cost or liability
(including any Tax liability) thereunder from and after the Closing on the part of the Company or
any Division Entity.
(b) As of the Closing, all intercompany accounts receivable and accounts payable between the
Company or any Division Entity, on the one hand, and Seller or any of its Affiliates (other than
the Company or any Division Entity), on the other hand, shall be cancelled and terminated in all
respects (pursuant to documentation reasonably acceptable to Buyer) such that there is no cost or
liability (including any Tax liability) thereunder from and after the Closing on the part of the
Company or any Division Entity.
(c) Except as provided in the Transition Agreement, at or prior to the Closing, all
information technology, accounting, insurance, banking, human resources, legal, tax, communications
and other products or services (i) provided to the Company or any Division Entity (A) by Seller or
any of its Affiliates (other than the Company or any Division Entity) or (B) pursuant to
agreements, licenses or arrangements between Seller or its Affiliates (other than the Company or a
Division Entity), on the one hand, and third parties, on the other hand, under which goods or
services are provided to the Company or any Division Entity, or (ii) provided by either the Company
or any Division Entity to Seller or any of its Affiliates (other than the Company or any Division
Entity), including any agreements or understandings (written or oral) with respect thereto, will
terminate. Except as otherwise specifically provided in the Transition Agreement, on and after the
Closing Date, Buyer shall be solely responsible for the operation of the Division. Section 2.2(c)
of the Disclosure Letter sets forth all (x) Contracts between Seller or its Affiliates (other than
the Company or a Division Entity), on the one hand, and third parties, on the other hand, pursuant
to which the Company or any Division Entity is entitled to receive
6
payments or other benefits, which will not be transferred to the Company or a Division Entity and, following the Effective
Time, the Company or such Division Entity will no longer be entitled to such payments or benefits
provided thereunder and (y) other assets, properties and rights of the Division that will be
retained by Seller and will not be available for use by the Division following the Effective Time.
2.3 Resignations. At the Closing, Seller shall cause to be delivered to Buyer and the
Company duly signed resignations from the members of the board of directors, board of managers or
similar governing bodies, effective as of the Closing, of each Division Entity, unless otherwise
requested by Buyer, and shall take such other action as is necessary to accomplish the foregoing.
2.4 Restructuring Transactions.
(a) Prior to the Closing, Seller shall, and shall cause its Subsidiaries to, consummate the
transactions listed in Section 2.4(a) of the Disclosure Letter in order to transfer and convey to
the Company or the Division Entities all of Seller’s right, title and interest in and to (i) the
equity interests in the Division Entities held by Seller or any of its Subsidiaries (other than the
Company or a Division Entity) and (ii) such other properties, assets and Contracts primarily used
in the conduct of the Business as are set forth on Section 2.4(a) of the Disclosure Letter.
Section 2.4(a) of the Disclosure Letter shall also set forth a list of each of the current
operating outpatient rehabilitation clinics that will be owned by the Company or the Division
Entities immediately after the Closing (the “Going Clinics”), and shall include a listing of the
legal entity that owns each such Going Clinic.
(b) Prior to the Closing, Seller shall, and shall cause its Subsidiaries to, consummate the
transactions listed in Section 2.4(b) of the Disclosure Letter in order to transfer or convey to
Seller or a Subsidiary of Seller (other than the Company or a Division Entity) all of their right,
title and interest in and to (i) the equity interests in all Subsidiaries of or other entities
owned by the Company and the Division Entities that are not engaged in the conduct of the Business
and (ii) such other properties, assets and Contracts that are not primarily used in the conduct of
Business and which are set forth in Section 2.4(b) of the Disclosure Letter (collectively, the
“Excluded Assets”). Section 2.4(b) of the Disclosure
Letter shall also set forth a list of each of the outpatient rehabilitation clinics owned or
controlled by Seller or its Subsidiaries at any time since September 30, 2005 that will not be
owned by the Company or the Division immediately after the Closing. Such outpatient rehabilitation
clinics and any other clinic presently or formerly owned or operated by Seller or its Subsidiaries
(other than the Going Clinics) shall be referred to as the “Staying Clinics.” Buyer and Seller
agree that any liabilities or obligations of the Company or any Division Entity that relate to the
Excluded Assets or the Staying Clinics will also be transferred to or assumed by Seller or a
Subsidiary of Seller (other than the Company or its Subsidiaries) prior to the Effective Time, and
that the Company and the Division Entities shall be released from any obligation relating to such
liabilities as of the Effective Time and indemnified by Seller from and against such liabilities.
The transactions listed in Sections 2.4(a) and 2.4(b) of the Disclosure Letter shall be
collectively referred to herein as the “Restructuring Transactions,” and the agreements to
effectuate the Restructuring Transactions shall be referred to herein as the “Restructuring
Agreements.” Together, the Transition Agreement and the Restructuring Agreements are referred to
herein as the “Ancillary
7
Agreements.” Seller will consult with and take into account Buyer’s
reasonable suggestions regarding the manner to effectuate the Restructuring Transactions;
provided, however, that Seller shall be free to structure the Restructuring
Transactions in such manner as it determines, in its sole discretion, as to maximize tax
efficiencies to Seller without Buyer’s prior consent so long as such structure does not adversely
affect the parties’ ability to effect either the Election or the DRE Sales (each as hereinafter
defined); provided, further, that if Buyer shall propose changes to the
Restructuring Transactions, then (i) Seller shall effect the Restructuring Transactions in
accordance with Buyer’s proposal to the extent commercially practicable and (ii) Buyer shall
reimburse and indemnify Seller from and against any and all incremental Taxes, on a grossed up
basis, and out-of-pocket expenses incurred by Seller in effectuating the Restructuring Transactions
in accordance with Buyer’s proposal to the extent such Taxes and out-of-pocket expenses exceed the
amount thereof that would have been incurred by Seller had Seller effectuated the Restructuring
Transactions in the manner proposed by Seller (the “Excess Restructuring Costs”).
(c) To the extent any property, asset or Contract that is required to be transferred or
conveyed pursuant to the Restructuring Transactions or the transactions contemplated by this
Agreement is not assignable or transferable without the consent of any Person other than Seller,
Buyer or any of their respective Affiliates, and such consent shall not have been given prior to
the Closing, Seller shall have the continuing obligation after the Closing to use its commercially
reasonable efforts to endeavor to obtain any such consent. After the Closing, Seller and Buyer
shall cooperate with each other in any reasonable arrangement that is designed to (i) relieve
Seller of the obligations of any such property, assets and Contracts that are required to be
transferred or conveyed to the Company or the Division Entities pursuant to the Restructuring
Transactions or the transactions contemplated by this Agreement and provide Buyer the benefits
thereunder and (ii) relieve Buyer of the obligations of any such property, assets and Contracts
that are required to be transferred or conveyed to Seller or a Subsidiary of Seller (other than the
Company or the Division Entities) pursuant to the Restructuring Transactions or the transactions
contemplated by this Agreement and provide Seller the benefits thereunder. Without limiting the
generality of the preceding sentence, with respect to Required Consent Leases that are not
Consented Leases as of the Closing, Seller shall be entitled, in its
reasonable discretion, to (i) enter into one or more management agreements with the Company,
in form and substance reasonably acceptable to Buyer, with respect to the Facilities covered by
each such Required Consent Lease whereby Seller will maintain the Required Consent Lease and
operate such Facility for the benefit of Buyer, or (ii) cooperate with Buyer in relocating the
Facility to a location, and on lease terms, reasonably acceptable to Buyer (each, a “Replacement
Lease”), with Seller reimbursing and indemnifying Buyer from and against all reasonable
out-of-pocket expenses incurred by Buyer in connection with such relocation, including, without
limitation, reasonable (x) moving expenses, (y) tenant improvements and (z) any incremental rent
expense required under such Replacement Lease above the amount that would have been required to be
paid by Buyer under the terms of the Required Consent Lease; provided, however,
that Seller’s obligation to reimburse and indemnify under clause (z) above shall be limited to
amounts incurred with respect to the period commencing on the Closing Date and ending on the
earliest date that the Required Consent Lease could be terminated by the lessor (or, if earlier,
the date such Required Consent Lease would have expired) in accordance with its terms had the
relocation not occurred.
8
2.5 Guaranties. Buyer shall use its commercially reasonable efforts to cause itself or
one of its Affiliates to be substituted in all respects for Seller, effective as of the Closing, in
respect of all obligations of Seller under each of the guaranties of leases of real property which
are set forth in Section 2.5 of the Disclosure Letter for the benefit of the Division or any of the
Division Entities or any extensions or modifications thereto in accordance with this Agreement
(collectively, the “Guaranties”), and to use its commercially reasonable efforts to cause each
other party to such Guaranty to release Seller and its Affiliates (other than the Company and any
Division Entity) from any and all obligations and liabilities under such Guaranty. To the extent
that it is commercially impracticable with respect to any given Guaranty for Buyer to effect such
substitution and release, Buyer shall indemnify and hold harmless the Seller Indemnified Parties
(as hereinafter defined) from and against all Damages (as hereinafter defined) asserted against,
resulting to, imposed upon or incurred by the Seller Indemnified Parties by reason of or arising
from any liability or obligation resulting from any such Guaranty in accordance with Section
11.4(e) hereof. Buyer shall take all actions that are necessary to comply with this Section 2.5 as
promptly as practicable after the date hereof and shall keep Seller reasonably informed of any
developments associated therewith. Seller agrees to reasonably cooperate with Buyer in connection
with the fulfillment of Buyer’s obligations under this Section 2.5.
2.6 Payment of Division Indebtedness. At or prior to the Closing, Seller shall repay
or assume, or cause to be repaid or assumed, on behalf of the Company and the Division Entities,
all outstanding Indebtedness (together with accrued interest thereon) of the Company and the
Division Entities as of the Closing Date (other than Capitalized Lease Indebtedness and Earn-Out
Indebtedness), and shall take all actions as may be required to release the Company and the
Division Entities from any and all obligations and liabilities under such Indebtedness (other than
Capitalized Lease Indebtedness and Earn-Out Indebtedness) and any Lien or guaranty in respect of
any such Indebtedness (other than Capitalized Lease Indebtedness and Earn-Out Indebtedness) or any
Indebtedness of Seller or its Subsidiaries (other than Capitalized Lease Indebtedness and Earn-Out
Indebtedness) pursuant to releases in form and substance reasonably acceptable to Buyer.
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF SELLER
REPRESENTATIONS AND WARRANTIES OF SELLER
Except as set forth in the Disclosure Letter (as updated pursuant to Section 5.7 hereof) (with
specific reference to the particular Section or subsection of this Agreement to which the
information set forth in such Disclosure Letter relates; provided, that any information set
forth in one section of the Disclosure Letter shall be deemed to apply to each other Section or
subsection thereof or hereof to which its relevance is readily apparent on its face), Seller
represents and warrants to Buyer as follows:
3.1 Organization of Seller; Authority. Seller is a corporation duly organized,
validly existing and in good standing under the laws of the State of Delaware, and has all
requisite corporate power and corporate authority to enter into this Agreement and the Ancillary
Agreements, to perform its obligations hereunder and thereunder and to consummate the transactions
contemplated hereby and thereby. The execution, delivery and performance by Seller and its
Affiliates of this Agreement and each of the Ancillary Agreements to which it is a party, and the
consummation of the transactions contemplated hereby and thereby, have been
9
duly authorized by all necessary corporate action on the part of Seller, and no other acts or proceedings on the part of
Seller, including stockholder approval, are necessary for Seller to authorize this Agreement or the
Ancillary Agreements or the transactions contemplated hereby or thereby. This Agreement has been
(and each such Ancillary Agreement, upon execution and delivery, will be) duly executed and
delivered by Seller and each of its Affiliates a party thereto and constitutes (and each such
Ancillary Agreement, upon execution and delivery, will constitute) a valid and binding obligation
of Seller and each of its Affiliates a party thereto, enforceable against Seller and each of its
Affiliates a party thereto in accordance with its and their respective terms, except that (i) such
enforcement may be subject to bankruptcy, insolvency, reorganization, moratorium, fraudulent
transfer or other Laws, now or hereafter in effect, relating to or limiting creditors’ rights
generally and (ii) the remedy of specific performance and injunctive and other forms of equitable
relief may be subject to equitable defenses and to the discretion of the court before which any
proceeding therefor may be brought.
3.2 Title to Shares. Seller has good and valid title to the Shares, free and clear of
all Liens, and upon delivery to Buyer at the Closing of a certificate or certificates representing
the Shares, duly endorsed by Seller for transfer to Buyer or accompanied by stock powers duly
executed in blank, and upon receipt by Seller of the Initial Purchase Price at the Closing, good
and valid title to the Shares will pass to Buyer, free and clear of any Liens. Other than this
Agreement, the Shares are not subject to any voting trust agreement or other Contract, including
any such Contract restricting or otherwise relating to the voting, dividend rights or disposition
of the Shares. Except as set forth in Section 3.2 of the Disclosure Letter, Seller, directly or
indirectly through one of its Subsidiaries, has good and valid title to all of the outstanding
shares of capital stock or other equity interests of the Division Entities, directly or indirectly
(the “Subsidiary Shares”), free and clear of all Liens.
3.3 Organization and Qualification. The Company and each of the Division Entities is
duly organized or formed, validly existing and in good standing under the laws of the jurisdiction
of its incorporation or formation and has all requisite corporate or other power and authority to
own, lease and operate its properties and to conduct its business as conducted on the
date hereof, except where the failure to be in good standing would not, individually or in the
aggregate, reasonably be expected to result in a Material Adverse Effect (as hereinafter defined).
Except as set forth in Section 3.3 of the Disclosure Letter, the Company and each of the Division
Entities is duly qualified or licensed to do business as a foreign corporation, partnership or
limited liability company and is in good standing in each jurisdiction in which the property owned,
leased or operated by it or the nature of the business conducted by it makes such qualification
necessary, except in those jurisdictions where the failure to be so duly qualified or licensed and
in good standing would not, individually or in the aggregate, reasonably be expected to result in a
Material Adverse Effect.
3.4 Capitalization of the Company. The authorized capital stock of the Company
consists of 1,000 shares of common stock, par value $0.01 per share, of which 1,000 shares,
constituting the Shares, are validly issued and outstanding. The Shares were duly authorized and
are fully paid and nonassessable. The Shares are owned of record and beneficially by Seller. Such
Shares have not been issued in violation of, and are not subject to, any preemptive, subscription
or similar rights. Except for the Shares, there are no shares of capital stock or other equity
securities of the Company outstanding. There are no outstanding
10
warrants, options, “phantom” stock
rights, agreements, convertible or exchangeable securities or other commitments pursuant to which
Seller or the Company is or may become obligated to issue, sell, purchase, return or redeem any
shares of capital stock or other securities of the Company, or which give any Person the right to
receive any benefits or rights similar to any rights enjoyed by or accruing to the holders of
shares of capital stock of the Company. There are no outstanding bonds, debentures, notes or other
Indebtedness having the right to vote on any matters upon which stockholders of the Company may
vote.
3.5 Capitalization of the Division Entities.
(a) Except for the Division Entities, the Company does not own, directly or indirectly, any
capital stock, equity securities or other equity interest in any other Person. The Subsidiary
Shares for each Division Entity that is a corporation were duly authorized and are validly issued,
fully paid and nonassessable. The Subsidiary Shares of each Division Entity that is not a
corporation were duly authorized, and are validly issued. Except as set forth in Section 3.5(a) of
the Disclosure Letter, all issued and outstanding shares of capital stock or other equity interests
of each Division Entity will, as of the Closing, be owned of record and beneficially by the Company
or another Division Entity. The Subsidiary Shares as of the Closing will be owned of record and
beneficially by the Company, either directly or indirectly through a Division Entity.
(b) The Subsidiary Shares of each Division Entity have not been issued in violation of, and
are not subject to, any preemptive, subscription or similar rights (except as otherwise required by
applicable Law). Except as set forth in Section 3.5(b) of the Disclosure Letter, there are no
outstanding warrants, puts, calls, options, “phantom” stock rights, agreements, convertible or
exchangeable securities or other commitments pursuant to which Seller, the Company or any of the
Division Entities is or may become obligated to issue, sell, purchase, return or redeem any shares
of capital stock, equity interests or other securities of the Division Entities or which give any
Person the right to receive any benefits or rights similar to any rights enjoyed by or accruing to
the holders of the Subsidiary Shares of the Division Entities.
There are no outstanding bonds, debentures, notes or other Indebtedness having the right to
vote on any matters on which stockholders of any of the Division Entities may vote.
3.6 No Violation; Consents and Approvals.
(a) The execution and delivery by Seller and each of its Affiliates that are a party thereto
of this Agreement and the Ancillary Agreements do not, and the performance by Seller and its
Affiliates of their obligations hereunder and thereunder and compliance with the terms hereof and
thereof will not, (i) conflict with the Restated Certificate of Incorporation or Amended and
Restated Bylaws of Seller or the comparable governing instruments of the Company or any of the
Division Entities; (ii) subject to receipt of the Consents and making of the Filings listed in
Section 3.6(b) of the Disclosure Letter and the making of Filings under the HSR Act and the
Exchange Act, violate or conflict with, in each case in any material respect, any Law applicable to
Seller, the Company or any of the Division Entities, including any statute, regulation and rule of
any health care authority having jurisdiction over the Division or the Facilities, including such
Laws relating to health care fraud and abuse; or (iii) subject to the receipt of the Consents and
making of the Filings listed in Section 3.6(b) of the Disclosure Letter
11
and the making of Filings under the HSR Act and the Exchange Act, result in any material violation of or material breach or
default under (or with notice or lapse of time or both would result in a material violation of or a
material breach or default under), or result in or give rise to a right of termination,
cancellation or acceleration, or result in the creation, of any Lien upon, any of the material
properties or assets of the Company or any of the Division Entities under any Material Contract (as
hereinafter defined) or Permit (as hereinafter defined) to which Seller, the Company or any of the
Division Entities is a party or by or to which Seller, the Company or any of the Division Entities
or any of their respective properties or assets is bound or subject, except, in the case of (ii)
and (iii) above, for any such conflict, violation, breach, default, right of termination or
cancellation which arises from or relates to the legal or regulatory status of Buyer or the nature
of Buyer’s businesses or its participation in the transactions contemplated hereby.
(b) Set forth in Section 3.6(b) of the Disclosure Letter is a list of each (i) consent,
approval, waiver, license, certification, Permit, order or authorization of (each, a “Consent”) and
registration, declaration or filing (each, a “Filing”) with, any court, administrative agency or
commission or other governmental entity, authority or instrumentality, domestic or foreign (a
“Governmental Entity”), that is material to the conduct of the Business required to be obtained or
made by or with respect to Seller or the Division in connection with the execution and delivery of
this Agreement or the Ancillary Agreements, or the consummation by Seller of the transactions
contemplated hereby and thereby, other than (A) compliance with and Filings under the
Xxxx-Xxxxx-Xxxxxx Antitrust Improvements Act of 1976, as amended (the “HSR Act”), and (B)
compliance with and Filings under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”); and (ii) Consent of any third party required to be obtained or made by or with respect to
Seller or the Division in connection with the execution and delivery of this Agreement or the
Ancillary Agreements or the consummation by Seller of the transactions contemplated hereby and
thereby, other than such Consents, the failure of which to obtain would not, individually or in the
aggregate, reasonably be expected to result in a Material Adverse Effect.
3.7 Financial Statements; Undisclosed Liabilities.
(a) Section 3.7(a) of the Disclosure Letter contains the audited financial statements of the
Division as of and for the two years ended December 31, 2005 (collectively, the “Audited Financial
Statements”). The Audited Financial Statements and notes thereto (i) have been prepared from the
books and records of Seller and the Division, (ii) have been prepared in accordance with GAAP,
consistently applied (except as disclosed therein), and (iii) fairly present in all material
respects the financial condition and results of operations of the Division for the periods
presented, as more fully described in the notes to the Audited Financial Statements.
(b) Section 3.7(b)(i) of the Disclosure Letter contains the unaudited interim pro forma income
statements of the Division prepared on a quarterly basis for each of the quarters during the
nine-month period ended September 30, 2006 (the “Interim Pro Forma Income Statements”). The
Interim Pro Forma Income Statements (i) are pro forma for the ongoing and continuing operations of
the Division, prepared in the manner set forth in Section 3.7(b)(ii) of the Disclosure Letter, (ii)
have been prepared from the books and records of Seller and the Division, (iii) fairly present in
all material respects the results of operations of the
12
Division on the basis of reporting to Seller for the periods presented, and (iv) reflect the results of operations of the Division as presented
in Seller’s quarterly segment reporting in its interim report on Form 10-Q for the nine months
ended September 30, 2006, filed with the Securities and Exchange Commission (the “September 30 Form
10-Q”).
(c) Section 3.7(c) of the Disclosure Letter contains the unaudited pro forma financial
information of the Division as of and for the year ended December 31, 2005 prepared on a quarterly
basis (collectively, the “2005 Pro Forma Financial Information”). The 2005 Pro Forma Financial
Information (i) are pro forma for the ongoing and continuing operations of the Division, prepared
in the manner set forth in Section 3.7(b)(ii) of the Disclosure Letter, (ii) has been prepared from
the books and records of Seller and the Division, and (iii) fairly presents in all material
respects the financial condition and results of operations of the Division on the basis of
presentation outlined in Section 3.7(c) of the Disclosure Letter, which presents the results of
operations and financial position of the Division being sold by Seller and acquired by Buyer.
(d) Section 3.7(d) of the Disclosure Letter contains the following reconciliations:
(i) From the segment financial information presented in Seller’s annual report on Form
10-K for the fiscal year ended December 31, 2005, filed with the Securities and Exchange
Commission (the “2005 Segment Information”) to the 2005 Pro Forma Financial Information;
(ii) From the 2005 Segment Information to the Audited Financial Statements; and
(iii) From the quarterly segment income statement information presented in Seller’s
September 30 Form 10-Q (the “Interim Segment Information”) to the Interim Pro Forma Income
Statement.
The reconciliations set forth in Section 3.7(d) of the Disclosure Letter have been fairly presented
and properly disclose the reconciling items from each of (i) the 2005 Segment Information to the
2005 Pro Forma Financial Information, (ii) the 2005 Segment Information to the Audited Financial
Statements and (iii) the Interim Segment Information to the Interim Pro Forma Income Statement as
of and for the periods presented in Section 3.7(d) of the Disclosure Letter (details of which have
been disclosed previously to Buyer).
(e) Except as set forth in Section 3.7(e) of the Disclosure Letter, since December 31, 2005,
except for liabilities and obligations (i) disclosed in the Audited Financial Statements or the
notes thereto, (ii) incurred since December 31, 2005 in the ordinary course of business, consistent
with past practice, or (iii) disclosed in Section 3.7(b) of the Disclosure Letter, neither the
Company nor any of the Division Entities has incurred any material liabilities or obligations
(whether direct or indirect, accrued, contingent or otherwise).
3.8 Absence of Certain Changes or Events. Since December 31, 2005, there has not been
any effect, change, fact, event, occurrence or circumstance that, individually or in the aggregate,
has had or would reasonably be expected to result in a Material Adverse Effect.
13
Except as set forth in Section 3.8 of the Disclosure Letter, during the period from December 31, 2005 to the date
of this Agreement, (a) the Company and the Division Entities have, in all material respects,
operated the Division in the ordinary course of business consistent with past practice, and (b) the
Company and the Division Entities have not taken any action which, if taken after the date hereof
to the Closing Date, would be prohibited by Section 5.1(a), (c), (d), (e), (g) (other than adopting
or modifying any Benefit Plan) (h), (i), (j), (r) or (t) hereof.
3.9 Real Property. As used in this Agreement, the term “Real Property” shall mean all
real property owned in fee or leased by the Company and the Division Entities and used primarily in
the conduct of the Business. Section 3.9 of the Disclosure Letter sets forth all of the Real
Property. Except as would not, individually or in the aggregate, reasonably be expected to result
in a Material Adverse Effect, the Company or one of the Division Entities has (a) good and valid
title to all Real Property owned by it or (b) valid and subsisting leasehold interests in all Real
Property leased by it (“Leased Real Property”), in each case, free and clear of all Liens, except
Permitted Liens and Liens set forth in Section 3.9 of the Disclosure Letter which Liens on Section
3.9 of the Disclosure Letter shall be released as of the Closing Date.
3.10 Intellectual Property.
(a) The Company or one of the Division Entities owns or possesses valid, enforceable and
adequate licenses or other legal rights to use all material copyrights, trade names, trademarks,
service marks, service names, trade secrets, designs, licenses, patents, inventions, software,
Internet domain names and other intellectual property rights wherever recognized throughout the
world, including, without limitation, know-how (whether related to any of the foregoing or
otherwise) (including pending applications for any of the foregoing)
(collectively, “Intellectual Property Rights”) used by the Company and the Division Entities
to operate the Division as operated on the date hereof, and, except as set forth in Section 3.10(a)
of the Disclosure Letter, all such Intellectual Property Rights shall be fully available in all
material respects for use in the business of the Company and Division Entities immediately after
the Closing on materially identical terms, except as provided in the Transition Agreement.
(b) Except as set forth in Section 3.10(b) of the Disclosure Letter: (i) no material claims or
proceedings are pending, or, to the Knowledge of Seller, threatened, by any Person related to the
use in the operation of the Division of any Intellectual Property Rights or challenging or
questioning the validity, enforceability, extent or effectiveness of any Intellectual Property
Rights owned by the Company or any Division Entity, or any license or agreement by which the
Company or any Division Entity uses Intellectual Property Rights in its business; (ii) to the
Knowledge of Seller, the operation of the Division, as conducted on the date hereof, does not
infringe, dilute or misappropriate the intellectual property rights of any Person; and (iii) all
material Filings, registrations and issuances pertaining to the Intellectual Property Rights owned
by the Company and the Division Entities, including any and all material patents, registered
trademarks and copyright registrations, have been duly and timely made and all such material
patents, registered trademarks, registered copyrights and applications for the foregoing are, to
the Knowledge of Seller, valid and in full force and effect.
(c) Except as set forth in Section 3.10(c) of the Disclosure Letter, the material information
technology systems owned, licensed, leased, operated on behalf of, or
14
otherwise held for use in the
Business by the Company and the Division Entities, including all material computer hardware,
software, firmware and telecommunications systems used in the Business of the Company and the
Division Entities (the “IT Systems”): (i) perform reliably and in material conformance with the
appropriate specifications or documentation for such IT Systems, (ii) shall be fully available for
use in the Business by the Company and the Division Entities immediately following the Closing, and
(iii) constitute all of the material information technology systems used in the Business of the
Company and the Division Entities.
3.11 Litigation.
(a) Except for any qui tam action of which none of Seller, the Company nor any Division Entity
has Knowledge or received written notice, Section 3.11(a) of the Disclosure Letter sets forth all
actions, suits, proceedings, investigations and inquiries (“Litigation”) pending or, to the
Knowledge of Seller, threatened in writing to assert such Litigation by or before any Governmental
Entity, by or on behalf of any third party, against Seller, the Company or any of the Division
Entities which relate to the Division, the Company or any of the Division Entities, which, if
adversely determined, would, individually or in the aggregate, reasonably be expected to result in
a Material Adverse Effect or materially impact the ability of Seller to consummate the transactions
contemplated by this Agreement or the Ancillary Agreements.
(b) Except as disclosed in Section 3.11(b) of the Disclosure Letter, neither the Company nor
any of the Division Entities nor any of their respective properties is
subject to any order, judgment, injunction or decree material to the Division or the conduct
of the Business.
3.12 Employee Benefit Plans.
(a) Neither the Company nor any Division Entity sponsors or maintains any Benefit Plans. No
ERISA Affiliate sponsors or maintains any Benefit Plan that covers employees of the Company or any
Division Entity or with respect to which the Company or any Division Entity has or could reasonably
be expected to have any material liability.
(b) Each Benefit Plan has been administered in all material respects in accordance with its
terms and each of the Benefit Plans that is sponsored, participated in or maintained by the Company
or any of the Division Entities is in compliance in all material respects with applicable Law,
including ERISA and the Code.
(c) No Benefit Plan is, or was at any time for which any statute of limitations remains open,
subject to Title IV of ERISA. Neither the Company, any Division Entity nor any ERISA Affiliate is
or at any time for which any relevant statute of limitations remains open was required to
contribute to any “multiemployer plan” as defined in Section 4001(a)(3) of ERISA or has withdrawn
from any such multiemployer plan where such withdrawal has resulted or could result in any
“withdrawal liability” (within the meaning of Section 4201 of ERISA) that has not been fully paid.
(d) The Company, each Division Entity and each ERISA Affiliate have complied in all material
respects with the notice and continuation coverage requirements of
15
section 4980B of the Code and
the regulations thereunder, including, without limitation, the “M&A regulations” issued as Treasury
Regulations Section 54.4980B-9, with respect to each Benefit Plan that is, or was during any
taxable year of the Company or any ERISA Affiliate for which the statute of limitations on the
assessment of federal income taxes remains open, by consent or otherwise, a group health plan
within the meaning of section 5000(b)(1) of the Code.
(e) Except as set forth in Section 3.12(e) of the Disclosure Letter, the consummation of the
transactions contemplated by this Agreement shall not, either alone or in combination with another
event, (i) entitle any current or former employee of the Company or one of the Division Entities to
severance pay, unemployment compensation or any other payment from Buyer, or (ii) accelerate the
time of payment or vesting, or increase the amount of compensation or benefits due to any such
employee or former employee. No payment which is or may be made by, from or with respect to any
Benefit Plan, to any employee, former employee, director or agent of the Company or any Division
Entity or any ERISA Affiliate, either alone or in conjunction with any other payment, could
properly be characterized as an excess parachute payment under section 280G of the Code.
(f) There are no Benefit Plans or any other material pension, welfare, bonus, stock purchase,
stock ownership, stock option, deferred compensation, incentive, severance, termination or other
compensation plan or arrangement, or other material employee fringe benefit plan presently
maintained by, or contributed to by, the Company or any Division Entity maintained outside the
jurisdiction of the United States.
3.13 Taxes. (a) Except as set forth in Section 3.13 of the Disclosure Letter or as
would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse
Effect:
(i) All federal, state, local, and foreign Tax Returns (as hereinafter defined)
relating to the Division required to be filed by or on behalf of the Company, the Division
Entities and each consolidated, combined, unitary, affiliated or aggregate group of which
Seller and the Company or any of the Division Entities is a member (an “Affiliated Group”)
have been timely filed (taking into account applicable extensions), and each such Tax Return
was complete and correct in all respects.
(ii) All Taxes (as hereinafter defined) relating to the Division due and owing by the
Company, the Division Entities or any Affiliated Group, have been paid, or adequate reserves
therefor have been established.
(iii) All Tax withholding and deposit requirements relating to the Company and the
Division Entities (including any withholding with respect to wages or other amounts paid to
employees) have been satisfied in full.
(b) Except as set forth in Section 3.13 of the Disclosure Letter:
(i) There is no material deficiency, proposed adjustment, or matter in controversy that
has been asserted or assessed in writing relating to the Division with respect to any Taxes
due and owing by the Company, the Division Entities or any Affiliated Group, that has not
been paid or settled in full.
16
(ii) Neither the Company nor any of the Division Entities is a party to any agreement
providing for the allocation or sharing of, or indemnification for, Taxes.
(iii) There are no Liens relating to Taxes upon the assets of the Company or the
Division Entities, other than Liens relating to Taxes not yet due and payable.
(iv) There are no outstanding agreements or waivers extending the statutory period of
limitations applicable to any Tax Return of the Company or any of the Division Entities.
(v) Neither the Company nor any of the Division Entities is a party to any “listed
transaction,” as defined in Treasury Regulations Section 1.6011-4(b)(2).
(vi) The federal Consolidated Income Tax Returns of the Affiliated Group of which
Seller is the common parent have been examined, and such examinations have been resolved, or
the statute of limitations has expired, for all taxable years through 1995.
(c) For purposes of this Agreement, (i) “Tax” or “Taxes” means any and all U.S. federal,
state, local and foreign taxes, including income, alternative or add-on minimum, gross receipts,
profits, lease, service, service use, wage, employment, workers compensation, business occupation,
environmental, estimated, excise, sales, use, transfer, license, payroll, franchise, severance,
stamp, occupation, windfall profits, withholding, social security, unemployment, disability, ad
valorem, capital stock, paid in capital, recording, registration, property, real property gains,
value added, business license, custom duties and other taxes, charges, fees, levies, imposts,
duties or assessments of any kind whatsoever, imposed or required to be withheld by any Tax
authority, including any interest, additions to Tax or penalties applicable or related thereto, and
(ii) “Tax Return” means any return, report or similar statement (including the attached schedules)
required to be filed with respect to any Tax, including any information return, claim for refund,
amended return or declaration of estimated Tax.
3.14 Material Contracts and Commitments.
(a) As used herein, “Material Contracts” shall mean: (i) any Contract that provides for
payment to the Company or any Division Entity for the performance of services in an amount in
excess of $1,000,000 annually; (ii) any Contract requiring payments by the Company or any Division
Entity in excess of $1,000,000 annually; (iii) any Contract which contains restrictions with
respect to payment of dividends or any other distributions in respect of the capital stock or other
equity interests of the Company or any Division Entity; (iv) any guarantee in respect of any
Indebtedness or obligation of any Person in an amount in excess of $1,000,000 (other than in the
ordinary course of business and other than with respect to any Indebtedness or any Indebtedness or
obligation of the Company or any Division Entity to another Division Entity); (v) any Contract
limiting the ability of the Company or any Division Entity to engage in any line of business or to
compete with any Person; (vi) any Contract under which the
17
Company or a Division Entity has
borrowed or loaned money in excess of $250,000, or any mortgage, note, bond, indenture or other
evidence of Indebtedness (excluding advances, deposits, trade payables in the ordinary course of
business, and leases for telephones, copy machines, facsimile machines and other office equipment);
(vii) any joint venture, partnership or other similar joint ownership agreements; (viii) Contracts
with Governmental Entities or consent decrees of Governmental Entities to which the Division is
bound; (ix) any employment, severance, change of control or “golden parachute” Contract of a
Transferred Employee; (x) any Contract (A) granting or obtaining any right to use any Intellectual
Property Rights material to the conduct of the Business of the Company and Division Entities (other
than Contracts granting rights to use readily available commercial software available to consumers
for a combined license and maintenance fee of less than $250,000 per year or subject to “shrink
wrap” or “click through” license agreements) or (B) restricting the right of the Company or any
Division Entity or permitting any third Person to use any Intellectual Property Rights material to
the conduct of the Business of the Company and Division Entities; (xi) any lease (or sublease) of
Leased Real Property requiring payments by the Company or any Division Entity in an amount in
excess of $250,000 annually; (xii) any collective bargaining or other labor or union contracts or
agreements to which the Division is bound; (xiii) all agreements relating to the future disposition
or acquisition of any business enterprise or any interest in any business enterprise; (xiv) any
medical director agreements and all other agreements with physicians; and (xv) agreements with any
Affiliate of Seller.
(b) (i) Each of the Material Contracts is a valid and binding obligation of the Company or a
Division Entity, except that (A) enforcement of any Material Contract may be subject to any
bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer or other Laws, now or
hereafter in effect, relating to or limiting creditors’ rights generally and (B) the remedy of
specific performance and injunctive and other forms of equitable relief may be subject to equitable
defenses and to the discretion of the court before which any proceeding therefor may be brought;
(ii) there is no pending default under or breach of any Material Contract by the Company or any
Division Entity party thereto, and to Seller’s Knowledge, there is no pending default under or
breach of any Material Contract by any other party thereto, and no event has occurred that, with
the lapse of time or the giving of notice or both, would constitute a default thereunder by the
Company or any Division Entity party thereto, except, in any such case, any such default, breach or
event which would not, individually or in the aggregate, reasonably be expected to result in a
Material Adverse Effect; and (iii) no party to any such Material Contract has given written notice
to the Company or any Division Entity of, or made a written claim against the Company or any
Division Entity with respect to, any breach or default thereunder, except, in any such case, any
such default, breach or event, which would not, individually or in the aggregate, reasonably be
expected to result in a Material Adverse Effect.
3.15 Compliance with Laws; Permits.
(a) Except as set forth in Section 3.15(a) of the Disclosure Letter, each of the Company and
the Division Entities is in compliance in all material respects with all applicable Laws with
respect to the Division except where such non-compliance would not, individually or in the
aggregate, reasonably be expected to result in a Material Adverse Effect; provided,
however, that the provisions of this Section 3.15(a) shall not apply to: (i) ERISA and
other Laws applicable to the Benefit Plans, which are addressed in Section 3.12 hereof; (ii) Laws
18
regarding the payment of Taxes, which are addressed in Section 3.13 hereof; (iii) Laws regarding
employment and employment practices, which are addressed in Section 3.16 hereof; (iv) Environmental
Laws (as hereinafter defined), which are addressed in Section 3.17 hereof, and (v) Laws regarding
healthcare regulatory matters, which are addressed in Section 3.18 hereof.
(b) Except as set forth in Section 3.15(b) of the Disclosure Letter and as would not,
individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect:
(i) each Facility possesses all permits, certificates, licenses, approvals, governmental franchises
and other authorizations (“Permits”) presently required or necessary to own or lease, as the case
may be, and to operate its respective properties and to carry on its respective businesses as
presently conducted; (ii) each Facility has fulfilled and performed all of its obligations with
respect to such Permits and no event has occurred which allows, or after notice or lapse of time
would allow, revocation or the termination thereof or results in any other impairment of the rights
of the holder of any such Permits; and (iii) none of the Facilities has received any written notice
of the institution of any proceeding to revoke any such Permits.
3.16 Labor Matters. With respect to the Division: (a) each of the Company and the
Division Entities is in compliance in all material respects with all applicable Laws regarding
employment and employment practices; (b) there are no material unfair labor practice charges or
complaints against the Company or any of the Division Entities brought before the
National Labor Relations Board nor is there any material grievance or any material arbitration
proceeding arising out of or under collective bargaining agreements with respect to the Business of
the Company or the Division Entities nor, to the Knowledge of Seller, is any such charge,
complaint, grievance or proceeding threatened; (c) since January 1, 2005, there has not been any
labor strike or material work stoppage pending or, to the Knowledge of Seller, threatened against
the Company or the Division Entities; and (d) there is no material charge or complaint pending or,
to the Knowledge of Seller, threatened against the Company or any of the Division Entities before
the Equal Employment Opportunity Commission or any similar state, local or foreign agency
responsible for the prevention of unlawful employment practices. Since January 1, 2005, to the
Knowledge of Seller, neither the Company nor any Division Entity has received written notice of the
intent of any federal, state, local or foreign Governmental Entity responsible for the enforcement
of employment Laws to conduct an investigation of or relating to the Company, or the Division
Entities, and no such investigation is in progress.
3.17 Environmental. (a) The Company, the Division Entities and the Facilities are
and, since January 1, 2005, have been in compliance in all material respects with all Environmental
Laws and environmental Permits and have not received any material written claim, notice, request
for information, penalty assessment or demand, and no Litigation is pending or, to the Knowledge of
Seller, threatened in writing, regarding any material violation of or material liability under any
Environmental Law or environmental Permit, which is pending and unresolved; (b) there have been no
material Releases of any Hazardous Substances which have required or would reasonably be expected
to require reporting, investigation, remediation or other response action or the payment of
material costs with respect thereto by the Company or any of the Division Entities or with respect
to the Facilities; and (c) Seller has provided copies or otherwise reasonably made available for
review by Buyer, copies of all material environmental reports, studies, assessments or audits in
Seller’s, the Company’s or any Division Entities’ possession or control.
19
3.18 Health Care Regulatory Matters.
(a) Compliance with Health Care Law/Fraud and Abuse. Except as set forth in Section
3.18(a) of the Disclosure Letter, Seller, the Company and each Division Entity are, and, to the
Knowledge of Seller, at all times for the two years immediately preceding the date of this
Agreement have been, in compliance with all applicable federal, state and municipal statutes,
regulations, rules and orders and other requirements of any Governmental Entity to which it is
subject with respect to health care laws and health care regulatory and fraud and abuse matters,
including, without limitation, those relating to third-party reimbursement (including, but not
limited to, Medicare, Medicaid, CHAMPUS, TRICARE and other federal health care programs
(collectively “Federal Health Care Programs”)), the federal health care program anti-kickback law,
42 U.S.C. § 1320a-7b (commonly referred to as “Anti-Kickback Law”), the federal physician
self-referral law, 42 U.S.C. § 1395nn (commonly referred to as the “Xxxxx Law”), the federal False
Claims Act, 31 U.S.C. § 3729 et seq., the Health Insurance Portability and Accountability Act of
1996, Pub. Law. 104-99 (commonly referred to as “HIPAA”), and applicable sections of the Social
Security Act, except for any such non-compliance which would not, individually or in the aggregate,
reasonably be expected to result in a Material Adverse Effect.
(b) No Medicare and Medicaid Exclusion. Except as set forth in Section 3.18(b) of the
Disclosure Letter, since January 1, 2005, (i) neither the Company nor any Division Entity has (A)
had a civil monetary penalty assessed against it under Section 1128A of the Social Security Act or
any regulations promulgated thereunder; (B) been convicted of, charged with, indicted or
investigated for a Medicare, Medicaid or other Federal Health Care Program (as defined in 42 U.S.C.
§ 1320a-7b(f)) related offense, or convicted of, charged with, indicted or investigated for a
violation of federal or state law relating to fraud, theft, embezzlement, breach of fiduciary
responsibility, financial misconduct, obstruction of an investigation or controlled substances, (C)
been excluded or suspended from participation in Medicare, Medicaid or any other Federal Health
Care Program, or have been disbarred, suspended or are otherwise ineligible to participate in
federal programs, or (D) committed any offense which may reasonably serve as the basis for any such
exclusion, suspension, disbarment or other ineligibility, and (ii) Seller has not arranged or
contracted with any individual or entity that is suspended, excluded or disbarred from
participation in, or otherwise ineligible to participate in, a Federal Health Care Program, except,
in each case, for any such non-compliance which would not, individually or in the aggregate,
reasonably be expected to result in a Material Adverse Effect.
(c) Participation. The Company and each Division Entity are, to the extent applicable
to their operations, (i) eligible to receive payment under Titles XVIII and XIX of the Social
Security Act, (ii) providers under existing provider agreements with the Medicare program through
applicable intermediaries and with each state Medicaid program under which they have been providers
at any time since January 1, 2005 and (iii) except as set forth on Section 3.18(c) of the
Disclosure Letter, in compliance with, and at all times since January 1, 2005 have been in material
compliance with, all applicable laws, regulations and policies of the Medicare, Medicaid and
CHAMPUS/TRICARE programs, except where such inability in the case of either item (i) or (ii) or
non-compliance in item (iii) could not reasonably be expected to have a Material Adverse Effect.
The Company is a party to a corporate integrity agreement (a
20
“CIA”), as set forth in Section
3.18(c) of the Disclosure Letter, a true and correct copy of which has been provided to Buyer. The
Company is in full compliance with all terms and conditions required of the Company under such CIA.
(d) Medicare, Medicaid and Third-Party Payor Participation/ Accreditation/Contracts.
Except as set forth in Section 3.18(d) of the Disclosure Letter, all health care facilities owned
or operated by the Company or any Division Entity and all services provided by the Company, each
Division Entity or any professional employee or agent acting on behalf of any of them or for which
the Company and/or each Division Entity directly or indirectly receives payment under Medicare,
Medicaid or other Federal Health Care Programs are, to the extent required by law, certified for
participation or enrollment in all such Federal Health Care Programs, have a current and valid
provider contract with such Federal Health Care Programs, are in compliance with the conditions of
participation or enrollment of such Federal Health Care Programs except, in each case, for any such
non-compliance which would not, individually or in the aggregate, reasonably be expected to result
in a Material Adverse Effect. Set forth in Section 3.18(d) of the Disclosure Letter are all of the
Company’s and each Division Entity’s Federal Health Care Program and third-party payor provider
numbers and which outpatient clinics are billing for services rendered utilizing each provider
number. Except as set forth in Section 3.18(d) of the Disclosure Letter, neither the Company nor
any Division Entity has received notice from any governmental agency, fiscal intermediary, carrier or similar
entity which enforces or administers the statutory or regulatory provisions with respect to any
Federal Health Care Program, or from any third-party payor, of any pending or threatened
investigations, and to the Knowledge of Seller and each Division Entity, no such investigations are
pending, threatened or imminent, which could reasonably be expected to have a Material Adverse
Effect. Except as set forth in Section 3.18(d) of the Disclosure Letter, to the Knowledge of
Seller, no action is pending to suspend, limit, terminate, or revoke the status of the Company or
any Division Entity as a provider in any such program, and neither the Company nor any Division
Entity has been provided notice by any such third-party payor of its intention to suspend, limit,
terminate, revoke, or fail to renew any contractual arrangement with the Company or any Division
Entity as a participating provider of services in whole or in part. All returns, cost reports and
other filings made by the Company or any Division Entity with Medicare, Medicaid or any other
governmental health care program or third-party payor are complete and accurate except where the
failure to be so complete and accurate could not reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect. Except as set forth in Section 3.18(d) of the Disclosure
Letter and in connection with the CIA referenced in Section 3.18(c) hereof, no adjustment or
disallowance in any such cost reports and other requests for payment, including adjustments or
disallowances for late filings, has been made or, to the Knowledge of Seller, threatened by any
federal or state agency or instrumentality or other provider reimbursement entities relating to
Medicare or Medicaid or by any third-party payor which, individually or in the aggregate, could
reasonably be expected to have a Material Adverse Effect, and, to the Knowledge of Seller, there is
no basis for any successful claims or requests for recovery of overpayments from any such agency,
instrumentality, entity or third-party payor except for any such claims or requests which could not
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. All
payments required in connection with the CIA referenced in Section 3.18(c) hereof have been made
and no further payments or financial obligations in connection therewith are due and owing or
required thereunder.
21
(e) Reimbursement and Billing. Except as set forth in Section 3.18(e) of the
Disclosure Letter, since January 1, 2005, (a) the Company and each Division Entity has not received
any written notice of denial of payment or overpayment of a material nature from a Federal Health
Care Program or any other third-party reimbursement source (inclusive of managed care
organizations) with respect to items or services provided by the Company and/or any Division
Entity, other than those which have been finally resolved in any settlement for an amount less than
$100,000, (b) to the Knowledge of Seller, there is no basis for the assertion after the Closing of
any such denial or overpayment claim, and (c) neither the Company nor any Division Entity has
received written notice from a Federal Health Care Program or any other third-party reimbursement
source (inclusive of managed care organizations) of any pending or threatened claims, proceedings,
investigations or surveys specifically with respect to, or arising out of, items or services
provided by the Company or any Division Entity, and to the Knowledge of Seller, no such
investigation or survey is pending, threatened or imminent which, individually or in the aggregate,
would have a Material Adverse Effect. All billing by, or on behalf of, the Company or any Division
Entity to third-party payors, including, but not limited to, Federal Health Care Programs and
insurance companies has been true and correct in all material respects except where the failure to
be so complete and accurate could not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect. Except as set forth in Section 3.18(e) of the Disclosure
Letter, neither the Company nor any Division Entity has received any
notice from any third-party payor, including, but not limited to, Federal Health Care
Programs, that indicates that Buyer could not continue to xxxx in substantially the same manner and
structure as the Company or any Division Entity is billing on the date hereof, which change in
billing could reasonably be expected to have a Material Adverse Effect.
3.19 Assets of the Division. Except for Staying Clinics and the services to be
provided under the Transition Agreement, as of the Closing, the assets of the Division Entities
will constitute all of the assets necessary to operate the Business in the manner presently
conducted and as reflected in the Interim Pro Forma Income Statements, except for assets disposed
of by the Division in the ordinary course of Business. At Closing, the Company and the Division
Entities will be the only Affiliates of Seller that are engaged in the operation of the Division.
Except as set forth in Section 3.19 of the Disclosure Letter, none of the Excluded Assets (other
than Staying Clinics) are primarily used in or necessary for the operation of the Business in the
manner presently conducted or as reflected in the Interim Pro Forma Income Statements. Except for
Staying Clinics and as set forth in Section 3.19 of the Disclosure Letter, after giving effect to
the Restructuring Transactions, Seller will not, directly or indirectly, own any assets that are
primarily used in or, except as reflected in the Transition Agreement, are necessary for the
operation of the Business in the manner presently conducted or as reflected in the Interim Pro
Forma Income Statements. The Interim Pro Forma Income Statements do not reflect the operations of
any Staying Clinics, except for Staying Clinics closed after September 30, 2006, as set forth in
Section 3.19 of the Disclosure Letter.
3.20 Brokers. Except for Xxxxxxx, Xxxxx & Co., no broker, finder or financial advisor
or other Person is entitled to any brokerage fees, commissions, finders’ fees or financial advisory
fees in connection with the transactions contemplated hereby or by the Ancillary Agreements by
reason of any action taken by Seller, the Company or any Division Entity. Such fees and expenses
of Xxxxxxx, Sachs & Co. shall be borne by Seller.
22
3.21 NO OTHER REPRESENTATIONS. EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES
EXPRESSLY SET FORTH IN THIS AGREEMENT OR IN ANY DOCUMENT DELIVERED PURSUANT TO THIS AGREEMENT,
SELLER HAS NOT MADE AND DOES NOT HEREBY MAKE ANY EXPRESS OR IMPLIED REPRESENTATIONS OR WARRANTIES,
STATUTORY OR OTHERWISE, OF ANY NATURE, INCLUDING WITH RESPECT TO ANY EXPRESS OR IMPLIED
REPRESENTATION OR WARRANTY AS TO THE MERCHANTABILITY, QUALITY, QUANTITY, SUITABILITY OR FITNESS FOR
ANY PARTICULAR PURPOSE OF THE ASSETS AND PROPERTIES OF, OR THE RESULTS TO BE OBTAINED BY, THE
DIVISION. EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES EXPRESSLY SET FORTH IN THIS AGREEMENT OR
IN ANY DOCUMENT DELIVERED PURSUANT TO THIS AGREEMENT, ALL OTHER WARRANTIES, EXPRESS OR IMPLIED,
STATUTORY, COMMON LAW OR OTHERWISE, OF ANY NATURE, INCLUDING WITH RESPECT TO THE MERCHANTABILITY,
QUALITY, QUANTITY, SUITABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE OF THE ASSETS AND PROPERTIES
OF, OR THE RESULTS TO BE OBTAINED BY, THE COMPANY OR THE DIVISION ENTITIES, ARE HEREBY DISCLAIMED
BY SELLER.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF BUYER
REPRESENTATIONS AND WARRANTIES OF BUYER
Buyer hereby represents and warrants to Seller as follows:
4.1 Organization; Authority. Buyer is a corporation duly organized, validly existing
and in good standing under the laws of the State of Delaware. Buyer has all requisite corporate
power and authority to enter into this Agreement and the Transition Agreement, to perform its
obligations hereunder and thereunder and to consummate the transactions contemplated hereby and
thereby. The execution, delivery and performance by Buyer of this Agreement, and the consummation
of the transactions contemplated hereby and thereby, have been duly authorized by all necessary
corporate action on the part of Buyer. This Agreement has been (and the Transition Agreement, upon
execution and delivery, will be) duly executed and delivered by Buyer and constitutes (and the
Transition Agreement, upon execution and delivery, will constitute) a valid and binding obligation
of Buyer, enforceable against Buyer in accordance with its and their respective terms, except that
(i) such enforcement may be subject to any bankruptcy, insolvency, reorganization, moratorium,
fraudulent transfer or other laws, now or hereafter in effect, relating to or limiting creditors’
rights generally and (ii) the remedy of specific performance and injunctive and other forms of
equitable relief may be subject to equitable defenses and to the discretion of the court before
which any proceeding therefor may be brought.
4.2 No Violation; Consents and Approvals. The execution and delivery by Buyer of this
Agreement and the Transition Agreement do not, and the performance by Buyer of its obligations
hereunder and thereunder and compliance with the terms hereof and thereof will not, (a) conflict
with the certificate of incorporation or by-laws of Buyer, or (b) subject to the receipt of the
Consents and the making of the Filings referred to in this Section 4.2, result in any violation of
or default under, or give rise to a right of termination or cancellation, or result in the creation
of any Lien upon any of the properties or assets of Buyer under, (i) any Law applicable to Buyer or
(ii) any material note, bond, mortgage, indenture, license, agreement, lease or other
23
instrument
or obligation to which Buyer is a party or by which Buyer or its assets may be bound, other than any
such items as to which requisite waivers or Consents have been obtained or which would not,
individually or in the aggregate, reasonably be expected to impair Buyer’s ability to consummate
the transactions contemplated by this Agreement or the Ancillary Agreements. Except as set forth
in Section 4.2 of the Disclosure Letter, no Consent of, or Filing with, any Governmental Entity, or
any third Person, is required to be obtained or made by or with respect to Buyer or its Affiliates
in connection with the execution and delivery of this Agreement or the Ancillary Agreements, or the
consummation by Buyer of the transactions contemplated hereby and thereby, other than: (A)
compliance with and Filings under the HSR Act; and (B) compliance with and Filings under the
Exchange Act, except for any such Consents which would not, individually or in the aggregate,
reasonably be expected to impair the ability of Buyer to consummate the transactions contemplated
by this Agreement and the Ancillary Agreements.
4.3 Litigation. (a) There is no Litigation pending or, to the knowledge of Buyer,
threatened, by or before any Governmental Entity, or by or on behalf of any third party, which, if
adversely determined, would reasonably be expected to impair the ability of Buyer to consummate the
transactions contemplated by this Agreement and the Ancillary Agreements, and (b) there are no
outstanding judgments, decrees or orders of any court or Governmental
Entity affecting Buyer or its assets, which would reasonably be expected to impair the ability
of Buyer to consummate the transactions contemplated by this Agreement and the Ancillary
Agreements.
4.4 Financing. Buyer has, and shall have at the Effective Time, access to sufficient
funds to perform its obligations under this Agreement and to consummate the transactions
contemplated hereby.
4.5 Acquisition of the Shares for Investment; Securities Act. Buyer is acquiring the
Shares for investment purposes only and not with any present intention of distributing or selling
the Shares in violation of federal, state or other United States securities laws. Buyer agrees
that it will not sell, transfer, offer for sale, pledge, hypothecate or otherwise dispose of the
Shares in violation of any federal, state or other United States securities laws.
4.6 Vote/Approval Required. No vote or consent of the holders of any class or series
of capital stock of Buyer is necessary to approve this Agreement or the Transition Agreement or the
transactions contemplated hereby or thereby. The vote or consent of Buyer is the only vote or
consent necessary to approve this Agreement or the Transition Agreement or the transactions
contemplated hereby or thereby.
4.7 Solvency. Buyer is not entering into the transactions contemplated by this
Agreement with the actual intent to hinder, delay or defraud either present or future creditors.
Assuming that the representations and warranties of Seller contained in this Agreement (without
giving effect to any materiality, Material Adverse Effect or Knowledge qualifiers set forth
therein) are true and correct in all material respects, at and immediately after the Closing, and
after giving effect to this Agreement and the other transactions contemplated hereby, the Company
and the Division Entities: (i) will be solvent (in that both the fair value of their respective
assets will not be less than the sum of their respective debts and that the present fair saleable
value of their respective assets will not be less than the amount required to pay their
24
respective probable liabilities on their respective debts as they become absolute and matured); (ii) will have
adequate capital and liquidity with which to engage in their respective businesses; and (iii) will
not have incurred and do not plan to incur debts beyond their respective abilities to pay as they
become absolute and matured.
4.8 Investigation by Buyer. Buyer has conducted its own independent investigation,
review and analysis of the business, operations, assets, liabilities, results of operations,
financial condition, software, technology and prospects of the Company and the Division Entities,
which investigation, review and analysis was done by Buyer and its Affiliates and, to the extent
Buyer deemed appropriate, by Buyer’s representatives. Buyer acknowledges that Seller has provided
Buyer with access to the properties, premises, Contracts and records of the Company and the
Division Entities for this purpose. Buyer acknowledges that, except for those representations or
warranties expressly set forth in this Agreement, it has not relied on, and shall not be entitled
to rely on, any representation or warranty, either express or implied, previously made by Seller,
the Company or any of their respective agents, representatives, employees or Affiliates as to the
accuracy or completeness of any of the information provided or made available to Buyer or its
agents or representatives. Buyer agrees that none of Seller, the Company, the Division Entities
nor any of their respective agents, representatives, employees or
Affiliates has or shall have any liability or responsibility whatsoever to Buyer or any of its
agents or representatives on any basis (including in contract or tort, under federal or state
securities laws, or otherwise but excluding fraud) based upon any information provided or made
available, or statements made, to Buyer or its agents or representatives prior to the date hereof,
except as provided in this Agreement or the Transition Agreement.
4.9 Brokers. No broker, finder or financial advisor or other Person is entitled to
any brokerage fees, commissions, finders’ fees or financial advisory fees in connection with the
transactions contemplated hereby or by the Transition Agreement by reason of any action taken by
Buyer.
ARTICLE V
COVENANTS OF THE PARTIES
COVENANTS OF THE PARTIES
5.1 Conduct of the Division. Except as contemplated by the terms of this Agreement,
or as set forth in Section 5.1 of the Disclosure Letter, during the period from the date hereof to
the Closing Date, Seller shall cause the Company and the Division Entities to operate the Division
only in the ordinary course consistent with past practice. For the avoidance of doubt, Buyer
acknowledges that notwithstanding anything contained in this Section 5.1 to the contrary, each of
the Company and each Division Entity shall be free to pay cash dividends and other cash
distributions to Seller and the Division Entities and their respective equity owners at any time
and from time to time prior to the Closing Date and to consummate the Restructuring Transactions.
Without limiting the generality of the foregoing, except as expressly contemplated by this
Agreement or as set forth in Section 5.1 of the Disclosure Letter, during the period from the date
of this Agreement to the Closing Date, without the prior written consent of Buyer (which will not
be unreasonably withheld, delayed or conditioned), Seller, with respect to the Division, shall not
permit the Company or any of the Division Entities to:
25
(a) amend its respective certificate of incorporation or by-laws or comparable organizational
documents, other than to the extent required to change the name of the Company or any Division
Entity prior to Closing to eliminate any reference to “HealthSouth” in the name of the Company or
such Division Entity;
(b) create, incur, assume or guarantee any Indebtedness for borrowed money to any Person,
other than Seller or its Subsidiaries or any Division Entity, in an amount in excess of $500,000;
(c) make any loans, advances, capital contributions to, or investments in, any Person, other
than (i) to a Division Entity in the ordinary course of business or (ii) as required by the terms
of any existing written agreement disclosed to Buyer in the Disclosure Letter;
(d) issue, sell, deliver, redeem, repurchase, pledge or otherwise encumber any shares of its
capital stock or other equity interests or any securities convertible into or exchangeable for any
shares of its capital stock or other equity interests, or grant or enter into any options,
warrants, rights, agreements or commitments with respect to the issuance of its capital stock or
other equity interests, or amend any terms of any such securities;
(e) split, combine or reclassify any of its capital stock or other equity interests or issue
or authorize the issuance of any other securities in respect of, in lieu of or in substitution for
shares of their capital stock or other equity interests;
(f) increase the rate of compensation of, or pay or agree to pay any benefit to, its directors
or officers, except as may be required by any existing plan, including any Benefit Plan, agreement
or arrangement, and except in the ordinary course of business, including as part of the Company’s
and the Division Entities’ normal periodic performance reviews and related compensation and benefit
increases;
(g) enter into, adopt or amend in any material respect any written employment (other than
employment agreements terminable at will without liability to the Division), severance or change of
control agreement, or adopt or modify any Benefit Plan, except, in each case, as required by Law;
(h) enter into, adopt, amend or terminate any collective bargaining agreement, other than any
adoption, amendment or termination (i) required by the terms of any existing written agreements
disclosed to Buyer, or (ii) required by Law;
(i) except for any such actions required in connection with the Restructuring Transactions or
the relocation of any Facilities in the ordinary course of business, sell, lease, transfer, or
otherwise dispose of any material properties or assets, real, personal or mixed, or permit any such
asset to become subject to any Lien other than a Permitted Lien, other than in the ordinary course
of business consistent with past practice;
(j) except for any such actions required in connection with the Restructuring Transactions,
acquire by merging or consolidating with, or by purchasing the stock or a substantial portion of
the assets of, or by any other manner, any business or any corporation,
26
partnership, association or other business organization or division thereof or otherwise acquire any assets (other than
inventory in the ordinary course of business of the Company and the Division Entities and other
than as permitted by clause (m) below) for consideration having a fair value in excess of
$1,000,000, for any single transaction or series of related transactions, or $5,000,000 in the
aggregate;
(k) except in the ordinary course of business consistent with past practice, amend or modify
in any material respect or terminate any Material Contract, other than as contemplated in Section
2.4(a) or Section 2.4(b) of the Disclosure Letter or the relocation of any Facilities in the
ordinary course of business;
(l) enter into any joint venture, jointly owned partnership or other similar joint ownership
agreements, other than such agreements entered into in the ordinary course of business consistent
with past practice;
(m) except for such expenditures incurred in the ordinary course of business and which are
paid for before Closing or included as a liability in the calculation of Net Working Capital, make
or incur any capital expenditure that is not contemplated by the Division’s budget for fiscal 2007;
(n) make or change any election related to Taxes (unless required by Law), the making or
changing of which would materially increase the Company’s or any of the Division Entities’
liability for Taxes subsequent to the Closing Date;
(o) settle or compromise any material Tax liability, except in the ordinary course of
business;
(p) make any change in any method of accounting or accounting practice or policy, other than
as required by changes in GAAP or in Law;
(q) dissolve, wind-up or liquidate, other than any such dissolution, winding up or liquidation
which is in process on the date hereof;
(r) cancel any material Indebtedness owed to any Division Entity or waive any rights or claims
of substantial value, in each case other than in the ordinary course of business consistent with
past practice;
(s) initiate any Litigation that is not Retained Litigation, other than in the ordinary course
of business consistent with past practice;
(t) amend or modify any CIA in a manner adverse to the Company or any Division Entity; or
(u) agree in writing to do any of the foregoing or not to take any action required by this
Agreement.
5.2 Access to Information Prior to the Closing; Confidentiality; Cooperation.
27
(a) During the period from the date of this Agreement through the Closing Date, Seller shall,
and shall cause the Company and the Division Entities to, give Buyer and its authorized employees,
accountants, counsel and other representatives (such entities and representatives other than Buyer
being referred to as “Buyer Representatives”) reasonable access during regular business hours to
all offices, personnel, facilities, books and records of Seller, the Company or the Division
Entities as they may reasonably request, and shall furnish or cause to be furnished to Buyer such
financial and operating data and other information with respect to the business and properties of
the Division as Buyer may from time to time reasonably request and as may be necessary to enable
Buyer to have its own financial, payroll and accounting systems in place as of the Closing Date so
as to not need to rely on Seller to provide such services after the Closing, and Seller agrees to
reasonably cooperate with Buyer in connection with such transition matters; provided,
however, that (i) Buyer and Buyer Representatives shall take such action as is deemed
necessary in the reasonable judgment of Seller to schedule such access and visits through only
those specifically identified representatives of Seller and in such a way as to avoid unreasonably
disrupting the normal business of the Company and the Division Entities; (ii) the Company and the
Division Entities shall not be required to take any action which would constitute a waiver of the
attorney-client or other privilege; (iii) the Company and the Division Entities need not supply
Buyer with any information which, in the reasonable judgment of Seller, the Company or any of the
Division Entities is under a legal obligation not to supply; and (iv) Seller, the Company and the
Division Entities shall not be required to supply Buyer with any information that does not relate to
the Division. No information received pursuant to this Section 5.2 shall affect or be deemed to
modify or update any of the representations and warranties of Seller contained in this Agreement.
(b) Buyer shall hold, and shall cause Buyer Representatives to hold, any information which it
or they receive in connection with the activities and transactions contemplated by this Agreement
and the Ancillary Agreements in strict confidence in accordance with and subject to the terms of
the confidentiality agreement between Buyer and Seller (the “Confidentiality Agreement”), which
shall survive the execution and delivery of this Agreement, and any termination of this Agreement
pursuant to Article X hereof, but shall be terminated and of no further force and effect as of the
Closing.
5.3 Commercially Reasonable Efforts. Subject to the terms and conditions of this
Agreement, each of the parties hereto shall use all commercially reasonable efforts to take, or
cause to be taken, all actions, and to do, or cause to be done, all things necessary, proper or
advisable under applicable Laws and regulations to consummate the transactions contemplated by this
Agreement and the Ancillary Agreements at the earliest practicable date.
5.4 Consents. Without limiting the generality of Section 5.3 hereof, each of the
parties hereto shall use commercially reasonable efforts to obtain all Consents of, and make all
Filings with, all Governmental Entities and third parties required in connection with the
consummation of the transactions contemplated by this Agreement prior to the Closing. Without
limiting the generality of the preceding sentence, Buyer specifically agrees to reasonably
cooperate with Seller in obtaining Consents for Required Third Party Payor Contracts. Within ten
(10) Business Days following the date hereof, each of the parties hereto shall make or cause to be
made all Filings under Laws applicable to it as may be required for the consummation of the
transactions contemplated by this Agreement and the Ancillary Agreements. In addition to
28
the foregoing, Buyer agrees to provide such assurances as to financial capability, resources and
creditworthiness as may be reasonably requested by any Governmental Entity or third party whose
Consent is sought or to whom a Filing is made hereunder. Buyer and Seller shall coordinate and
cooperate with each other in exchanging such information and assistance as any of the parties
hereto may reasonably request in connection with the foregoing.
5.5 Antitrust Notification. Subject to Section 10.2(b) hereof, Buyer and Seller shall
use their respective reasonable best efforts to obtain all authorizations or waivers required under
the HSR Act to consummate the transactions contemplated hereby and by the Ancillary Agreements,
including (a) making all Filings with the Antitrust Division of the Department of Justice (“DOJ”)
or the Federal Trade Commission (“FTC”) required in connection therewith (the initial filing to
occur no later than ten (10) Business Days following the execution and delivery of this Agreement),
(b) responding as promptly as practicable to all inquiries received from the DOJ or the FTC for
additional information or documentation, and (c) resolving any objections that may be asserted by
any Governmental Entity with respect to the transactions contemplated by this Agreement in
connection with any Filings made in accordance with this Section 5.5. Each of Buyer and Seller
shall furnish to the other such necessary information and reasonable assistance as the other may
request in connection with its preparation of any filing or submission which is necessary under the
HSR Act. Seller and Buyer shall keep
each other apprised of the status of any communications with, and any inquiries or requests
for additional information from, the DOJ or the FTC. Notwithstanding anything to the contrary in
this Agreement, Buyer and Seller will use their respective reasonable best efforts to offer to
take, or cause to be taken, all other actions and do, or cause to be done, all other things
necessary, proper or advisable to consummate and make effective the transactions contemplated by
this Agreement and the Ancillary Agreements, including taking all such further action as reasonably
may be necessary to resolve such objections, if any, as the DOJ or the FTC or state antitrust
enforcement authorities or any other Person may assert under the HSR Act with respect to the
transactions contemplated hereby, and to avoid or eliminate each and every impediment under any Law
that may be asserted by any Governmental Entity with respect to the transactions contemplated
hereby so as to enable the Closing to occur as soon as expeditiously possible, including, without
limitation, (i) proposing, negotiating, committing to and effecting, by consent decree, hold
separate order or otherwise, the sale, divestiture or disposition of such assets or businesses of
the Division or of Buyer or any of its Subsidiaries, and (ii) otherwise taking or committing to
take actions that after the Closing Date would limit the freedom of the Division or of Buyer or any
of its Subsidiaries with respect to, or its ability to retain, one or more of their respective
businesses or assets, in each case, as may be required in order to avoid the entry of, or to effect
the dissolution of, any injunction, temporary restraining order or other order in any suit or
proceeding which would otherwise have the effect of preventing or materially delaying the Closing,
provided, however, that nothing in this Agreement shall require or be construed to
require any of Buyer or any of its Subsidiaries to take any action, propose or make any divestiture
or other undertaking, or propose or enter into any consent decree, except for those that would not,
individually or in the aggregate, reasonably be expected to be materially adverse to the outpatient
segment of Buyer and its Subsidiaries taken as a whole (assuming for this purpose, that the
transactions contemplated hereby have already been consummated).
5.6 Public Announcements. Seller and Buyer shall not, and shall cause their
respective Subsidiaries not to, issue any public report, statement or press release or otherwise
29
make any public statement with respect to this Agreement or the Ancillary Agreements and the
transactions contemplated hereby or thereby, from the date hereof through the Closing Date, without
prior consultation with and approval of the other party (which approval shall not be unreasonably
withheld, delayed or conditioned), except as may be required by Law or securities exchange
regulations applicable to any such party, in which case such party shall advise the other party and
discuss the contents of the disclosure before issuing any such report, statement or press release.
In addition, except as provided in this Section 5.6, Seller and Buyer shall not make any general
communication to suppliers, creditors, distributors, employees, customers or others having business
or financial relationships with the Division pertaining to this Agreement or the Ancillary
Agreements and the transactions contemplated hereby or thereby, without the prior written approval
of the other party (which approval will not be unreasonably withheld, delayed or conditioned).
Immediately following the execution and delivery of this Agreement, Seller and Buyer shall issue a
press release to be mutually agreed upon with respect to this Agreement and the transactions
contemplated hereby.
5.7 Supplemental Disclosure.
(a) Seller shall from time to time prior to the Closing promptly supplement or amend the
Disclosure Letter with respect to (i) any matter that existed as of the
date of this Agreement and should have been set forth or described in the Disclosure Letter
and (ii) any matter hereafter arising which, if existing as of the date of this Agreement, would
have been required to be set forth or described in the Disclosure Letter; provided,
however, that, with respect to clause (i) above, any such supplemental or amended
disclosure shall not be deemed to have been disclosed as of the date of this Agreement unless
expressly consented to in writing by Buyer; provided further, that, with respect to
clause (ii) above, any such supplement or amended disclosure shall, for purposes of this Agreement
and the Ancillary Agreements (other than for the purposes of determining whether the conditions set
forth in Article IX hereof are satisfied), be deemed to have been disclosed as of the date of this
Agreement.
(b) Seller shall promptly notify Buyer of, and furnish Buyer any information it may reasonably
request with respect to, the occurrence, to the Knowledge of Seller, of any event or condition or
the existence, to the Knowledge of Seller, of any fact that would cause any of the conditions to
Buyer’s obligation to consummate the purchase and sale of the Shares not to be fulfilled.
5.8 Certain Licenses and Permits. Seller covenants that all Permits which are held in
the name of Seller or any of its Affiliates (other than the Company and the Division Entities) or
any employee, officer, director, stockholder or agent of Seller or any of its Affiliates (including
the Company and the Division Entities) or otherwise on behalf of the Company or any of the Division
Entities, that are used in the Business shall be duly and validly transferred, to the extent
legally transferable, to the Company or one of the Division Entities without consideration prior to
the Closing and that the warranties, representations, covenants and conditions contained in this
Agreement shall apply to such Permits as if held by the Company or such Division Entity as of the
date hereof.
5.9 Records; Cooperation.
30
(a) On the Closing Date or at such other time as may be specified in Section 5.9(a) of the
Disclosure Letter, Seller shall deliver or cause to be delivered to Buyer, but only to the extent
permitted by applicable Law, all original agreements, documents, books, records and files,
including without limitation financial information, asset management information, cash management
information, licensing or certification files, Medicare or Medicaid cost reports, audits, appeals
and related documentation, Real Property leases and other information listed in Section 5.9(a) of
the Disclosure Letter (collectively, “Records”), if any, in the possession of Seller or any of its
Affiliates, relating primarily to the Division and the Division Entities to the extent not then in
the possession of the Company and the Division Entities (and in the case of Records available in
electronic form, such Records will also be delivered to Buyer in electronic form in a manner
reasonably acceptable to Buyer), subject to the following exceptions:
(i) Buyer recognizes that certain Records may contain incidental information relating
to the Company and the Division Entities or may relate primarily to Subsidiaries or
divisions of Seller other than the Company and the Division Entities, and that Seller may
retain such Records and shall provide copies of the relevant portions thereof to Buyer; and
(ii) Seller may retain all Records prepared in connection with the sale of the Shares,
including all information and correspondence received from other parties and analyses
relating to the Company and the Division Entities; provided, however, that
any confidentiality agreements entered into by Seller with respect to the proposed sale of
the Division shall be assigned to Buyer or the Company effective as of the Closing Date to
the extent assignable.
(b) In order that Seller may (i) properly respond to, conduct, manage or otherwise participate
in any Litigation which may arise from, or relate to, any of the matters set forth on Section
5.9(b) of the Disclosure Letter, or any settlement, arrangement or agreement entered into in
connection therewith (collectively, the “Retained Litigation”) and (ii) investigate, defend and
otherwise respond to or satisfy Retained Liabilities, Buyer agrees to use its commercially
reasonable efforts to reasonably cooperate, and to cause its Affiliates, employees, accountants,
counsel and other representatives to reasonably cooperate, with Seller, its Affiliates, employees,
accountants, counsel and other representatives in connection with the Retained Litigation and
Retained Liabilities, and Seller agrees to reimburse Buyer for any reasonable out-of-pocket costs
of any such cooperation. Following the Closing, neither Buyer, the Company, nor any Division
Entity shall have any rights or liabilities in connection with the Retained Litigation or the
Retained Liabilities and Seller shall have the right to settle the Retained Litigation on behalf
and in the name of the Company and/or any of the Division Entities; provided,
however, that Seller shall not, without the consent of Buyer (which consent shall not be
unreasonably withheld, delayed or conditioned), enter into any settlement with respect to any
Retained Litigation which settlement provides for any injunctive or other equitable relief with
respect to the Business of the Division or which requires the Company or the Division to pay any
amount of money. Without limiting the scope of the foregoing and except for books and records
relating to Taxes, which are addressed by Section 6.1(b)(vi) hereof, following the Closing, Buyer
shall permit Seller and its authorized representatives, during normal business hours and upon
reasonable notice, to have reasonable access to, and examine and make copies of (at Seller’s
31
expense), all books, records and personnel of the Company and the Division Entities which relate to
transactions or events occurring prior to the Closing, including, without limitation, the events or
circumstances giving rise to the Retained Litigation and Retained Liabilities (“Pre-Closing
Transactions”) or transactions or events occurring subsequent to the Closing which are related to
or arise out of Pre-Closing Transactions, in each case, to the extent such Pre-Closing Transactions
relate to obligations of Seller or as necessary to comply with applicable financial reporting
obligations. Buyer agrees that it shall retain all such books and records for a period of seven
years following the Closing Date, or for such longer period following the Closing Date as may be
required by Law. Seller shall hold, and shall cause its Affiliates and representatives to hold,
any information which it or they receive in connection with the access granted pursuant to this
Section 5.9(b) in strict confidence and will not disclose such information to any Person unless
required by applicable law or with the prior written consent of Buyer (which will not unreasonably
be conditioned, withheld or delayed).
(c) Seller and Buyer agree that it is the parties’ mutual intent that all Division Offerees
who are to become Transferred Employees be transitioned over to Buyer’s payroll system at the
Closing, and each of Seller and Buyer agree to use their respective commercially reasonable efforts
in order to reasonably cooperate, and to cause their respective
Affiliates, employees, accountants, counsel and other representatives to reasonably cooperate,
with the other party in accomplishing such transition. In the event that, despite the exercise of
the efforts set forth in the preceding sentence, Buyer is not able to reflect such Division
Offerees on its payroll system as of Closing, then such Division Offerees shall continue to be
employees of Seller or its applicable Subsidiary until such time, not later than ninety (90) days
after the Closing Date, as Buyer is able to reflect such Division Offerees on its payroll (the
later of such date and the Closing Date being hereinafter referred to as the “Transition Date”).
From the period beginning on the Closing Date and ending on the Transition Date, (i) Seller agrees
to continue to reflect such Division Offerees who are to become Transferred Employees on Seller’s
payroll system and to lease or second such employees to Buyer pursuant to the terms of an employee
lease agreement on terms to be mutually agreed upon by Buyer and Seller, and (ii) Buyer agrees to
reimburse Seller for all associated costs and expenses incurred by Seller in its performance of
this Section 5.9(c), including, without limitation, all expenses relating to such Division
Offerees’ base salary or wage rate, as applicable, bonuses and employee benefits and all reasonable
costs and overhead of Seller in connection with providing the payroll services provided
hereunder.
(d) Seller and Buyer agree that the Division and Buyer are not and will not be, by virtue
of this Agreement or the transactions contemplated hereunder, assuming any liabilities or
obligations under the Amended and Restated Class Settlement Procedure Agreement and Consent Decree
or any other obligations stemming from a proposed class action styled Access Now, Inc., a
Florida Corporation, Xxxxxx Xxxxxxx, Xxxxx Xxxxxxxxx Xxxxx and Xxxxx Xxxx, individuals v. St.
Petersburg Surgery Center, Ltd., et al., Civil Action No. 8:01-CV-T-17EAJ filed in the United
States District Court for the Middle District of Florida.
5.10 Preparation of Financial Statements. In the event that Buyer reasonably
determines, based upon the advice of its independent accountants or a request by the Securities and
Exchange Commission (“SEC”), that it requires any financial statements (audited or otherwise) with
respect to the Division in addition to the financial statements described in
32
Section 3.7 hereof in
order to comply with the requirements of the SEC, Seller shall use commercially reasonable efforts
to afford Buyer and its auditors access to (a) the books and records of Seller, the Company and the
Division Entities (to the extent related to the Division only) and (b) Seller’s auditors and
personnel to the extent reasonably required by Buyer to prepare and/or audit all such financial
statements. The cost and expense of preparing such additional financial statements (including the
costs of Seller’s auditors) shall be borne solely by Buyer. Seller agrees to, and to use
reasonable efforts to cause its Affiliates, advisors, accountants, auditors, attorneys and
representatives to, reasonably cooperate with Buyer and its auditor in the preparation of such
additional financial statements, including by using commercially reasonable efforts to provide
customary auditor representation letters, and Buyer agrees to reimburse Seller for any reasonable
out-of-pocket costs incurred in connection with such cooperation. For the avoidance of doubt, any
information obtained by Buyer or its auditors pursuant to this Section 5.10 shall be subject, prior
to the Closing Date, to the restrictions set forth in Section 5.2(b) hereof. From and after the
Closing Date, Buyer shall, and shall use reasonable efforts to cause its Affiliates, advisors,
accountants, auditors, attorneys and representatives to, hold any material non-public information
concerning or relating to Seller or any of its Subsidiaries (other than the Company and the
Division Entities) in confidence except for such disclosures as may be (i) consented to by Seller
in writing or (ii) required by Law.
5.11 Covenant Not to Compete.
(a) Seller Covenant.
(i) In order to induce Buyer to enter into this Agreement, Seller hereby covenants and
agrees that, except as otherwise provided herein, from and after the Closing and until the
fifth (5th) anniversary of the Closing Date, it shall not, and shall cause its controlled
Affiliates not to, directly or indirectly, participate in the management, operation or
control of, or have any financial or ownership interest in, or aid or knowingly assist
anyone else in the conduct of (including providing financing or leasing any assets to), any
business or entity that (a) engages in the Business in any Restricted Territory, or (b) is,
to Seller’s Knowledge, making preparations for engaging in such Business in any Restricted
Territory; provided, however, that Seller may (y) acquire a Person that
engages in the Business, among other activities of such Person, in any Restricted Territory,
provided that such Person’s EBITDA from the conduct of the Business in such Restricted
Territory do not exceed 10% of its total EBITDA for the completed portion of its then
current fiscal year or the full fiscal year immediately prior to such acquisition, and (z)
enter into, at arm’s length, any bona fide joint venture (or partnership or other business
arrangement) with any Person who is not directly engaged in the Business but which is an
Affiliate of another Person engaged in the Business; and provided, further,
that nothing contained in this Section 5.11(a)(i) shall prohibit or otherwise restrict
Seller’s current or future operation of (a) the facilities listed in Section 5.11(a)(i) of
the Disclosure Letter which provide outpatient therapy in affiliation with one of Seller’s
inpatient rehabilitation facilities or (b) any of the four facilities listed in Section
5.11(a)(i) of the Disclosure Letter which provide outpatient therapy in affiliation with one
of Seller’s long-term acute care hospitals, or, with respect to both clauses (a) and (b), a
relocation of such a facility. In addition, nothing contained in this Section 5.11(a)(i)
will prohibit Seller from operating one (but not more than one) facility that
33
provides
outpatient therapy in affiliation with an inpatient rehabilitation facility that is built,
developed or acquired by Seller after the date hereof. In the event Seller acquires a
Person that engages in the Business in compliance with clause (b)(y), then in each such case
Seller shall, within twelve (12) months after the date that such acquisition is consummated,
sell or otherwise divest itself of the portion of such acquired Person that engages in the
Business and promptly provide written notice to Buyer of such intended divestiture.
(ii) For a period of two (2) years from and after the date hereof, neither Seller nor
any of its Subsidiaries shall, directly or indirectly, without the prior written consent of
Buyer: (x) solicit or direct any other Person to solicit any officer or other employee (or
any Person who was an officer or employee of the Company or any Division Entity within six
(6) months of the date of any such solicitation, if such Person’s employment was not
terminated by the Company or such Division Entity) to: (A) terminate such officer’s or
employee’s employment with the Company or any Division Entity; or (B) seek or accept
employment or other affiliation with Seller or its Subsidiaries (other than, in each case,
any solicitation directed at the public in general in publications available to the public
in general or any contact which Seller or its Subsidiaries can demonstrate was initiated by
such officer, director or employee or any contact six (6) months after such officer’s or
employee’s employment with the Company
or any Division Entity is terminated) or (y) hire, employ or retain as a consultant or
direct any other person to hire, employ or retain as a consultant, any such officer or other
employee of the Company or any Division Entity (or any Person who was an officer or employee
of the Company or any Division Entity within six (6) months of the date of any such hiring,
if such Person’s employment was not terminated by the Company or any Division Entity).
Seller’s obligations under this Section 5.11(a)(ii) with respect to new Company and Division
Entity employees hired after the Closing Date shall be subject to the condition that Buyer
shall have notified Seller of the names of such new employees.
(iii) Seller hereby acknowledges and agrees that if Seller or any one or more of its
Subsidiaries breaches any provision of this Section 5.11(a), any remedy at law would be
inadequate and that Buyer, in addition to seeking monetary damages in connection with any
such breach (other than a breach arising under Section 5.11(a)(ii)(y)), shall be entitled to
specific performance, and injunctive and other equitable relief to prevent or restrain a
breach of this Section 5.11(a) or to enforce the provisions hereof. Buyer and Seller
acknowledge and agree that, notwithstanding anything to the contrary in this Agreement,
including Article XI hereof, in the event of a breach by Seller or any one or more of its
Subsidiaries of Section 5.11(a)(ii)(y) with regard to any given Person, Buyer’s sole and
exclusive remedy for such breach shall be to cause Seller to terminate the employment or
consultancy of such Person; provided, however, that the foregoing shall not
relieve Seller from any liability for its failure to comply with the provisions of this
sentence.
(b) Buyer Covenant.
(i) For a period of two (2) years from and after the date hereof, neither Buyer nor any
of its Subsidiaries shall, directly or indirectly, without the prior written consent of
Seller, hire, employ or retain as a consultant or direct any other person
34
to hire, employ or
retain as a consultant, any officer or other employee of Seller or its Subsidiaries who is
directly associated with a facility of Seller or its Subsidiaries that provides outpatient
therapy in affiliation with an inpatient rehabilitation facility or (solely with respect to
the four facilities listed in Section 5.11(a)(i) of the Disclosure Letter that provide
outpatient therapy in affiliation with a long-term acute care hospital) long-term acute care
hospital (a “Seller Outpatient Employee”) (or any Person who was a Seller Outpatient
Employee within six (6) months of the date of any such hiring, if such Person’s employment
was not terminated by Seller or its Subsidiaries). Section 5.11(b)(i) of the Disclosure
Statement, as supplemented pursuant to Section 5.7, sets forth a list of all current Seller
Outpatient Employees. Buyer’s obligations under this Section 5.11(b)(i) with respect to new
employees of Seller or its Subsidiaries hired after the Closing Date shall be subject to the
condition that Seller shall have notified Buyer of the names of such new employees.
(ii) Buyer hereby acknowledges and agrees that if Buyer or any one or more of its
Subsidiaries breaches any provision of this Section 5.11(b), any remedy at law would be
inadequate and that Buyer, in addition to seeking monetary damages in connection with any
such breach (other than a breach arising under Section 5.11(b)(i)(y)), shall be entitled to
specific performance, and injunctive and other equitable relief to prevent or restrain a
breach of this Section 5.11(b) or to enforce the provisions
hereof. Buyer and Seller acknowledge and agree that, notwithstanding anything to the
contrary in this Agreement, including Article XI hereof, in the event of a breach by Buyer
or any one or more of its Subsidiaries of Section 5.11(b)(i)(y) with regard to any given
Person, Seller’s sole and exclusive remedy for such breach shall be to cause Buyer to
terminate the employment or consultancy of such Person; provided, however,
that the foregoing shall not relieve Buyer from any liability for its failure to comply with
the provisions of this sentence.
(c) Mutual Covenant. Seller and Buyer intend that the provisions of this Section 5.11
be enforced to the fullest extent permissible under the laws applied in each jurisdiction in which
enforcement is sought. If any provision of this Section 5.11, or any part hereof, shall be held by
a court of competent jurisdiction to be invalid or unenforceable, this Section 5.11 shall be
amended to revise the scope of such provision, to make it enforceable to the fullest extent
permitted by applicable Law, if possible, or to delete such provision or such part, such revision
or deletion to apply only with respect to the operation of this Section 5.11 in the jurisdiction of
such court.
ARTICLE VI
ADDITIONAL AGREEMENTS
ADDITIONAL AGREEMENTS
6.1 Tax Matters.
(a) Section 338(h)(10) Election; Actions to Treat The Company and The Division Entities as
Disregarded.
(i) Seller and Buyer shall jointly make an election under Section 338(h)(10) of the
Code (and any comparable provision of applicable state or local income Tax Law) with respect
to the purchase of the shares of the Company by Buyer
35
(and with respect to the Division
Entities, except those if any as shall be mutually agreed upon by Buyer and Seller) and
shall cooperate with each other to take all actions necessary and appropriate (including
filing such additional forms, returns, elections schedules and other documents as may be
required) to effect and preserve a timely election, in accordance with the provisions of
Treasury Regulation Section 1.338(h)(10)-1 (or any comparable provisions of state or local
Tax Law) (the “Election”).
(ii) In connection with the Election, Buyer and Seller shall mutually prepare an
Internal Revenue Service Form 8023 (or successor form) and all other schedules and documents
as may be required (“Form 8023”) and any comparable forms required by provisions of state or
local Law. With the cooperation of Buyer, Seller shall prepare a draft Form 8023 and
provide such draft Form 8023 to Buyer within twenty (20) days of the provision of the
Conclusive Statement, as provided in Section 1.6(a)(v) hereof. If, within twenty (20) days
of the receipt of the draft Form 8023, Buyer notifies Seller that it disagrees with the
draft Form 8023 and provides Seller with a statement setting out the reasons for its
disagreement, then Seller and Buyer shall attempt to resolve their disagreement within the
twenty (20) days following Buyer’s notification to Seller of such disagreement; otherwise,
the draft Form 8023 shall become the Final Form 8023. If Seller and Buyer are unable to resolve their
disagreement, the dispute shall be submitted to the Accounting Arbiter or such other
internationally recognized accounting firm as Seller and Buyer shall in good faith agree
(the “Independent Accounting Firm”), whose expense shall be borne equally by Seller and
Buyer, for resolution within twenty (20) days of such submission. The Form 8023 delivered
by the Independent Accounting Firm shall be the Final Form 8023. The Final Form 8023 shall
be binding on Seller, Buyer, and their respective Affiliates. Seller and Buyer shall take
no position, and cause their respective Affiliates to take no position, inconsistent with
the Final Form 8023. Neither Seller nor Buyer shall, or shall permit the Company and the
Division Entities to, take any action to modify the Form 8023 (including any corrections,
amendments or supplements thereto) after their execution or to modify or revoke the Election
following the filing of the Form 8023 by Seller without the written consent of Seller or
Buyer, as the case may be.
(iii) In connection with the Election, on or prior to the six-month anniversary of the
Closing Date, (a) Buyer shall provide to Seller a proposed determination of the “Aggregate
Deemed Sales Price” and the “Adjusted Grossed Up Basis” (each, as defined under applicable
Treasury Regulations) with respect to the Company and the Division Entities (except those if
any as shall be mutually agreed upon by Buyer and Seller), which allocations shall be made
in accordance with Section 338(b) of the Code and any applicable Treasury Regulations.
Within fifteen (15) days following such provision, Seller shall have the right to dispute
any such proposed determination or proposed allocation; otherwise, such proposed
determination or proposed allocation shall become final. If Seller so disputes any such
determination or allocation and Buyer and Seller are unable to resolve their disagreement
within the twenty (20) days following notification of such dispute, the dispute shall be
submitted to the Independent Accounting Firm, whose expense shall be borne equally by Buyer
and Seller, for resolution within twenty (20) days of such submission. The decision of the
Independent Accounting Firm with respect to such dispute shall be binding upon Buyer and
Seller. Seller and Buyer (a)
36
shall be bound by the determinations and the allocations
determined pursuant to this paragraph consistently therewith for purposes of determining any
Taxes, including the preparation and filing of Internal Revenue Service Form 8883; (b) shall
prepare and file all Tax Returns to be filed with any Tax authority in a manner consistent
with such allocations; and (c) shall take no position inconsistent with such allocations in
any Tax Return, any proceeding before any Tax authority or otherwise. In the event that any
such allocation is disputed by any Tax authority, the party receiving notice of such dispute
shall promptly notify and consult with the other party hereto concerning resolution of such
dispute.
(iv) Buyer and Seller shall mutually prepare any forms or schedules similar to Form
8023 that are required for provisions of state or local Law that are comparable to Treasury
Regulations Section 1.338(h)(10)-1 in a manner similar to the above procedure. In the event
that the Final Form 8023 (or similar forms or schedules required for provisions of state or
local Law) is disputed by any Tax authority, the party
receiving written notice of the dispute shall promptly notify the other party hereto
concerning such dispute.
(v) Notwithstanding the provisions of Sections 6.1(a)(i) through (iv) or any provision
of Section 5.1, to the extent permitted by applicable Law, Seller may take such action,
including converting the Company and Division Entities to limited liability companies or
similar forms of organization, and shall make such elections as may be required to cause the
Company and each of the Division Entities, other than those Division Entities as may be
mutually agreed between Buyer and Seller prior to Closing, to be treated as entities each of
which is disregarded as separate from its owner, within the meaning of Treasury Department
Regulation 301.7701-2(c)(2) (and any analogous provision of state or local Tax law)
(“Disregarded Entities”), so that, with respect to each such Disregarded Entity Seller shall
be treated as selling, and Buyer shall be treated as purchasing, for all Federal and
applicable state and local income tax purposes, the assets (other than stock of another
Disregarded Entity) held by such Disregarded Entity; provided, however, that
Seller may not take such action without the prior written consent of Buyer with respect to
the Company or any Division Entity if such action would preclude Buyer from obtaining a tax
basis in the assets of such entity equal to the allocable portion of the Purchase Price
pursuant to the provisions of Section 6.1(f) or would otherwise adversely affect Buyer.
Deemed sales of assets pursuant to the provisions of this Section 6.1(a)(v) are referred to
herein as “DRE Sales.”
(b) Tax Return Filings, Refunds, and Credits.
(i) Seller shall timely prepare and file (or cause such preparation and filing) with
the appropriate Tax authorities all required Tax Returns (including any Consolidated Income
Tax Returns), and any amended Tax Returns, with respect to the Division, the Company and
the Division Entities for Tax periods that end on or before the Closing Date (the “Seller
Returns”), and will pay (or cause to be paid) all Taxes due with respect to Seller Returns.
Seller shall provide Buyer with a copy of any such Seller Return.
37
(ii) Buyer shall timely prepare and file (or cause such preparation and filing) with
the appropriate Tax authorities all required Tax Returns with respect to the Division, the
Company, and the Division Entities for all Tax periods that include, but do not end on, the
Closing Date (the “Straddle Period Returns”). The preparation and the filing shall be
consistent with (including, as necessary, attaching copies of any relevant forms of its U.S.
federal income Tax Return for the year including the Closing Date), and Buyer shall take no
position that is inconsistent with, the Election (or, if applicable, the DRE Sales), or the
forms filed with the Tax authorities with respect to the Election (or, if applicable, the
DRE Sales) in any proceeding before any Tax authority. Buyer shall provide Seller with
copies of any Straddle Period Returns at least thirty (30) Business Days (or such lesser
period if, in the case of non-income Taxes, such forty-five (45) Business Day deadline is
not reasonably practicable) prior to the due date thereof (giving effect to any extensions
thereto), accompanied by a statement (the “Straddle Statement”)
setting forth and calculating in reasonable detail the Pre-Closing Taxes (as
hereinafter defined). If Seller agrees with the Straddle Period Return and Straddle
Statement, Seller shall pay to Buyer an amount equal to the Pre-Closing Taxes shown on the
Straddle Statement not later than two (2) Business Days before the due date (including any
extensions thereof) for payment of Taxes with respect to such Straddle Period Return. If,
within ten (10) days of the receipt of the Straddle Period Return and Straddle Statement,
Seller notifies Buyer that it disputes the manner of preparation of the Straddle Period
Return or the Pre-Closing Taxes shown on the Straddle Statement, then Buyer and Seller shall
attempt to resolve their disagreement within the five (5) days following Seller’s
notification to Buyer of such disagreement. If Buyer and Seller are unable to resolve their
disagreement, the dispute shall be submitted to the Independent Accounting Firm, whose
expense shall be borne equally by Buyer and Seller, for resolution within twenty (20) days
of such submission. The decision of the Independent Accounting Firm with respect to such
dispute shall be binding upon Buyer and Seller, and Seller shall pay to Buyer an amount
equal to the Pre-Closing Taxes, as decided by the Independent Accounting Firm, not later
than two (2) Business Days before the due date (including any extensions thereof) for
payment of Taxes with respect to such Straddle Period Return or, if later, within two (2)
Business Days following the resolution of the amount of such Pre-Closing Taxes, provided
that Seller shall reimburse Buyer for any undisputed amounts not later than two (2) Business
Days before the due date (including applicable extensions) for the payment of Taxes with
respect to such Straddle Period Return.
(iii) From and after the Closing Date, Buyer and its Affiliates (including the Company
and the Division Entities) shall not file any amended Tax Return, carryback claim, or other
adjustment request with respect to the Division, the Company or the Division Entities for
any Tax period that includes or ends on or before the Closing Date unless Seller consents in
writing; provided, however, that with respect to any Straddle Period, such
consent shall not be unreasonably withheld, delayed or conditioned.
(iv) For purposes of this Agreement, in the case of any Taxes of the Division, the
Company, or the Division Entities that are payable with respect to any Straddle Period, the
portion of any such Taxes that constitutes “Pre-Closing Taxes” shall:
38
(A) in the case of real property, personal property and other ad valorem Taxes imposed on a
periodic basis with respect to the business or assets of the Division, the Company, or the
Division Entities or otherwise measured by the level of any item, be deemed to be the amount
of such Taxes for the entire Straddle Period (or, in the case of such Taxes determined on an
arrears basis, the amount of such Taxes for the immediately preceding Tax period) multiplied
by a fraction, the numerator of which is the number of calendar days in the portion of the
Straddle Period ending on the Closing Date and the denominator of which is the number of
calendar days in the entire Straddle Period, and (B) in the case of all other Taxes that are
either (x) based upon or related to income or receipts or (y) imposed in connection with any
sale, transfer or assignment or any deemed sale, transfer or assignment of property (real or
personal, tangible or intangible), be deemed equal to the amount that would be payable if
the Tax period ended on the Closing Date. For purposes of clause (B) of the preceding
sentence, any exemption, deduction, credit or other item that is calculated on an annual
basis shall be allocated to the portion of the Straddle Period ending on the Closing Date on a pro
rata basis determined by multiplying the total amount of such item allocated to the Straddle
Period times a fraction, the numerator of which is the number of calendar days in the
portion of the Straddle Period ending on the Closing Date and the denominator of which is
the number of calendar days in the entire Straddle Period. The parties hereto shall, to the
extent permitted by applicable Law, elect with the relevant Tax authority to treat a portion
of any Straddle Period as a short taxable period ending as of the close of business on the
Closing Date. For purposes of this Agreement, “Post-Closing Taxes” shall include any Taxes
of the Division, the Company, and the Division Entities that are payable with respect to a
Straddle Period, except for the portion of any such Taxes that constitutes Pre-Closing
Taxes.
(v) Seller and Buyer shall reasonably cooperate in preparing and filing all Tax Returns
with respect to the Division, the Company, and the Division Entities, including maintaining
and making available to each other all records reasonably necessary in connection with Taxes
of the Division, the Company, or the Division Entities and in resolving all disputes and
audits with respect to all Tax periods relating to Taxes of the Division, the Company, and
the Division Entities. Buyer shall prepare (or cause such preparation) within one hundred
twenty (120) days after the Closing Date, usual and customary Consolidated Income Tax Return
reporting packages submitted to Buyer by Seller with respect to the Company and the Division
Entities for the taxable period ending on December 31, 2006 and for the taxable period
beginning January 1, 2007, and ending as of the Closing Date. Without limiting the
generality of the foregoing, Buyer shall reasonably cooperate (at Seller’s expense) in the
preparation, filing and prosecution of any claim for refunds of Taxes with respect to any
Tax Period ending on or before the Closing Date.
(vi) For a period of six years after the Closing Date, Seller and its representatives
shall have reasonable access to the books and records (including the right to make extracts
thereof) of the Division, the Company, and the Division Entities to the extent that such
books and records relate to Taxes and to the extent that such access may reasonably be
required by Seller in connection with matters relating to or affected by the operation of
the Division (including the Division Entities) prior to the Closing Date.
39
Such access shall
be afforded by Buyer upon receipt of reasonable advance notice and during normal business
hours. If Buyer shall desire to dispose of any of such books and records prior to the
expiration of such six-year period, Buyer shall, prior to such disposition, give Seller a
reasonable opportunity, at Seller’s expense, to segregate and remove such books and records
as Seller may select. In addition to the foregoing, the parties agree to cooperate with
each other with respect to the defense of any claims or litigation relating to Taxes
pertaining to the Division, the Company, or the Division Entities, provided that the party
requesting such cooperation shall reimburse the other party for the other party’s reasonable
out-of-pocket costs and expenses of furnishing such cooperation.
(vii) If a Tax Indemnified Party (as hereinafter defined) receives a refund or credit
or other reimbursement with respect to Taxes for which, or a Tax Period with respect to
which, it would be indemnified under this Agreement, the Tax
Indemnified Party shall pay over such refund or credit or other reimbursement to the
Tax Indemnifying Party (as hereinafter defined). For the avoidance of doubt, any refund of
Taxes relating to the Division received by Buyer with respect to a Taxable Period ending on
or before the Closing Date shall be paid over to Seller and any refund of Taxes relating to
the Division received by Seller with respect to a Taxable Period ending after the Closing
Date shall be paid over to Buyer.
(viii) To the maximum extent allowed by law, Buyer must carry back any Tax Benefit (as
hereinafter defined) which is attributable to the Division, the Company, or any of the
Division Entities for any Tax period ending on or before the Closing Date or the portion of
the Straddle Period ending on the Closing Date unless Buyer requests and obtains the written
consent of Seller to do otherwise.
(ix) Buyer shall not, and shall cause the Company and the Division Entities not to,
make, amend or revoke any Tax election if such action would adversely affect any Seller or
its Affiliates with respect to any Tax period ending on or before the Closing Date or for
the portion of a Straddle Period ending on the Closing Date or any Tax refund with respect
thereto; provided that Buyer may take such actions if it reimburses Seller for the amount of
Taxes resulting from such election that Seller would otherwise be responsible for hereunder.
(x) For purposes of this Agreement, a “Consolidated Income Tax Return” is any income
Tax Return filed with respect to any consolidated, combined, affiliated or unified group
provided for under Section 1501 of the Code and the Treasury Regulations under Section 1502
of the Code, or any comparable provisions of foreign, state or local Law, other than any
income Tax Return that includes only the Company and the Division Entities.
(c) Indemnity for Taxes.
(i) Notwithstanding any other provision of this Agreement, any indemnification with
respect to Taxes shall be exclusively governed by the provisions of this Section 6.1(c).
40
(ii) Seller shall indemnify Buyer Indemnified Parties against and hold them harmless
from all liability for (i) all Taxes imposed on the Division, the Company, or the Division
Entities with respect to Tax periods ending on or before the Closing Date, (ii) Pre-Closing
Taxes determined pursuant to Section 6.1(b)(iv) with respect to any Straddle Period, (iii)
all Taxes that are attributable to Seller or any member (other than the Company or the
Division Entities) of an Affiliated Group to which Seller is or was the common parent prior
to the Closing Date that is imposed under Treasury Regulations Section 1.1502-6 (or any
similar provision of state, local or foreign Tax Law) by reason of the Company or any of the
Division Entities being included in any such Tax group, (iv) all Damages imposed or suffered
by Buyer Indemnified Parties by reason of or arising from any breach of or inaccuracy in any
representation or warranty of Seller with regard to Taxes contained in Section 3.13 hereof,
and (v) all Taxes arising in
connection with or resulting from the Restructuring Transactions (other than Excess
Restructuring Costs).
(iii) Buyer, the Company, and the Division Entities shall indemnify Seller and its
Affiliates against and hold them harmless from all liability for (i) all Taxes of the
Division, the Company, and the Division Entities with respect to Tax periods beginning after
the Closing Date and (ii) Post-Closing Taxes, as determined pursuant to Section 6.1(b)(iv)
with respect to any Straddle Period.
(iv) The obligation of Seller to indemnify and hold harmless Buyer Indemnified Parties,
on the one hand, and the obligations of Buyer, the Company, and the Division Entities to
indemnify and hold harmless Seller, on the other hand, pursuant to this Section 6.1(c),
shall terminate sixty (60) days following the expiration of the applicable statutes of
limitations with respect to the Tax liabilities in question (giving effect to any waiver,
mitigation or extension thereof and except for claims that have been asserted prior to that
time).
(v) A party seeking indemnification provided for under this Agreement (a “Tax
Indemnified Party”) in respect of Taxes arising out of or involving a claim or demand made
by any third Person, including a Tax authority, against such party (a “Tax Third-Party
Claim”) must notify the party from whom such indemnification is sought (the “Tax
Indemnifying Party”) in writing of the Tax Third-Party Claim as promptly as possible but in
no event later than ten (10) days after receipt by the Tax Indemnified Party of written
notice of the Tax Third-Party Claim; provided, however, that failure to give
such notification shall not affect the indemnification provided hereunder except to the
extent the Tax Indemnifying Party shall have been actually prejudiced as a result of such
failure (except that the Tax Indemnifying Party shall not be liable for any expenses
incurred during the period in which the Tax Indemnified Party failed to give such notice).
Thereafter, the Tax Indemnified Party shall deliver to the Tax Indemnifying Party, as
promptly as possible but in no event later than ten (10) days after the Tax Indemnified
Party’s receipt thereof, copies of all notices and documents (including court papers)
received by the Tax Indemnified Party, relating to the Tax Third-Party Claim.
41
If a Tax Third-Party Claim is made against the Tax Indemnified Party, the Tax Indemnifying
Party shall be entitled to participate in the defense thereof and (except in the case of Straddle
Period Taxes) to assume the defense thereof with counsel or other Tax advisors selected by the Tax
Indemnifying Party reasonably satisfactory to the Tax Indemnified Party, if the Tax Indemnifying
Party expressly agrees in writing that, as between the two, the Tax Indemnifying Party is solely
responsible to satisfy and discharge the claim. If the Tax Indemnifying Party assumes such
defense, the Tax Indemnifying Party shall not be liable to the Tax Indemnified Party for legal or
other expenses subsequently incurred by the Tax Indemnified Party in connection with the defense
thereof, provided, however, that the Tax Indemnifying Party shall be liable for the
reasonable fees and expenses of counsel employed by the Tax Indemnified Party, if and to the extent
that (i) the Tax Indemnifying Party has not employed counsel reasonably satisfactory to the Tax
Indemnified Party to assume the defense of such action within
a reasonable time after commencement of the action; (ii) the employment of counsel and the
amount reimbursable therefor by the Tax Indemnified Party has been authorized in writing by the Tax
Indemnifying Party; or (iii) representation of the Tax Indemnifying Party and the Tax Indemnified
Party by the same counsel would, in the reasonable opinion of such counsel, create a conflict of
interest. If the Tax Indemnifying Party assumes such defense, the Tax Indemnified Party shall have
the right to participate in the defense thereof and to employ counsel or other Tax advisors, at its
own expense separate from the counsel or other Tax advisors employed by the Tax Indemnifying Party.
Whether or not the Tax Indemnifying Party chooses to defend or prosecute any Tax Third-Party
Claim, all of the parties hereto shall reasonably cooperate in the defense or prosecution thereof.
Such cooperation shall include the provision to the Tax Indemnifying Party of records and
information which are reasonably relevant to such Tax Third-Party Claim, and making employees
available on a mutually convenient basis to provide additional information and explanation of any
material provided hereunder. Whether or not the Tax Indemnifying Party shall have assumed the
defense of a Tax Third-Party Claim, the Tax Indemnified Party shall not admit any liability with
respect to, or settle, compromise or discharge, such Tax Third-Party Claim without the Tax
Indemnifying Party’s prior written consent, which consent shall not be unreasonably withheld,
delayed or conditioned.
(d) Transfer and Similar Taxes. Notwithstanding any other provisions of this
Agreement to the contrary, all sales, use, transfer, gains, stamp, duties, recording and similar
Taxes (collectively, “Transfer Taxes”) incurred in connection with the transactions contemplated by
this Agreement shall be borne one-half by Buyer and one-half by Seller, provided that all Transfer
Taxes incurred in connection with the Restructuring Transactions (other than Excess Restructuring
Costs) shall be borne by Seller. Seller shall accurately prepare and file all necessary Tax
Returns and other documentation with respect to Transfer Taxes and timely pay all such Transfer
Taxes. Buyer shall have reasonable opportunity to review and comment on any such Tax Return prior
to filing, and Seller shall make such changes thereto as Buyer shall reasonably request. Buyer
shall pay to Seller its share, if any, of the Transfer Tax shown to be due on the Tax Return as
agreed within ten (10) Business Days after such Tax Return is given to Buyer. If required by
applicable Law, Buyer will join in the execution of any such Return.
(e) Termination of Tax Sharing Agreements. On or prior to the Closing Date, any
agreement with respect to Taxes to which the Company or any of the Division Entities is a party
shall be terminated (other than agreements, arrangements or practices solely
42
between or among the
Company and the Division Entities), all obligations thereunder shall be settled no later than
immediately prior to the Closing and no additional payments shall be made under any provisions
thereof after the Closing Date.
(f) Allocation of Purchase Price. Within thirty (30) Business Days following the date
hereof, Buyer shall prepare and deliver, or cause to be prepared and delivered, to Seller, an
allocation of the Initial Purchase Price among the assets of the Company and the Division Entities
and the non-competition covenant set forth in Section 5.11 hereof (the “Allocation”). If, within
thirty (30) Business Days of the receipt of the Allocation, Seller notifies Buyer that it disagrees
with the Allocation and provides Buyer with a notice setting out in reasonable detail the reasons
for its disagreement (the “Allocation Dispute Notice”), then Seller and Buyer shall attempt to
resolve their disagreement within the ten (10) days following Buyer’s receipt of Seller’s Allocation Dispute
Notice; otherwise, the Allocation shall become the “Final Allocation.” If Seller and Buyer are
unable to resolve their disagreement, the disputed items set forth in the Allocation Dispute Notice
shall be submitted to the Independent Accounting Firm, whose expense shall be borne equally by
Seller and Buyer. The Independent Accounting Firm shall determine and report in writing to Seller
and Buyer as to its determination of all disputed matters submitted to the Independent Accounting
Firm and the effect of such determinations on the Allocation within ten (10) Business Days after
such submission, and such determinations shall be final, binding and conclusive as to Seller, Buyer
and their respective Affiliates. In resolving any disputed item set forth in the Allocation
Dispute Notice, the Independent Accounting Firm, acting in its capacity as an expert and not as an
arbitrator: (i) shall limit its review to matters specifically set forth in Buyer’s Allocation
Dispute Notice as a disputed item (other than those items thereafter resolved by mutual written
agreement of Seller and Buyer) and (ii) shall not assign a value to any item greater than the
greatest value for such item claimed by any party or less than the smallest value for such item
claimed by any other party in the Allocation prepared by Seller or Buyer’s Allocation Dispute
Notice delivered pursuant to this Section 6.1(f). Each of Seller and Buyer shall have the right,
within five (5) Business Days of submission of any disputed item to the Independent Accounting
Firm, to meet with representatives of the Independent Accounting Firm and present its position as
to the resolution of such disputed item. In addition, Seller and Buyer shall each furnish to the
Independent Accounting Firm such work papers and other documents and information relating to the
disputed items, as the Independent Accounting Firm may reasonably request. Buyer and Seller agree
to (i) be bound by the Final Allocation, (ii) act in a manner consistent with the Final Allocation
for all purposes, including, without limitation, the preparation of financial statements and filing
of all Tax Returns and in the course of any Tax audit, Tax review or Tax litigation relating
thereto, and (iii) take no position, and cause their Affiliates to take no position, inconsistent
with the Final Allocation for any purpose, in each case, except as otherwise required by Law.
6.2 Division Employees; Employee Contracts and Benefits.
(a) Continuation of Employment. At or prior to the Closing, Buyer shall make “at
will” offers of employment to all employees of Seller and its Subsidiaries who are actively
employed by Seller and who work at any of the Facilities, as well as those employees of Seller and
its Subsidiaries who are primarily involved in actively providing services to the Division and who
are listed in Section 6.2(a) of the Disclosure Letter (the “Division Offerees”) on the terms
described in Section 6.2(b). Any employees of Seller and its Subsidiaries who are
43
normally
employed in connection with the operation of the Facilities, or primarily in providing services to
the Division and who are listed on Schedule 6.2(a) of the Disclosure Letter and are on approved
leave of absence, including by reason of short or long term disability, shall become Division
Offerees if, and only if, they are able to return to active employment within 180 days after
Closing. Buyer agrees to hire the Division Offerees who accept such offer of employment. Division
Offerees who accept their employment offers and commence employment with Buyer pursuant to such
offers shall be referred to herein as “Transferred Employees.” If, at any time from the Transition
Date until the date that is one year after the Transition Date, Buyer, the Company or any Division
Entity terminate the employment of any Transferred Employee (other than any Transferred Employee
listed in Section 6.2(g) of the Disclosure Letter), Buyer shall be
responsible for any severance due such employees under the severance plan of Seller disclosed
in Section 6.2(a) of the Disclosure Letter (the “Severance Policy”) and shall indemnify and hold
harmless Seller against any Damages arising in connection therewith. If, at any time from and
after the date that is one year after the Transition Date, Buyer, the Company or any Division
Entity terminate the employment of any Transferred Employee (other than any Transferred Employee
listed in Section 6.2(g) of the Disclosure Letter), Buyer shall be responsible for any severance
due such employees under any applicable severance plan of Buyer and shall indemnify and hold
harmless Seller against any Damages arising in connection therewith. If a Division Offeree does
not accept Buyer’s offer of employment where such offer did not reflect a base salary or wage rate,
as applicable, bonus opportunities and employee benefits comparable in the aggregate to (or in
excess of) the base salary or wage rate, as applicable, bonus opportunities (excluding transaction,
retention or similar bonuses) and employee benefits provided to such Division Offeree as of the
date hereof, Buyer shall be responsible for any severance due such Division Offeree under the
Severance Policy and shall indemnify and hold harmless Seller against any Damages arising in
connection therewith. If a Division Offeree does not accept Buyer’s offer of employment where such
offer reflected a base salary or wage rate, as applicable, bonus opportunities and employee
benefits comparable in the aggregate to (or in excess of) the base salary or wage rate, as
applicable, bonus opportunities (excluding transaction, retention or similar bonuses) and employee
benefits provided to such Division Offeree as of the date hereof, Seller shall be responsible for
any severance due such Division Offeree under the Severance Policy and shall indemnify and hold
harmless Buyer against any Damages arising in connection therewith.
(b) Compensation and Benefits. Subject to Section 6.2(g) hereof, upon the Transition
Date, Buyer shall offer, or shall cause, as applicable, a Subsidiary of Buyer to offer, a base
salary or wage rate, as applicable, bonus opportunity and employee benefits to the Transferred
Employees that are substantially similar to those offered by Buyer, or the relevant Subsidiary of
Buyer, to its own similarly situated employees. Any employee benefits provided to such Transferred
Employees will be provided under existing or newly established employee benefit plans which will,
in either case, be employee benefit plans of Buyer, a Subsidiary of Buyer, the Company or a
Division Entity (any such employee benefit plan in which Transferred Employees participate, the
“Applicable Buyer Plan”) and which may be modified at any time.
(c) Seller Plans. Transferred Employees shall cease participation, vesting, benefit
and service accruals under all Benefit Plans of Seller immediately upon the Transition Date.
44
(d) Benefit Plan Liabilities. Except as set forth in Sections 6.2(e) and 6.2(g)
hereof, all Benefit Plan liabilities accrued by Seller with respect to Transferred Employees prior
to the Transition Date, and all liabilities for benefits under any Benefit Plan that, on the
Transition Date, are incurred but not yet reported, shall be the liability of and paid by Seller in
accordance with applicable requirements. A liability under any Benefit Plan shall be deemed to be
incurred for purposes of this Section 6.2(d) on the date on which the services or other benefits
giving rise to that liability are provided without regard to when any xxxx or other demand for
payment is made. Seller shall not be liable for any liabilities that are incurred, or that relate
to any period, on or after the Transition Date.
(e) Certain Other Liabilities. As of the Transition Date, all liabilities and
obligations whatsoever with respect to Transferred Employees relating to or arising under any
accrued wages and holiday, vacation and sick day benefits, shall to the extent accrued and
reflected in the Net Working Capital be assumed by, and the sole responsibility of, Buyer or the
Company or a Division Entity.
(f) Participation and Service Credit.
(i) Except as otherwise expressly provided in this Agreement, effective as of the
Transition Date, Buyer or a Division Entity, as applicable, shall give Transferred Employees
service credit for purposes of eligibility and vesting under any Applicable Buyer Plan to
the extent such service was recognized under the corresponding Benefit Plan of Seller.
(ii) Any Applicable Buyer Plan providing health benefits shall provide that each
Transferred Employee who, on the Transition Date, is participating under a Welfare Plan of
Seller providing health benefits, shall be immediately eligible to participate in and
receive coverage under the Applicable Buyer Plan as of the Transition Date. Buyer shall
waive any restrictions on coverage for pre-existing conditions or requirements for evidence
of insurability under the Applicable Buyer Plan for Transferred Employees to the extent such
restrictions have been or would have been satisfied under Seller Welfare Plans. Transferred
Employees shall receive credit under each Applicable Buyer Plan for co-payments and payments
under a deductible limit made by them and for out-of-pocket maximums and similar limits
applicable to them during the plan year of Seller Welfare Plan in which the Transition Date
occurs in accordance with the corresponding Seller Welfare Plan.
(g) Certain Plans and Agreements. Buyer agrees that Buyer will, or will cause the
Company or the Division Entities to reimburse Seller for an amount up to $4,958,000 for severance
costs that may be incurred by Seller in connection with the termination of employment of any
employee listed in Section 6.2(g) of the Disclosure Letter, provided that, as a condition of that
reimbursement Seller has taken all such actions as are reasonably necessary to ensure that Buyer,
its Subsidiaries, the Company and the Division Entities are entitled to the protections of all
restrictive covenants, including without limitation, non-competition, protection of confidential
information and non-solicitation of employees, to which any of the individuals listed in Section
6.2(g) of the Disclosure Letter are subject by reason of any sale or other bonuses contingent upon
the consummation of the transactions contemplated hereunder. All other liabilities of Seller or
the Division Entities for severance pay (other than in connection with the
45
Severance Plan), stay bonuses, stock options or other equity incentives, retention plans, sale or other bonuses
contingent upon the consummation of the transactions contemplated hereunder or any similar
arrangements shall be retained by Seller and shall constitute “Retained Liabilities” hereunder and
Buyer shall not assume any such liabilities or any other employee benefit or compensation
liabilities, except as specifically set forth in Section 6.2(e) above.
(h) FUTA; FICA. Buyer and Seller shall (i) treat Buyer or a Subsidiary of Buyer as a
“successor employer” and the Company and the Division Entities, as applicable, as a “predecessor,” within the meaning of Sections 3121(a)(1) and 3306(b)(1) of
the Code, with respect to Transferred Employees employed by Buyer or a Subsidiary of Buyer for
purposes of Taxes imposed under the United States Federal Unemployment Tax Act or the United States
Federal Insurance Contributions Act, and (ii) cooperate with each other to avoid the filing of more
than one IRS Form W-2 with respect to each such Transferred Employee for the calendar year in which
the Transition Date occurs.
(i) WARN Act Requirements. On and after the Transition Date, Buyer shall be
responsible with respect to Transferred Employees and their beneficiaries for compliance with the
Worker Adjustment and Retraining Notification Act of 1988 and any other applicable state Law of
similar purpose.
6.3 Workers’ Compensation. Prior to Closing, Buyer shall use commercially reasonable
efforts to fulfill the necessary requirements of each state in which the Company or any of the
Division Entities operates with respect to workers’ compensation insurance, including posting
surety bonds or purchasing insurance policies.
6.4 Use of Seller’s Name and Logo. It is expressly agreed that Buyer is not
purchasing, acquiring or otherwise obtaining any right, title or interest in and to the name
“HealthSouth” or any trade names, trademarks, Internet domain names, identifying logos or service
marks related thereto or employing the words “HealthSouth” or any part or variation of any of the
foregoing or any confusingly similar trade name, trademark, Internet domain name, logo or service
xxxx (collectively, “Seller’s Trademarks and Logos”). Notwithstanding the foregoing, the parties
agree that during the period from the Closing Date until one hundred eighty (180) days after the
Closing Date (the “Wind-down Period”), the Division Entities shall be entitled to continue to use
Seller’s Trademarks and Logos to the extent that such Seller’s Trademarks and Logos exist or are
contained as of the Closing Date on any business cards, schedules, stationery, displays, signs,
promotional materials, manuals, forms, computer software and other similar material used by the
Division prior to the Closing Date in the operation of the Division. The nature and quality of all
uses of Seller’s Trademarks and Logos made by the Division Entities shall conform to the quality
standards set by Seller and communicated to Buyer, the Company or the Division Entities, either
directly or indirectly. Buyer, the Company and the Division Entities shall not use Seller’s
Trademarks and Logos in any manner which might dilute, tarnish or disparage Seller or Seller’s
Trademarks and Logos. Buyer agrees that immediately upon termination of the Wind-down Period,
Buyer shall cause the Division Entities to cease and desist from all further use of Seller’s
Trademarks and Logos and shall adopt new trade names, trademarks, Internet domain names,
identifying logos and service marks related thereto which are not confusingly similar to Seller’s
Trademarks and Logos.
46
6.5 Software. Seller shall deliver to Buyer at or prior to the Closing, via means and
media to be mutually determined by the parties, the computer software source code and any computer
aided software engineering tools, application program interfaces, developer toolkits, utilities and
user documentation for the HPAS, Data Warehouse and Intranet applications developed for or used by
the Division, including, without limitation, programming statements, instructions and notes,
diagrams, schematics, help files, documentation and other material that a reasonably skilled
programmer would need to operate, maintain, support and
modify the HPAS, Data Warehouse and Intranet applications. Seller shall deliver the Hyperion
Cubes associated with the Data Warehouse application used by the Division. In connection with the
delivery of the HPAS, Data Warehouse and Intranet source code as provided herein, Seller hereby
grants to Buyer and its Subsidiaries a perpetual, irrevocable, assignable, non-exclusive,
worldwide, royalty-free and fully paid-up license to use, reproduce, distribute, display, modify,
create derivative works of and otherwise exploit the HPAS, Data Warehouse and Intranet
applications.
6.6 Enterprise Systems. Seller and Buyer acknowledge and agree that it may be
necessary to transfer to Buyer, the Company or the Division Entities, as applicable, certain rights
under the computer hardware and software licenses, leases and service agreements used by the
Division Entities and set forth in Section 6.6 of the Disclosure Letter, which have been acquired
by Seller on an enterprise basis on behalf of the Company, the Division Entities or, as applicable,
other Affiliates of Seller (the “Enterprise Systems”). Seller shall assist Buyer in effecting such
assignments or transfers under the Enterprise System agreements as are set forth in Section 6.6 of
the Disclosure Letter, which Buyer and Seller have determined are necessary for the Division
Entities to continue to use such Enterprise Systems following the Closing, provided that any such
transfer or assignment shall involve only the capacity or volume used by the Division Entities
under such agreements. Buyer shall be fully responsible for the payment of any fee or charge
imposed by a licensor, lessor, or service provider under any Enterprise Systems as a consequence of
such transfer. No other rights under computer hardware and software licenses, leases and service
agreements used by the Division Entities which have been acquired by Seller on an enterprise basis
on behalf of the Company, the Division Entities or, as applicable, other Affiliates of Seller shall
be assigned or transferred to Buyer, the Company or any Division Entity pursuant to this Agreement,
and Buyer, the Company and the Division Entities shall not be responsible for the payment of any
support, lease or license fees due and owing after Closing with respect to any such other computer
hardware and software licenses, leases and service agreements.
ARTICLE VII
CONDITIONS TO OBLIGATIONS OF EACH OF SELLER AND BUYER
CONDITIONS TO OBLIGATIONS OF EACH OF SELLER AND BUYER
7.1 Mutual Conditions. The respective obligations of each of Seller and Buyer to
consummate the transactions contemplated by this Agreement are subject to the satisfaction, or
waiver to the extent permitted, at or prior to the Closing of each of the following conditions:
(a) No Injunction or Statute. No statute, rule, regulation, executive order, decree,
injunction or other order enacted, entered, promulgated, enforced or issued by any
47
Governmental Entity preventing consummation of the transactions contemplated by this Agreement shall be in
effect on the Closing Date.
(b) No Proceeding. There shall not be pending any suit, action or proceeding by any
Governmental Entity challenging or seeking to restrain or prohibit the consummation of the
transactions contemplated by this Agreement.
(c) Expiration or Termination of HSR Periods. All waiting periods applicable to the
transactions contemplated by this Agreement under the HSR Act shall have expired or been
terminated.
ARTICLE VIII
CONDITIONS TO OBLIGATIONS OF SELLER
CONDITIONS TO OBLIGATIONS OF SELLER
8.1 Conditions. The obligations of Seller to consummate the transactions contemplated
by this Agreement are subject to the fulfillment at or prior to the Closing of each of the
following conditions (any or all of which may be waived in whole or in part by Seller):
(a) Representations and Warranties. The representations and warranties of Buyer
contained in this Agreement shall be true and correct (without giving effect to any “materiality”
qualifiers set forth therein) as of the date of this Agreement and on and as of the Closing Date
with the same force and effect as if made at and as of the Closing Date (other than those
representations and warranties that address matters only as of a particular date or only with
respect to a specific period of time, which need only be true and correct as of such date or with
respect to such period), except where the failure of such representations and warranties to be true
and correct (without giving effect to any “materiality” qualifiers set forth therein) would not
materially impair the ability of Buyer to consummate the transactions contemplated hereby.
(b) Performance. Buyer shall have performed and complied, in all material respects,
with all agreements and covenants required by this Agreement to be so performed or complied with by
Buyer at or prior to the Closing.
(c) Officer’s Certificate. Buyer shall have delivered to Seller a certificate, dated
as of the Closing Date, executed by an executive officer of Buyer, certifying the fulfillment of
the conditions specified in Sections 8.1(a) and 8.1(b) hereof.
(d) Secretary’s Certificates. Seller shall have received certificates, dated the
Closing Date, duly executed by the Secretary or Assistant Secretary of Buyer, on behalf of Buyer,
certifying as to: (i) the attached copy of the resolutions of the Board of Directors of Buyer,
authorizing and approving the execution, delivery and performance of, and the consummation of the
transactions contemplated by, this Agreement and any other documents or instruments contemplated
hereby, and stating that the resolutions thereby certified have not been amended, modified, revoked
or rescinded; and (ii) the incumbency, authority and specimen signature of each officer of Buyer
executing this Agreement or any other document or instrument contemplated hereby.
48
ARTICLE IX
CONDITIONS TO OBLIGATIONS OF BUYER
CONDITIONS TO OBLIGATIONS OF BUYER
9.1 Conditions. The obligations of Buyer to consummate the transactions contemplated
by this Agreement are subject to the fulfillment at or prior to the Closing of each of the
following conditions (any or all of which may be waived in whole or in part by Buyer):
(a) Representations and Warranties. The representations and warranties of Seller (i)
contained in Sections 3.2, 3.4 and 3.5 of this Agreement shall be true and
correct as of the date of this Agreement and on and as of the Closing Date with the same force
and effect as if made at and as of the Closing Date (other than those representations and
warranties that address matters only as of a particular date or only with respect to a specific
period of time, which need only be true and correct as of such date or with respect to such
period), (ii) contained in Section 3.19 of this Agreement shall be true and correct in all material
respects as of the date of this Agreement and on and as of the Closing Date with the same force and
effect as if made at and as of the Closing Date, and (iii) contained in this Agreement other than
those referenced in clauses (i) or (ii) above, shall be true and correct (without giving effect to
any “materiality” or “Material Adverse Effect” qualifiers set forth therein) as of the date of this
Agreement and at and as of the Closing Date with the same force and effect as if made at and as of
the Closing Date (other than those representations and warranties that address matters only as of a
particular date or only with respect to a specific period of time, which need only be true and
correct as of such date or with respect to such period), except in the case of clauses (iii) where
the failure of such representations and warranties to be true and correct (without giving effect to
any “materiality” or “Material Adverse Effect” qualifiers set forth therein) would not,
individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.
(b) Performance. Seller shall have performed and complied, in all material respects,
with all agreements and covenants required by this Agreement to be so performed or complied with by
Seller at or prior to the Closing.
(c) Officer’s Certificate. Seller shall have delivered to Buyer a certificate, dated
as of the Closing Date, executed by an executive officer of Seller, certifying the fulfillment of
the conditions specified in Sections 9.1(a) and 9.1(b) hereof.
(d) Restructuring Transactions. Seller shall have caused the Restructuring
Transactions to be consummated pursuant to agreements in form and substance reasonably satisfactory
to Buyer.
(e) Regulatory Consents and Notices. All consents, approvals, waivers,
authorizations, licenses and Filings required to be obtained from or made with any Governmental
Entity so as to permit Buyer or the Division Entities to continue to operate the Business after the
Closing in substantially the same manner as the Business is currently operated shall have been
obtained and made, and any waiting period applicable to the transactions contemplated by this
Agreement in connection with any Filing required to be made with or notice required to be given to
any Governmental Entity under applicable Law shall have expired.
(f) Third Party Lease Consents. The aggregate EBITDA of the outpatient rehabilitation
clinics of the Division for the nine months ended September 30, 2006 located at Real Properties
which are Consented Leases (excluding clinics that have negative EBITDA, without any allocation of
corporate overhead) shall equal at least eighty percent (80%)
49
of the aggregate EBITDA of the outpatient rehabilitation clinics that are Required Consent Leases (excluding clinics that have
negative EBITDA, without any allocation of corporate overhead) for the nine months ended September
30, 2006.
(g) Third Party Payor Contract Consents. The aggregate revenues of the Division for
the nine months ended September 30, 2006 derived from third party payor
contracts which are (i) Consented Third Party Payor Contracts, or (ii) Non Required Consent
Third Party Payor Contracts, shall equal at least eighty percent (80%) of the aggregate revenues of
the Division derived from all third party payor contracts for the nine months ended September 30,
2006.
(h) Repayment of Indebtedness. Seller shall have repaid or assumed, or caused to be
repaid or assumed, on behalf of the Company and the Division Entities, all outstanding Indebtedness
(together with accrued interest thereon) of the Company and the Division Entities (other than
Capitalized Lease Indebtedness and Earn-Out Indebtedness), and the Company and the Division
Entities shall have been released from any and all obligations and liabilities related to such
Indebtedness (other than Capitalized Lease Indebtedness and Earn-Out Indebtedness) and any Lien or
guaranty in respect of any such Indebtedness (other than Capitalized Lease Indebtedness and
Earn-Out Indebtedness) shall have been released.
(i) Secretary’s Certificate. Buyer shall have received a certificate, dated the
Closing Date, duly executed by the Secretary or an Assistant Secretary of Seller, on behalf of
Seller, certifying as to: (i) the attached copy of the resolutions of the Board of Directors of
Seller authorizing and approving the execution, delivery and performance of, and the consummation
of the transactions contemplated by, this Agreement, the Restructuring Agreements and any other
documents or instruments contemplated hereby, and stating that the resolutions thereby certified
have not been amended, modified, revoked or rescinded; (ii) the incumbency, authority and specimen
signature of each officer of Seller executing this Agreement, the Restructuring Agreements or any
other document or instrument contemplated hereby.
ARTICLE X
TERMINATION, AMENDMENT AND WAIVER
TERMINATION, AMENDMENT AND WAIVER
10.1 Termination. This Agreement may be terminated and the transactions contemplated
hereby and by the Ancillary Agreements may be abandoned:
(a) at any time, by mutual written agreement of Seller and Buyer;
(b) at any time after the date that is six months following the date hereof (the “Termination
Date”), by either Seller or Buyer upon five (5) Business Days’ prior written notice to the other
party, if the Closing shall not have occurred for any reason on or prior to the Termination Date,
provided, however, that the right to terminate this Agreement pursuant to this
Section 10.1(b) shall not be available to any party whose failure to perform any of its obligations
under this Agreement required to be performed by it at or prior to the Closing has been the cause
of, or resulted in, the failure of the Closing to occur.
50
(c) (i) by Seller, if the conditions set forth in Section 7.1 or 8.1 hereof have not been
satisfied, and are not reasonably capable of being satisfied on or prior to the Termination Date,
or (ii) by Buyer, if the conditions set forth in Section 7.1 or 9.1 have not been satisfied, and
are not reasonably capable of being satisfied, on or prior to the Termination Date; or
(d) by Buyer or Seller, if any court of competent jurisdiction or any Governmental Entity
shall have issued an order, decree or ruling or taken any other action permanently enjoining,
restraining or otherwise prohibiting the consummation of the transactions contemplated by this
Agreement and such order, decree, ruling or other action shall have become final and
non-appealable.
10.2 Procedure and Effect of Termination. In the event of the termination of this
Agreement and the abandonment of the transactions contemplated hereby and by the Ancillary
Agreements pursuant to Section 10.1 hereof, written notice thereof shall be given by the party so
terminating to the other party to this Agreement, and this Agreement shall terminate and the
transactions contemplated hereby and thereby shall be abandoned without further action by Seller or
Buyer. If this Agreement is terminated pursuant to Section 10.1 hereof:
(a) Buyer shall return all documents, work papers and other materials (and all copies thereof)
obtained from Seller or the Company or any of the Division Entities or their respective employees,
agents or representatives relating to the transactions contemplated hereby and by the Restructuring
Agreements, whether so obtained before or after the execution hereof, to the party furnishing the
same, and all confidential information received by Buyer with respect to the Division shall be
treated in accordance with Section 5.2(b) hereof and the Confidentiality Agreement referred to in
such Section;
(b) At the option of Seller, all Filings, applications and other submissions made pursuant to
Sections 5.3, 5.4 and 5.5 hereof shall, to the extent practicable, be withdrawn from the agency or
other Person to which made;
(c) If this Agreement is terminated and the transactions contemplated hereby are abandoned as
described in this Section 10.2, this Agreement shall become null and void and of no further force
or effect, except for the obligations provided for in Sections 5.6, 10.2, 12.3, 12.10 and 12.11
hereof, the confidentiality provision contained in Section 5.2(b) hereof and the Confidentiality
Agreement referred to in such Section shall survive any such termination of this Agreement without
limitation; and
(d) Such termination shall not be deemed to release and shall not relieve either party hereto
from any liability for any breach or violation by such party of any of its representations,
warranties, covenants or agreements contained in this Agreement, nor shall such termination impair
the rights of either party to (i) compel specific performance by the other party of its obligations
under this Agreement or (ii) seek any other remedy under law or in equity.
10.3 Amendment and Modification. This Agreement may be amended, modified or
supplemented at any time but only by written agreement of the parties hereto.
51
ARTICLE XI
SURVIVAL OF REPRESENTATIONS; INDEMNIFICATION
SURVIVAL OF REPRESENTATIONS; INDEMNIFICATION
11.1 Survival of Representations. The representations and warranties in this
Agreement shall survive the Closing solely for purposes of this Article XI and shall terminate on
the date that is eighteen (18) months after the Closing Date; provided, however,
the representations and warranties under Sections 3.1, 3.2, 3.4 and 3.5 hereof (and solely to the
extent relating to the foregoing representations, the certificate delivered pursuant to Section
9.1(c) hereof) shall survive indefinitely. Notwithstanding the foregoing, Seller’s obligation to
indemnify Buyer Indemnified Parties (as hereinafter defined) pursuant to Sections 11.2(b), 11.2(c),
11.2(d), 11.2(e), 11.2(f), 11.2(g), 11.2(h), 11.2(i), 11.2(j) and 11.2(k) hereof shall survive
indefinitely. The parties intend to shorten the statute of limitations and agree that no claims or
causes of action may be brought against Seller or Buyer based upon, directly or indirectly, any of
the representations and warranties contained in Articles III and IV hereof after the applicable
survival period. Notwithstanding anything to the contrary contained herein, the foregoing time
limitations shall not apply to any claims with respect to which the claiming party has delivered a
written notice prior to the expiration of the applicable time period in accordance with the
provisions hereof.
11.2 Seller’s Agreement to Indemnify. Upon the terms and subject to conditions of
this Article XI, from and after the Closing Date, Seller shall indemnify, defend and hold harmless
Buyer, its Affiliates (including the Company and its Subsidiaries) and their respective officers,
directors, and employees (“Buyer Indemnified Parties”), from and against all demands, claims,
actions or causes of action, assessments, losses, damages, liabilities, costs and expenses,
including reasonable attorneys’ fees and expenses (collectively, “Damages”), asserted against,
resulting to, imposed upon, or suffered or incurred by Buyer Indemnified Parties by reason of or
arising from: (a) a breach of any representation or warranty of Seller contained in this Agreement
or any certificate delivered hereunder; (b) a breach of any covenant or agreement of Seller
contained in this Agreement or any certificate delivered hereunder; (c) Unrelated Liabilities (as
hereinafter defined); (d) the Retained Litigation; (e) any liability for Indebtedness of the
Company or any Division Entity (other than any Capitalized Lease Indebtedness or Earn-Out
Indebtedness) outstanding as of the Closing; (f) any Retained Liabilities; (g) any Health Care
Related Liabilities; (h) the failure to obtain Consent to a Required Consent Lease such that it
becomes a Consented Lease unless, at the time that such Damages are incurred, the 90% Lease
Condition is satisfied; (i) the failure to obtain Consent to a Required Consent Third Party Payor
Contract such that it becomes a Consented Third Party Payor Contract unless, at the time that such
Damages are incurred, the 90% Payor Contract Condition is satisfied; (j) any escheat law with
respect to unclaimed property; or (k) the costs of enforcing any Buyer Indemnified Party’s rights
hereunder (collectively, “Buyer Claims”).
11.3 Seller’s Limitation of Liability. Notwithstanding any provision in this
Agreement to the contrary, the liability of Seller to indemnify Buyer Indemnified Parties pursuant
to Section 11.2(a) hereof against any Damages sustained by reason of any Buyer Claim with respect
to a breach of a representation or warranty shall be limited to Buyer Claims as to which a Buyer
Indemnified Party has given Seller written notice, setting forth therein in reasonable detail the
basis for such Buyer Claim, on or prior to the termination of such representation or warranty
pursuant to Section 11.1 hereof; provided, however, that (a) Seller
52
shall be liable pursuant to the provisions for indemnification contained in Section 11.2(a) hereof with respect to
breaches of representations and warranties (other than the representations and warranties contained
in Sections 3.1, 3.2, 3.3, 3.4, 3.19 and 3.20 hereof and, solely to the extent relating to the
foregoing representations, the certificate delivered pursuant to Section 9.1(c) hereof
(collectively, the “Excluded Representations”)), only
after the aggregate amount of all such Buyer Claims for which Seller is liable under this
Agreement (without regard to the limitation contained in this proviso) exceeds an amount equal to
$1,840,000 (the “Basket”), and only to the extent of such excess, and (b) no Buyer Claim (or series
of related Buyer Claims) pursuant to the provisions for indemnification contained in Section
11.2(a) hereof with respect to breaches of representations and warranties in an amount less than
$50,000 may be asserted. Notwithstanding any other provision of this Agreement, in no event shall
the aggregate amount of all Buyer Claims for which Seller is liable pursuant to: (i) Section
11.2(a) hereof (other than as a result of the breach of any Excluded Representations), exceed an
amount equal to $19,187,000, and (ii) Section 11.2(a) hereof (solely as a result of the breach of
Excluded Representations), 11.2(b). 11.2(f), 11.2(g), 11.2(h) and 11.2(i), exceed an amount equal
to the Purchase Price, less the aggregate amount of all Buyer Claims for which Seller is liable
pursuant to Section 11.2(a) hereof with respect to breaches of representations and warranties other
than the Excluded Representations. Without limiting in any manner the applicability of the
preceding provisions of this Section 11.3, Buyer and Seller agree that (i) Seller’s obligations
under Section 11.2(h) with respect to any given Required Consent Lease shall be limited to Damages
incurred with respect to the period commencing on the Closing Date and ending on the earliest date
that the Required Consent Lease could be terminated by the lessor (or, if earlier, the date such
Required Consent Lease would have expired) in accordance with its terms had Consent thereunder been
obtained, and (ii) Seller’s obligations under Section 11.2(i) with respect to any given Required
Consent Third Party Payor Contract shall be limited to Damages incurred with respect to the period
commencing on the Closing Date and ending on the earlier of the date one year after the Closing
Date and the date that such contract would normally expire in accordance with its terms had Consent
thereunder been obtained.
11.4 Buyer’s Agreement to Indemnify. Upon the terms and subject to the conditions of
this Article XI, from and after the Closing Date, Buyer shall indemnify, defend and hold harmless
Seller, its Affiliates and their respective officers, directors, and employees (“Seller Indemnified
Parties”), from and against all Damages asserted against, resulting to, imposed upon or incurred by
Seller Indemnified Parties by reason of or arising from: (a) a breach of any representation or
warranty of Buyer contained in this Agreement or any certificate delivered hereunder; (b) a breach
of any covenant or agreement of Buyer contained in this Agreement or any certificate delivered
hereunder; (c) any liability or obligation of the Company, the Division Entities or the Division
other than the Retained Litigation, Unrelated Liabilities, Pre-Closing Taxes, or any other
liability for which Seller has agreed to indemnify Buyer or the existence of which is a breach of
Seller’s representations and warranties under this Agreement; (d) any liability or obligation
resulting from any Guaranty made by Buyer or its Affiliates referred to in Section 2.5 hereof, to
the extent arising or incurred after the Closing; (e) any liability or obligation resulting from
any Guaranty referred to in Section 2.5 hereof for which Buyer shall not have caused itself or one
of its Affiliates to be substituted in all respects for Seller, effective as of the Closing; (f)
any liability for any Capitalized Lease Indebtedness or Earn-Out Indebtedness; (g) any Excess
Restructuring Costs, or (h) the costs of enforcing any Seller Indemnified Party’s rights hereunder
(collectively, “Seller Claims”).
53
11.5 Buyer’s Limitation of Liability. Notwithstanding any provision in this Agreement
to the contrary, the liability of Buyer to indemnify Seller Indemnified Parties
pursuant to Section 11.4(a) hereof against any Damages sustained by reason of any Seller Claim
with respect to the breach of a representation or warranty shall be limited to Seller Claims as to
which a Seller Indemnified Party has given Buyer written notice thereof, setting forth therein in
reasonable detail the basis for such Seller Claim, on or prior to the termination of such
representation or warranty pursuant to Section 11.1 hereof; provided, however, that
(i) Buyer shall be liable pursuant to the provisions for indemnification contained in Section
11.4(a) hereof with respect to breaches of warranties (other than the representations and
warranties contained in Section 4.1 hereof and, solely to the extent relating to the foregoing
representation, the certificate delivered pursuant to Section 8.1(c) hereof) only after the
aggregate amount of all such Seller Claims for which Buyer is liable under this Agreement (without
regard to the limitation contained in this proviso) exceeds an amount equal to $1,840,000, and only
to the extent of such excess, and (ii) no Seller Claim (or series of related Seller Claims)
pursuant to the provisions for indemnification contained in Section 11.4(a) hereof with respect to
breaches of representations and warranties in an amount less than $50,000 may be asserted.
Notwithstanding any other provision of this Agreement, in no event shall the aggregate amount of
all Seller Claims for which Buyer is liable pursuant to such Section 11.4(a) hereof (other than the
representations and warranties set forth in Section 4.1 hereof, and, solely to the extent relating
to the foregoing, the certificate delivered pursuant to Section 8.1(c) hereof) exceed an amount
equal to $19,187,000.
11.6 Conditions of Indemnification With Respect to Third-Party Claims. The
obligations and liabilities of Seller and Buyer with respect to Buyer Claims and Seller Claims,
respectively, which arise or result from claims for Damages made by third parties (“Third-Party
Claims”) shall be subject to the following terms and conditions:
(i) (A) The indemnified party shall give the indemnifying party prompt written notice
of any such Third-Party Claim; provided, however, that failure to give such
notification shall not affect the indemnification provided hereunder except to the extent
the indemnifying party shall have been materially prejudiced as a result of such failure;
and (B) the indemnifying party shall have the right to undertake the defense thereof by
counsel chosen by it that is reasonably acceptable to the indemnified party, if the claim
involves solely monetary damages and the indemnifying party expressly agrees in writing with
the indemnified party that, as between the two, the indemnifying party is solely responsible
to satisfy and discharge the claim; provided, that if the indemnifying party assumes such
defense, the indemnified party shall have the right to participate in the defense thereof
and to employ counsel, at its own expense, separate from the counsel employed by the
indemnifying party, it being understood that the indemnifying party shall control such
defense; provided further, however, that the indemnifying party shall be liable for the
reasonable fees and expenses of counsel employed by the indemnified party, if and to the
extent that (x) the indemnifying party has not employed counsel reasonably satisfactory to
the indemnified party to assume the defense of such action within a reasonable time after
receiving notice of the commencement of the action; (y) the employment of counsel and the
amount reimbursable therefor by the indemnified party has been authorized in writing by the
indemnifying party; or (z) representation of the indemnifying party and the indemnified
54
party by the same counsel would, in the reasonable opinion of such counsel, create a
conflict of interest;
(ii) Until the indemnifying party assumes the defense of a Third-Party Claim, the
indemnified party shall have the right to undertake the defense, compromise or settlement of
such Third-Party Claim on behalf of and for the account and risk of the indemnifying party
subject to the right of the indemnifying party to assume the defense of such Third-Party
Claim at any time prior to settlement, compromise or final determination thereof (subject to
subclause (B) of clause (i) above); and
(iii) Notwithstanding any provision in this Article XI to the contrary, without the
prior written consent of the indemnified party (which consent shall not be unreasonably
withheld, delayed or conditioned), the indemnifying party shall not admit any liability with
respect to, or settle, compromise or discharge, any Third-Party Claim or consent to the
entry of any judgment with respect thereto, except in the case of any settlement that (A)
includes as an unconditional term thereof the delivery by the claimant or plaintiff to the
indemnified party of a written release from all liability in respect of such Third-Party
Claim and which does not impose any obligation on the indemnified party, or (B) provides
solely for monetary relief to be paid by the indemnifying party and which does not otherwise
involve or purport to bind or limit the indemnified party. In addition, if the indemnifying
party shall have assumed the defense of the Third-Party Claim, the indemnified party shall
not admit any liability with respect to, or settle, compromise or discharge, any Third-Party
Claim or consent to the entry of any judgment with respect thereto, without the prior
written consent of the indemnifying party (which consent shall not be unreasonably withheld,
delayed or conditioned), and the indemnifying party will not be subject to any liability for
any such admission, settlement, compromise, discharge or consent to judgment made by an
indemnified party without such prior written consent of the indemnifying party.
11.7 Other Claims. In the event any indemnified party should have a claim against any
indemnifying party under Section 11.2 or 11.4 hereof that does not involve a Third-Party Claim
being asserted against or sought to be collected from such indemnified party, the indemnified party
shall, as promptly as practicable after discovery of such claim, deliver written notice of such
claim to the indemnifying party. The failure by any indemnified party so to notify the
indemnifying party shall not relieve the indemnifying party from any liability which it may have to
such indemnified party under Section 11.2 or 11.4 hereof, except to the extent that the
indemnifying party shall have been materially prejudiced by such failure. If the indemnifying
party does not notify the indemnified party within twenty (20) Business Days following its receipt
of such notice that the indemnifying party disputes its liability to the indemnified party under
Section 11.2 or 11.4 hereof, such claim specified by the indemnified party in such notice shall be
conclusively deemed a liability of the indemnifying party under Section 11.2 or 11.4 hereof and the
indemnifying party shall pay the amount of such liability to the indemnified party on demand or, in
the case of any notice in which the amount of the claim (or any portion thereof) is estimated, on
such later date when the amount of such claim (or such portion thereof) becomes finally determined.
If the indemnifying party has timely disputed its liability with respect to such claim, as
provided above, the indemnifying party and the indemnified party
shall proceed in
55
good faith to negotiate a resolution of such dispute and, if not resolved through negotiations, such dispute
shall be resolved by litigation in an appropriate Court of competent jurisdiction.
11.8 Sole Remedy.
(a) Buyer and Seller acknowledge and agree that, if the Closing occurs, their sole and
exclusive remedy for monetary damages following the Closing with respect to any and all claims,
including Buyer Claims and Seller Claims (whether Third-Party Claims or otherwise), relating to the
subject matter of this Agreement shall be pursuant to the provisions set forth in Section 6.1(c)
hereof and this Article XI; provided, however, that nothing contained herein shall
prevent an indemnified party from pursuing remedies as may be available to such party under
applicable Law in the event of an indemnifying party’s fraud or failure to comply with its
indemnification obligations hereunder.
(b) The indemnifying party shall be subrogated to the rights of the indemnified party in
respect of any insurance relating to the Damages to the extent of any indemnification payments made
hereunder. The parties agree that the indemnification obligations of the parties set forth in this
Agreement do not in any way change or modify any duty of any party to mitigate its Damages under
applicable Law; provided that, with regard to any indemnification obligation of Seller under
11.2(h), Seller and Buyer agree that Buyer’s duty to mitigate shall include the entry into a
management agreement with Seller or relocation of the applicable Facility in accordance with the
last sentence of Section 2.4(c). Any liability for indemnification hereunder shall be determined
without duplication of recovery by reason of the state of facts giving rise to such liability
constituting a breach of more than one representation, warranty, covenant or agreement.
(c) Buyer and Seller agree to treat (and cause their Affiliates to treat), to the extent
permitted by applicable Law, any indemnification payment under this Agreement as an adjustment to
the Purchase Price. Any indemnification obligation under this Agreement shall be net of (i) any
Tax Benefit actually realized by the indemnified party or its Affiliates, and (ii) any insurance
proceeds or any indemnity, contribution or other similar payment received by the indemnified party
or its Affiliates from any third party with respect thereto, net of any expenses related to the
recovery of such proceeds and net of any increase in premiums of retroactive premium adjustments.
The indemnified party shall use its commercially reasonable efforts, at no cost to the Indemnified
Party, to obtain full recovery under all insurance policies covering any indemnification obligation
to the same extent as they would if such indemnification obligation were not subject to
indemnification under this Agreement (it being understood that Buyer shall have no obligation to
make a claim against Buyer’s insurance policies with respect to any matter that is covered by
Seller’s self-insurance program). In the event that an insurance or other recovery is received by
any indemnified party with respect to any indemnification obligation for which any such Person has
been indemnified under this Agreement, then a refund equal to the aggregate amount of the recovery
shall be made promptly to the indemnifying party. As used herein, “Tax Benefit” shall mean the Tax
savings attributable to any deduction, expense, loss, credit or refund to the indemnified party or
its Affiliates, when actually realized, net of any Tax detriment associated with the receipt, or
right to receive indemnification hereunder. The amount of any Tax Benefit actually realized shall
be equal to the actual reduction in Taxes paid
56
in cash determined with the applicable Tax items
taken into account as compared with the Taxes that would have been payable without the applicable
Tax items.
(d) For purposes of this Agreement, except with respect to damages claimed by a third party,
the parties acknowledge and agree that Damages shall not include
damages incurred directly or indirectly as a result of lost profits or any special,
consequential or punitive damages. Notwithstanding the foregoing, it is understood and agreed that
the limitation on recovery of lost profits, special, consequential or punitive damages contained in
the preceding sentence shall not limit a party’s ability to recover direct or general damages or
change or have any bearing on the interpretation of what constitutes direct or general damages, it
being understood that direct and general damages shall be given its normal meaning under the Law.
(e) It is agreed that, solely in determining whether there has been a breach of any provision
under this Agreement for purposes of this Article XI, the concepts of materiality, Material Adverse
Effect, “in all material respects” and other similar qualifying language contained in such
provision shall be read to mean that the breach of or failure to comply with such provision has
resulted, or would reasonably be expected to result, in Damages to the non-breaching party in
excess of $100,000; provided, however, that in the event that there has been a
breach of such provision after giving effect to such qualifying language (as read in the manner set
forth above in this Section 11.8(e)), then for purposes of determining whether the Basket has been
exceeded with respect to such breach or breaches and the amount of any resulting Damages, the
concept of materiality, Material Adverse Effect, “in all material respects” and other similar
qualifying language contained in the representations and warranties and certifications of or on
behalf of the applicable party shall be disregarded.
(f) Notwithstanding anything to the contrary contained herein, no limitation or condition of
liability or indemnity shall apply to any rights or claims based upon fraud or intentional
misrepresentation.
(g) No right of indemnification hereunder shall be limited by reason of any investigation or
audit conducted before or after the Closing or the knowledge of the non-breaching party of any
breach of a representation, warranty, covenant or agreement contained in this Agreement or in any
certificate delivered pursuant hereto by the other party at any time, or the decision of any party
to complete the Closing.
ARTICLE XII
MISCELLANEOUS
MISCELLANEOUS
12.1 Fees and Expenses. Whether or not the transactions contemplated hereby and by
the Ancillary Agreements are consummated pursuant hereto and thereto, each of Seller and Buyer
shall pay all fees and expenses incurred by it or on its behalf and Seller shall pay all fees and
expenses incurred by or on behalf of the Company or any of the Division Entities in connection with
or in anticipation of this Agreement, the Restructuring Transactions and the consummation of the
transactions contemplated hereby.
12.2 Further Assurances. After Closing, at the request of the other party hereto and
at the expense of the party so requesting, Seller and Buyer shall execute and deliver to such
57
requesting party such documents, shall file with the appropriate Governmental Entities all
documents necessary or appropriate and take such other action as such requesting party may
reasonably request in order to consummate the transactions contemplated hereby and by the Ancillary
Agreements, including, without limitation, Section 2.4 hereof.
12.3 Notices. All notices, requests, demands, waivers and communications required or
permitted to be given under this Agreement shall be in writing (which shall include notice by
telecopy or like transmission) and shall be deemed given (i) on the day delivered (or if that day
is not a Business Day, or if delivered after the close of business on a Business Day, on the first
following day that is a Business Day) when (x) delivered personally against receipt or (y) sent by
overnight courier, (ii) on the day when transmittal confirmation is received if sent by telecopy
(or if that day is not a Business Day, or if after the close of business on a Business Day, on the
first following day that is a Business Day) and (iii) on the third Business Day after mailed by
certified or registered first-class mail to the parties at the following addresses (or to such
other addresses as a party may have specified by notice given to the other parties hereto pursuant
to this provision):
If to Buyer, to:
Select Medical Corporation
0000 Xxx Xxxxxxxxxx Xxxx
Xxxxxxxxxxxxx, Xxxxxxxxxxxx 00000
Telecopy: (000) 000-0000
Attention: Xxxxxxx X. Xxxxxx, Esq.
0000 Xxx Xxxxxxxxxx Xxxx
Xxxxxxxxxxxxx, Xxxxxxxxxxxx 00000
Telecopy: (000) 000-0000
Attention: Xxxxxxx X. Xxxxxx, Esq.
with a copy to:
Dechert LLP
Xxxx Centre
0000 Xxxx Xxxxxx
Xxxxxxxxxxxx, Xxxxxxxxxxxx 00000
Telecopy: (000) 000-0000
Attention: Xxxxxx X. Xxxxxx, Esq.
Xxxx Centre
0000 Xxxx Xxxxxx
Xxxxxxxxxxxx, Xxxxxxxxxxxx 00000
Telecopy: (000) 000-0000
Attention: Xxxxxx X. Xxxxxx, Esq.
If to Seller, to:
HealthSouth Corporation
Xxx XxxxxxXxxxx Xxxxxxx
Xxxxxxxxxx, Xxxxxxx 00000
Telecopy: (000) 000-0000
Attention: General Counsel
Xxx XxxxxxXxxxx Xxxxxxx
Xxxxxxxxxx, Xxxxxxx 00000
Telecopy: (000) 000-0000
Attention: General Counsel
with a copy to:
Skadden, Arps, Slate, Xxxxxxx & Xxxx LLP
Xxx Xxxxxx Xxxxxx
Xxxxxxxxxx, Xxxxxxxx 00000
Xxx Xxxxxx Xxxxxx
Xxxxxxxxxx, Xxxxxxxx 00000
58
Telecopy: (000) 000-0000
Attention: Xxxxxx X. Xxxxxx, Esq.
Xxxxxxx X. Land, Esq.
Attention: Xxxxxx X. Xxxxxx, Esq.
Xxxxxxx X. Land, Esq.
12.4 Entire Agreement. This Agreement, the Ancillary Agreements, the Disclosure
Letter and the exhibits, schedules and other documents referred to herein which form a part hereof
(including the Confidentiality Agreement referred to in Section 5.2(b) hereof) contain the entire
understanding of the parties hereto with respect to the subject matter hereof and supersede all
prior oral or written agreements, understandings, statements or proposals; provided,
however, that if there is any conflict between the Confidentiality Agreement and this
Agreement, the terms of this Agreement shall govern. This Agreement supersedes all prior
agreements and understandings, oral and written, with respect to its subject matter.
12.5 Severability. Should any provision of this Agreement for any reason be declared
invalid or unenforceable, such decision shall not affect the validity or enforceability of any of
the other provisions of this Agreement, which other provisions shall remain in full force and
effect and the application of such invalid or unenforceable provision to Persons or circumstances
other than those as to which it is held invalid or unenforceable shall be valid and be enforced to
the fullest extent permitted by Law.
12.6 Binding Effect; Assignment. This Agreement and all of the provisions hereof
shall be binding upon and inure to the benefit of the parties hereto and their respective heirs,
executors, successors and permitted assigns, except that (a) other than as contemplated herein,
neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned,
directly or indirectly, by Seller or Buyer without the prior written consent of the other party
hereto; (b) the rights and obligations of Seller may be assigned to any of its wholly-owned
subsidiaries, which at the time of such assignment own the Shares, provided that no such assignment
shall limit or affect Seller’s obligations hereunder; and (c) the rights and obligations of Buyer
may be assigned to any of its wholly-owned Subsidiaries, provided that no such assignment shall
limit or affect Buyer’s obligations hereunder.
12.7 No Third-Party Beneficiaries. This Agreement is not intended and shall not be
deemed to confer upon or give any Person except the parties hereto and their respective successors
and permitted assigns any remedy, claim, liability, reimbursement, cause of action or other right
under or by reason of this Agreement (except as set forth in Article XI hereof with respect to
Buyer Indemnified Parties and Seller Indemnified Parties).
12.8 Counterparts. This Agreement may be executed in counterparts (including by
facsimile), each of which shall be deemed an original, but all of which together shall constitute
one and the same instrument.
12.9 Interpretation. The article and section headings contained in this Agreement are
solely for the purpose of reference, are not part of the agreement of the parties and shall not in
any way affect the meaning or interpretation of this Agreement. As used in this Agreement, the
term “including” shall mean including, without limitation, and, unless the context otherwise
requires, the word “or” is not exclusive. All references in this Agreement to “dollars” or “$”
shall mean United States dollars.
59
12.10 Forum; Service of Process. Except as set forth in Section 1.6 hereof, any legal
suit, action or proceeding brought by Seller or Buyer, or any of their respective Affiliates,
arising out of or based upon this Agreement shall be instituted in the courts of the State of
Delaware or the courts of the United States of America located in the State of Delaware
(collectively, the “Courts”), and each of Seller and Buyer (on its behalf and on behalf of such
Affiliates) waives any objection which it may now or hereafter have to the laying of venue of any
such proceeding, and irrevocably submits to the exclusive jurisdiction of the Courts in any such
suit, action or proceeding. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO A
TRIAL BY JURY IN ANY SUIT, ACTION OR PROCEEDING (INCLUDING ANY COUNTERCLAIM) ARISING OUT OF OR
BASED UPON THIS AGREEMENT.
12.11 Governing Law. This Agreement shall be governed by and construed in accordance
with the laws of the State of Delaware, without regard to the principles of conflicts of law
thereof (to the extent that the application of the laws of another jurisdiction would be required
thereby).
12.12 Specific Performance. Each party hereto acknowledges that money damages would
be both incalculable and an insufficient remedy for any breach of this Agreement by such party and
that any such breach would cause the other party hereto irreparable harm. Accordingly, each party
hereto also agrees that, in the event of any breach or threatened breach of the provisions of this
Agreement by such party, the other party hereto shall be entitled to equitable relief without the
requirement of posting a bond or other security, including in the form of injunctions and orders
for specific performance, in addition to all other remedies available to such other parties at law
or in equity. The provisions of this Section 12.12 shall not apply with regard to Section 5.11,
which shall be governed by the terms set forth therein.
12.13 Waivers. Except as otherwise provided herein, no action taken pursuant to this
Agreement, including any investigation by or on behalf of any party, shall be deemed to constitute
a waiver by the party taking such action of compliance with any representations, warranties,
covenants or agreements contained in this Agreement or in any of the Ancillary Agreements. Any
term, covenant or condition of this Agreement may be waived at any time by the party which is
entitled to the benefit thereof, but only by a written notice signed by such party expressly
waiving such term or condition. The waiver by any party hereto of a breach of any provision
hereunder shall not operate or be construed as a waiver of any prior or subsequent breach of the
same or any other provision hereunder.
12.14 Defined Terms.
“2005 Pro Forma Financial Information” shall have the meaning ascribed to such term in Section
3.7(c) hereof.
“2005 Segment Information” shall have the meaning ascribed to such term in Section 3.7(d)(i)
hereof.
“90% Lease Condition” shall mean the condition that outpatient rehabilitation clinics of the
Division for the nine months ended September 30, 2006 located at Real Properties
60
which are Consented Leases (excluding clinics that have negative EBITDA, without any allocation of corporate
overhead) is equal to or greater than ninety percent (90%) of the aggregate EBITDA of the
outpatient rehabilitation clinics that are
Required Consent Leases (excluding clinics that have negative EBITDA, without any allocation
of corporate overhead) for the nine months ended September 30, 2006.
“90% Payor Contract Condition” shall mean the condition that the aggregate revenues of the
Division for the nine months ended September 30, 2006 derived from third party payor contracts
which are Consented Third Party Payor Contracts or Non Required Consent Third Party Payor Contracts
is equal to or greater than ninety percent (90%) of the aggregate revenues of the Division derived
from all third party payor contracts for the nine months ended September 30, 2006.
“Accounting Arbiter” shall have the meaning ascribed to such term in Section 1.6(a)(iii)
hereof.
“Accounting Principles” shall have the meaning ascribed to such term in Section 1.6(a)(i)
hereof.
“Actual Closing Cash Balance” shall have the meaning ascribed to such term in Section
1.6(a)(ii) hereof.
“Actual Net Working Capital” shall have the meaning ascribed to such term in Section
1.6(a)(ii) hereof.
“Adjusted Grossed Up Basis” shall have the meaning ascribed to such term in Section
6.1(a)(iii) hereof.
“Affiliate” shall have the meaning ascribed to such term in Rule 12b-2 promulgated under the
Exchange Act.
“Affiliated Group” shall have the meaning ascribed to such term in Section 3.13(a)(i) hereof.
“Aggregate Deemed Sales Price” shall have the meaning ascribed to such term in Section
6.1(a)(iii) hereof.
“Agreement” shall have the meaning ascribed to such term in the Preamble hereto.
“Allocation” shall have the meaning ascribed to such term in Section 6.1(f) hereof.
“Allocation Dispute Notice” shall have the meaning ascribed to such term in Section 6.1(f)
hereof.
“Ancillary Agreements” shall have the meaning ascribed to such term in Section 2.1 hereof.
61
“Anti-Kickback Law” shall have the meaning ascribed to such term in Section 3.18(a) hereof.
“Applicable Buyer Plan” shall have the meaning ascribed to such term in Section 6.2(b) hereof.
“Audited Financial Statements” shall have the meaning ascribed to such term in Section 3.7(a)
hereof.
“Basket” shall have the meaning ascribed to such term in Section 11.3 hereof.
“Benefit Plans” shall mean each Pension Plan, Welfare Plan, and each other plan or written
arrangement or policy relating to stock options, stock purchases, compensation, deferred
compensation, severance, fringe benefits or other employee benefits, in each case maintained,
participated in or contributed to by any ERISA Affiliate for the benefit of any present or former
employees of the Company or any of the Division Entities.
“Business” shall have the meaning ascribed to such term in the Recitals hereto.
“Business Day” shall mean any day other than a Saturday, a Sunday or a day on which banks in
the City of New York are authorized or obligated by Law to close.
“Buyer” shall have the meaning ascribed to such term in the Preamble hereto.
“Buyer Claims” shall have the meaning ascribed to such term in Section 11.2 hereof.
“Buyer Indemnified Parties” shall have the meaning ascribed to such term in Section 11.2
hereof.
“Buyer Representatives” shall have the meaning ascribed to such term in Section 5.2(a) hereof.
“Capitalized Lease Indebtedness” shall have the meaning ascribed to such term within the
definition of “Indebtedness” in this Section 12.14.
“Cash” shall mean unrestricted cash, immediately available, held by the Company and any
Division Entity as of the Effective Time.
“Cash Adjustment Amount” shall have the meaning ascribed to such term in Section 1.6(a)(ii)
hereof.
“Cash Due to Minority Interest Holders” shall mean the aggregate amount of Cash due to
Minority Interest Holders in respect of accrued but unpaid Distributions payable as of the
Effective Time by Division Entities, whether or not declared.
“CIA” shall have the meaning ascribed thereto in Section 3.18(c) hereof.
“Closing” shall have the meaning ascribed to such term in Section 1.1 hereof.
62
“Closing Cash Balance” shall have the meaning ascribed to such term in Section 1.6(a)(i)
hereof.
“Closing Date” shall have the meaning ascribed to such term in Section 1.3 hereof.
“Code” shall mean the Internal Revenue Code of 1986, as amended.
“Company” shall have the meaning ascribed to such term in the Recitals hereto.
“Conclusive Statement” shall have the meaning ascribed to such term in Section 1.6(a)(v)
hereof.
“Confidentiality Agreement” shall have the meaning ascribed to such term in Section 5.2(b)
hereof.
“Consent” shall have the meaning ascribed to such term in Section 3.6(b) hereof.
“Consented Leases” shall mean a Required Consent Lease for which the lessor or landlord has,
prior to (or, for purposes of Section 11.2(h) hereof, after) Closing, consented in writing to the
transactions contemplated by this Agreement without any conditions that are adverse to the Division
and, as a result of such Consent, the Company or any Division Entity will have, from and after the
Closing (or, for purposes of Section 11.2(h) hereof, the date of such Consent), no lesser rights or
greater burdens under such lease as it had on the date hereof unaffected by the transactions
contemplated hereby, including the continued right to exercise all renewal options under such
lease.
“Consented Third Party Payor Contracts” shall mean a Required Consent Third Party Payor
Contract for which one of the following conditions has been met: (a) the third party payor has,
prior to (or, for purposes of Section 11.2(i) hereof, after) Closing, consented in writing to the
transactions contemplated by this Agreement without any conditions that are adverse to the Division
and, as a result of such Consent, the Company or any Division Entity will have, from and after the
Closing (or, for purposes of Section 11.2(i) hereof, the date of such Consent), a payor contract
with such third party payor on substantially the same terms as it had on the date hereof unaffected
by the transactions contemplated hereby; (b) if requested by Buyer (it being understood that Buyer
shall have no obligation hereunder to make such request), the third party payor has, prior to (or,
for purposes of Section 11.2(i) hereof, after) Closing, consented in writing to the inclusion of
the Division, to the extent covered in such Required Consent Third Party Payor Contract, within a
then-existing contract between Buyer and such third party payor; or (c) the Company or a Division
Entity has entered into a new contract with such third party payor with substantially the same
terms for the Division as the contract with such third party payor that exists as of the date
hereof.
“Consolidated Income Tax Return” shall have the meaning ascribed to such term in Section
6.1(b)(x) hereof.
“Contract” shall mean any contract, obligation, plan, undertaking, arrangement, commitment,
note, bond, mortgage, indenture, agreement, license, lease or other instrument.
63
“Courts” shall have the meaning ascribed to such term in Section 12.10 hereof.
“Damages” shall have the meaning ascribed to such term in Section 11.2 hereof.
“Deficiency Amount” shall have the meaning ascribed to such term in Section 1.6(a)(ii) hereof.
“Disclosure Letter” shall have the meaning ascribed to such term in Section 2.2(a) hereof.
“Disregarded Entity” shall have the meaning ascribed to such term in Section 6.1(a)(i) hereof.
“Distributions” shall mean the amount of any dividends or other distributions accrued by a
Division Entity during the calendar quarter in which the Effective Time occurs; provided,
however, that, for purposes of determining the amount of Cash Due to Minority Interest
Holders, the amount of Distributions shall be determined by multiplying (i) the total amount of
such dividends or other distributions that would be payable by a Division Entity to Seller or its
Affiliates in respect of the entire calendar quarter in which the Effective Time occurs by (ii) a
fraction, the numerator of which is the number of days in such calendar quarter that have elapsed
up to and including the Effective Time, and the denominator of which is the total number of days in
such calendar quarter.
“Division” shall have the meaning ascribed to such term in the Recitals hereto.
“Division Entities” shall have the meaning ascribed to such term in the Recitals hereto.
“Division Offerees” shall have the meaning ascribed to such term in Section 6.2(a) hereof.
“DOJ” shall have the meaning ascribed to such term in Section 5.5 hereof.
“DRE Sales” shall have the meaning ascribed to such term in Section 6.1(a)(v) hereof.
“Earn-Out Indebtedness” shall have the meaning ascribed to such term within the definition of
“Indebtedness” in this Section 12.14.
“EBITDA” shall mean for any Person the net income before interest, taxes, depreciation and
amortization of such Person.
“Effective Time” shall have the meaning ascribed to such term in Section 1.3 hereof.
“Election” shall have the meaning ascribed to such term in Section 6.1(a)(i) hereof.
64
“Enterprise Systems” shall have the meaning ascribed to such term in Section 6.6 hereof.
“Environmental Law” shall mean any Law or common law relating to pollution, Hazardous
Substances or the protection of the environment, human health or safety;
“ERISA” shall mean the Employee Retirement Income Security Act of 1974, as amended and the
regulations promulgated thereunder.
“ERISA Affiliate” shall mean the Company or any other Person or entity that, together with
Seller, is, or at any time for which any relevant statute of limitations remaining open, was,
treated as a single employer under Section 414(b), (c), (m) or (o) of the Code.
“Estimated Closing Cash Balance” shall have the meaning ascribed to such term in Section
1.6(a)(i) hereof.
“Estimated Net Working Capital” shall have the meaning ascribed to such term in Section
1.6(a)(i) hereof.
“Estimated Net Working Capital Adjustment” shall have the meaning ascribed to such term in
Section 1.2 hereof.
“Excess Amount” shall have the meaning ascribed to such term in Section 1.6(a)(ii) hereof.
“Excess Restructuring Costs” shall have the meaning ascribed to such term in Section 2.4(b)
hereof.
“Exchange Act” shall have the meaning ascribed to such term in Section 3.6(b) hereof.
“Excluded Assets” shall have the meaning ascribed to such term in Section 2.4(b) hereof.
“Excluded Representations” shall have the meaning ascribed to such term in Section 11.3
hereof.
“Facilities” shall mean the outpatient rehabilitation facilities owned and operated by the
Division.
“Federal Health Care Programs” shall have the meaning ascribed to such term in Section
3.18(a) hereof.
“Filing” shall have the meaning ascribed to such term in Section 3.6(b) hereof.
“Final Allocation” shall have the meaning ascribed to such term in Section 6.1(f) hereof.
65
“Form 8023” shall have the meaning ascribed to such term in Section 6.1(a)(ii) hereof.
“FTC” shall have the meaning ascribed to such term in Section 5.5 hereof.
“GAAP” means U.S. generally accepted accounting principles, consistently applied throughout
the periods presented.
“Going Clinics” shall have the meaning ascribed to such term in Section 2.4(a) hereof.
“Good Faith Statement” shall have the meaning ascribed to such term in Section 1.6(a)(i)
hereof.
“Governmental Entity” shall have the meaning ascribed to such term in Section 3.6(b) hereof.
“Guaranties” shall have the meaning ascribed to such term in Section 2.5 hereof.
“Hazardous Substances” shall mean any hazardous or toxic substance, material or waste,
pollutant or contaminant, including, without limitation, any petroleum product or by-product,
asbestos-containing material, lead-containing paint or plumbing, polychlorinated biphenyls,
radioactive material, medical waste, infectious waste, mold or radon;
“Health Care Related Liabilities” shall mean any liabilities or obligations of the Division to
the extent arising from events or circumstances, or acts or omissions, which occur prior to the
Closing and which constitute an actual or alleged violation of the Xxxxx, Anti-Kickback or False
Claims Act Laws, or of any other statutes, rules, regulations regarding any Federal Health Care
Programs including, without limitation, alleged improper billing or coding activities, billing for
services that are not medically necessary or provided, fraud or abuse, criminal activity or fee
splitting or with respect to any document filed or to be filed by Seller or any claim made in
connection with any Federal Health Care Program or third party payor.
“HIPAA” shall have the meaning ascribed to such term in Section 3.18(a) hereof.
“HSR Act” shall have the meaning ascribed to such term in Section 3.6(b) hereof.
“Indebtedness” of any Person at any date means: (a) all indebtedness of such Person for
borrowed money or for the deferred purchase price of property or services, other than trade
liabilities and accrued expenses, including any interest and premiums and the earned portion of any
so-called “earn-out” obligations, including those listed
in Section 12.14(i) of the Disclosure Letter (the “Earn-Out Indebtedness”); (b) any other
indebtedness of such Person that is evidenced by a note, bond, debenture or similar instrument; (c)
all obligations of such Person under capitalized leases (“Capitalized Lease Indebtedness”); (d) all
liabilities secured by any Lien on any property owned by such Person even though such Person has
not assumed or otherwise become liable for the payment thereof; (e) any other long-term liabilities
as determined in accordance with GAAP; (f) all indebtedness created or arising under any
conditional sale or other title retention agreement with respect to acquired property; (g) all
66
reimbursement obligations, contingent or otherwise, under a drawn acceptance, letter of credit or
similar facility; (h) obligations with respect to any interest rate or currency, hedging, swap or
similar agreement; (i) any obligation classified as a refund due patients and other third-party
payors in the Audited Financial Statements, other than those reflected in account 2512; and (j)
direct or indirect guarantees of any of the foregoing for the benefit of another Person.
“Independent Accounting Firm” shall have the meaning ascribed to such term in Section
6.1(a)(ii) hereof.
“Initial Purchase Price” shall have the meaning ascribed to such term in Section 1.2 hereof.
“Intellectual Property Rights” shall have the meaning ascribed to such term in Section 3.10(a)
hereof.
“Intercompany Agreements” shall have the meaning ascribed to such term in Section 2.2(a)
hereof.
“Interest Rate” shall mean the rate of interest published as the “Prime Rate” in the “Money
Rates” column of the Eastern Edition of The Wall Street Journal calculated on the basis of a
365-day year and charged for the actual number of days elapsed.
“Interim Pro Forma Income Statement” shall have the meaning ascribed to such term in Section
3.7(b) hereof.
“Interim Segment Information” shall have the meaning ascribed to such term in Section
3.7(d)(iii) hereof.
“IT Systems” shall have the meaning ascribed to such term in Section 3.10(c) hereof.
“Knowledge of Seller” or “Seller’s Knowledge” shall mean the actual knowledge of Xxx Xxxxxxx,
Xxxx X. Xxxxxxx, Xxxxxxx X. Xxxx, Xxxxx X. Xxxxxx, Xxxxx XxXxxxxxx, Xxxx Xxxxxx, Xxx Xxxxxx, Xxxx
X. Xxxxxxxxxxx and Xxxxx Xxxxx.
“Law” shall mean shall mean any federal, state, county, municipal, local or foreign statute,
ordinance, rule, regulation, law, judgment, order, decree, injunction or other authorization.
“Leased Real Property” shall have the meaning ascribed to such term in Section 3.9 hereof.
“Liens” shall have the meaning ascribed to such term in Section 1.1 hereof.
“Litigation” shall have the meaning ascribed to such term in Section 3.11(a) hereof.
67
“Material Adverse Effect” shall mean a material adverse effect on the business, assets,
liabilities, results of operations or financial condition of the Company and the Division Entities,
taken as a whole, or on the ability of Seller to perform its obligations hereunder or consummate
the transactions contemplated by this Agreement; provided, however, that none of
the following shall be taken into account in determining whether a Material Adverse Effect has
occurred: (a) any adverse change, effect, event, occurrence, state of facts or development to the
extent attributable to this Agreement or the announcement or pendency of the transactions
contemplated by this Agreement (including any reduction in revenues, any disruption in supplier,
distributor, partner or similar relationships or any loss of employees); (b) any adverse change,
effect, event, occurrence, state of facts or development to the extent attributable to Buyer’s
announcement or other disclosure of its plans or intentions with respect to the operation of the
Division (or any portion thereof); (c) changes or conditions, including changes in the economy,
financial markets, or political conditions, whether resulting from acts of terrorism or war or
otherwise, affecting the U.S. economy generally or the industry in which the Division operates
(except to the extent such changes have a disproportionate impact on the Division, taken as a
whole, relevant to other companies in the industries and geographic markets where the Division
conducts business); (d) any adverse change, effect, event, occurrence, state of facts or
development resulting from the taking of any action by Seller required by, or the failure to take
any action by Seller prohibited by, this Agreement (including any reduction in revenues, any
disruption in supplier, distributor, partner or similar relationships or any loss of employees);
(e) any failure by the Division to meet projections or forecasts (provided that the underlying
cause of such failure may be considered in determining whether there is a Material Adverse Effect);
(f) any change after the date hereof in accounting requirements or principles required by GAAP or
required by any change in applicable Laws and any restatement of the Division’s financial
statements as a result thereof or public announcement related thereto; or (g) any adverse change,
effect, event, occurrence, state of facts or development attributable or relating to transaction
expenses incurred in connection with the transactions contemplated by this Agreement.
“Material Contracts” shall have the meaning ascribed to such term in Section 3.14(a) hereof.
“Minority Interest Holders” shall mean holders of capital stock or other equity interests in
the Division Entities other than Seller and its Subsidiaries.
“Net Working Capital” shall have the meaning ascribed to such term in Section 1.6(a)(i)
hereof.
“Net Working Capital Adjustment Amount” shall have the meaning ascribed to such term in
Section 1.6(a)(ii) hereof.
“Non Required Consent Third Party Payor Contract” means those third party payor contracts
that, without giving effect to the reference to “Material Adverse Effect” in the last sentence of
Section 3.6(b) hereof, would not be required to be listed in Section 3.6(b) of the Disclosure
Letter.
“Notice of Disagreement” shall have the meaning ascribed to such term in Section 1.6(a)(iii)
hereof.
68
“Pension Plan” shall mean each employee pension benefit plan as defined in Section 3(2) of
ERISA.
“Permits” shall have the meaning ascribed to such term in Section 3.15(b) hereof.
“Permitted Liens” shall mean (i) statutory material mechanics’, carriers’, workmen’s,
repairmen’s or similar Liens arising or incurred in the ordinary course of business with respect to
liabilities that are not yet due or delinquent, (ii) ordinary course Liens for Taxes, assessments
and other governmental charges which are not due and payable or which may hereafter be paid without
penalty and for which adequate reserves have been made in the 2005 Pro Forma Financial Information,
and (iii) in the case of Real Property, (A) immaterial imperfections of title or encumbrances, (B)
easements, covenants, rights-of-way and other encumbrances or restrictions of record, (C) zoning,
building and other similar restrictions, (D) Liens that have been placed by any developer, landlord
or other third party on any leased property and (E) unrecorded easements, covenants, rights of way
or other restrictions, none of which items materially impair the use of the property to which they
relate to the operation of the Division as operated on the date hereof.
“Person” shall mean and include an individual, a partnership, a joint venture, a corporation,
a trust, a limited liability company, an unincorporated organization and a government or any
department or agency thereof.
“Post-Closing Taxes” shall have the meaning ascribed to such term in Section 6.1(b)(iv)
hereof.
“Pre-Closing Taxes” shall have the meaning ascribed to such term in Section 6.1(b)(iv) hereof.
“Pre-Closing Transactions” shall have the meaning ascribed to such term in Section 5.9(b)
hereof.
“Purchase Price” shall have the meaning ascribed to such term in Section 1.6(b) hereof.
“Real Property” shall have the meaning ascribed to such term in Section 3.9 hereof.
“Records” shall have the meaning ascribed to such term in Section 5.9(a) hereof.
“Release” shall mean any release, deposit, discharge, emission, leaking, leaching, spilling,
seeping, migrating, injecting, pumping, pouring, emptying, escaping, dumping, disposal or other
movement of Hazardous Substances.
“Replacement Lease” shall have the meaning ascribed to such term in Section 2.4(c) hereof.
69
“Required Consent Lease” means those leases and subleases for Real Property that, without
giving effect to the reference to “Material Adverse Effect” in the last sentence of Section 3.6(b)
hereof, would be required to be listed in Section 3.6(b) of the Disclosure Letter.
“Required Consent Third Party Payor Contract” means the third party payor contracts that,
without giving effect to the reference to “Material Adverse Effect” in the last sentence of Section
3.6(b) hereof, would be required to be listed in Section 3.6(b) of the Disclosure Letter.
“Restricted Territory” shall mean the area within a twenty (20) mile radius of any location
where a Facility is owned or operated as of the Closing Date.
“Restructuring Agreements” shall have the meaning ascribed to such term in Section 2.4(b)
hereof.
“Restructuring Transactions” shall have the meaning ascribed to such term in Section 2.4(b)
hereof.
“Retained Liabilities” shall mean (i) any liabilities or obligations of Seller, the Company or
the Division for any severance pay, stay bonuses, stock options or other equity incentives,
retention plans, sale or other bonuses contingent upon the consummation of the transactions
contemplated hereunder or any similar arrangements except as set forth in Section 6.2(g) hereof,
and (ii) any and all liabilities or obligations of the Division to the extent arising from events
or circumstances, or relating to acts or omissions, which occur prior to the Closing and that are
normally covered by any commercial general liability, automobile, workers’ compensation, property
and casualty, professional malpractice, employer liability, health benefit or other insurance
policy or are covered by any self-insurance retention of Seller, other than any liabilities or
obligations to the extent reflected as a liability in Actual Net Working Capital.
“Retained Litigation” shall have the meaning ascribed to such term in Section 5.9(b) hereof.
“SEC” shall have the meaning ascribed to such term in Section 5.10 hereof.
“Seller” shall have the meaning ascribed to such term in the Preamble hereto.
“Seller Claims” shall have the meaning ascribed to such term in Section 11.4 hereof.
“Seller Indemnified Parties” shall have the meaning ascribed to such term in Section 11.4
hereof.
“Seller Outpatient Employee” shall have the meaning ascribed to such term in Section
5.11(b)(i) hereof.
“Seller Returns” shall have the meaning ascribed to such term in Section 6.1(b)(i) hereof.
70
“Seller’s Trademarks and Logos” shall have the meaning ascribed to such term in Section 6.4
hereof.
“September 30 Form 10-Q” shall have the meaning ascribed to such term in Section 3.7(b)
hereof.
“Severance Policy” shall have the meaning ascribed to such term in Section 6.2(a) hereof.
“Shares” shall have the meaning ascribed to such term in the Recitals hereto.
“Xxxxx Law” shall have the meaning ascribed to such term in Section 3.18(a) hereof.
“Statement” shall have the meaning ascribed to such term in Section 1.6(a)(ii) hereof.
“Staying Clinics” shall have the meaning ascribed to such term in Section 2.4(b) hereof.
“Straddle Period Returns” shall have the meaning ascribed to such term in Section 6.1(b)(ii)
hereof.
“Straddle Statement” shall have the meaning ascribed to such term in Section 6.1(b)(ii)
hereof.
“Subsidiary” means with respect to a specified Person, any other Person of which (i) a
majority of the voting power of the voting equity securities or equity interests is owned, directly
or indirectly, by such specified Person or (ii) the general partner, manager or other entity
governing such other Person is controlled by such specified Person.
“Subsidiary Shares” shall have the meaning ascribed to such term in Section 3.2 hereof.
“Target Net Working Capital” means Twenty-Seven Million One Hundred Twenty-Four Thousand
Dollars ($27,124,000), such
amount having been calculated in accordance with the calculation of Net Working Capital set
forth on Schedule II attached hereto.
“Tax” or “Taxes” shall have the meaning ascribed to such term in Section 3.13(c) hereof.
“Tax Benefit” shall have the meaning ascribed to such term in Section 11.8(c) hereof.
“Tax Indemnified Party” shall have the meaning ascribed to such term in Section 6.1(c)(v)
hereof.
71
“Tax Indemnifying Party” shall have the meaning ascribed to such term in Section 6.1(c)(v)
hereof.
“Tax Return” shall have the meaning ascribed to such term in Section 3.13(c) hereof.
“Tax Third-Party Claim” shall have the meaning ascribed to such term in Section 6.1(c)(v)
hereof.
“Termination Date” shall have the meaning ascribed to such term in Section 10.1(b) hereof.
“Third-Party Claims” shall have the meaning ascribed to such term in Section 11.6 hereof.
“Transfer Taxes” shall have the meaning ascribed to such term in Section 6.1(d) hereof.
“Transferred Employees” shall have the meaning ascribed to such term in Section 6.2(a) hereof.
“Transition Agreement” shall have the meaning ascribed to such term in Section 2.1(a) hereof.
“Transition Date” shall have the meaning ascribed to such term in Section 5.9(c) hereof.
“Unadjusted Purchase Price” shall have the meaning ascribed to such term in Section 1.2
hereof.
“Unrelated Liabilities” shall mean any obligation or liability of Seller or its Affiliates
(including the Company or a Division Entity) to the extent such obligation or liability does not
arise out of or relate to the Business of the Division to be sold to Buyer hereunder. For the
avoidance of doubt, Unrelated Liabilities shall include any liabilities assumed by Seller or any of
its Affiliates as part of the Restructuring Transactions or that relate to any Excluded Assets or
the Staying Clinics.
“Welfare Plan” shall mean each employee welfare benefit plan as defined in Section 3(1) of
ERISA.
“Wind-down Period” shall have the meaning ascribed to such term in Section 6.4 hereof.
[SIGNATURE PAGE FOLLOWS]
72
IN WITNESS WHEREOF, the parties hereto have executed this Stock Purchase Agreement as of the
day and year first above written.
HEALTHSOUTH CORPORATION |
||||
By: | /s/ Xxx Xxxxxxx | |||
Name: | Xxx Xxxxxxx | |||
Title: | President and Chief Executive Officer | |||
SELECT MEDICAL CORPORATION |
||||
By: | /s/ Xxxxxx X. Xxxxxxxx | |||
Name: | Xxxxxx X. Xxxxxxxx | |||
Title: | Chief Executive Officer | |||